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Abstract

Excess macronutrient intake leads to an increase in formation of reactive oxygen species (ROS).
This causes an imbalance between ROS generation and the ability of the body to neutralize these
radicals, a state known as oxidative stress. Previous research suggests the ability of dairy
products to attenuate the postprandial response, which may reduce ROS formation. Therefore,
this study aimed to elucidate the impact of low-fat yogurt consumption on fasting and
postprandial oxidative stress in obese women.
We hypothesized that co-consumption of low-fat yogurt and a high-calorie, high-fat meal would
reduce postprandial elevations in oxidative stress in obese women. To test this hypothesis,
healthy, lean and obese women co-consumed low-fat yogurt or soy pudding (control) and a highcalorie, high-fat meal on 2 occasions separated by 9-week daily yogurt or pudding consumption.
Postprandial blood samples were collected for 4 h during meal challenges and fasting samples
were collected at 3 week intervals throughout the duration of the intervention. Fasting and
postprandial plasma samples were analyzed for malondialdehyde (MDA), total thiols (SH), and
advanced glycation endproducts (AGEs). A secondary aim of this work was to classify changes
in dietary intake associated with the intervention; data was based on 3-day self-reported dietary
records.
Low-fat yogurt consumption did not lead to changes in BMI, waist circumference, or blood
pressure. Consumption of low-fat yogurt attenuated postprandial increases in MDA in obese
women at both the initial and final meal challenges. However, 9-week yogurt consumption did
not further attenuate the postprandial response and had no effect on fasting MDA concentrations
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in obese women. Yogurt and pudding prevented postprandial changes in SH and AGEs, while
chronic plasma SH and AGEs were unaffected by 9-week yogurt or soy pudding intake. Daily
consumption of low-fat yogurt and soy pudding increased calcium and vitamin D intake and
yogurt increased dairy intake in lean and obese women. Therefore, the addition of low-fat yogurt
to the diet may be a strategy to increase dairy, calcium, and vitamin D intake without inducing
any unfavorable changes in body composition, blood pressure, and postprandial or chronic levels
of oxidative stress.
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Introduction

Epidemiological studies support an association between optimal dairy intake and beneficial
health outcomes, including favorable changes in body composition and blood pressure, and
reduced incidence of certain metabolic diseases. Among obese individuals, regular dairy
consumption is also linked to reductions in biomarkers of oxidative stress and inflammation [13]. Obesity is associated with increased levels of oxidative stress and the presence of chronic,
low-level systemic inflammation, both of which play crucial roles in the development of many
chronic diseases, including cardiovascular disease (CVD) [4-6]. Therefore, regular intake of
dairy products may attenuate development of these diseases.
Increasingly, atherosclerosis is considered to be a postprandial phenomenon; postprandial
elevations in plasma glucose and triglycerides, as well as increases in oxidative stress and
inflammation, are considered more accurate markers of future cardiovascular risk than are
fasting levels of these biomarkers [7]. Postprandial hyperglycemia, hypertriglyceridemia,
oxidative stress, and inflammation can be induced even in healthy individuals by consumption of
a high-calorie, high-fat meal, which are common components of the Western diet [6-9]. Excess
energy intake overwhelms the metabolic and endogenous antioxidant systems, leading to
increased generation of reactive oxygen species (ROS) and reduced ability to neutralize these
harmful species [8]. This imbalance between generation and quenching of ROS is known as
oxidative stress [10].
The consequences of postprandial oxidative stress include the oxidation of lipids, proteins, and
nucleic acids by ROS [10, 11]. Malondialdehyde (MDA) is a product of polyunsaturated fatty
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acid oxidation and is a biomarker for lipid peroxidation [10, 12, 13]. Plasma thiols, including
glutathione, cysteine, and methionine, are easily oxidized by ROS [11]. Decreases in plasma
total thiols (SH) may therefore be a biomarker for oxidative damage [14, 15]. In addition, excess
carbohydrate intake results in hyperglycemia, which leads to an increase in the formation of
advanced glycation endproducts (AGEs) – aldehyde-adducted lipids, proteins, or nucleic acids
[16]. Therefore, plasma AGEs are a biomarker for elevated blood glucose. Postprandial increases
in ROS may also trigger postprandial increases in the inflammatory response [17].
Previous research suggests that the postprandial response to a high-calorie, high-fat meal may be
modified by co-consumption of certain foods. For example, orange juice favorably impacted the
postprandial inflammatory response as well as biomarkers of oxidative stress in healthy
individuals [18]. Calcium, protein, and low-fat milk have also been examined and found to
attenuate the postprandial glucose and lipid responses [19, 20]. In addition to calcium and
protein, low-fat yogurt also contains whey, casein, vitamin D and probiotics, all of which are
known to have beneficial impacts on health. In particular, average intake of calcium and vitamin
D is below recommendations for many women [21]. Therefore, regular consumption of low-fat
yogurt may decrease baseline levels of oxidative stress while increasing calcium and vitamin D
intake in obese women. Co-consumption of low-fat yogurt with a high-calorie, high-fat meal
may also attenuate postprandial increases in oxidative stress in obese women. This research aims
to examine these outcomes.
The study population consists of healthy, lean (BMI 18.5-27 kg/m2; n = 66) and obese (BMI 3040 kg/m2; n = 66), premenopausal women between the ages of 21 and 55. The primary outcome
of this research is to examine the impacts of low-fat yogurt intake on intestinal barrier function
and inflammation. The secondary outcomes of this research are to examine the impacts of low4

fat yogurt consumption on postprandial and chronic oxidative stress. These secondary outcomes
are the focus of the upcoming chapters; my colleagues will elaborate upon the acute and chronic
impacts of yogurt consumption on intestinal barrier function and inflammation at a later date.
The primary hypothesis for this study is that co-consumption of low-fat yogurt with a highcalorie, high-fat meal will reduce postprandial inflammation in obese women and, to a lesser
extent, in lean women by improving intestinal barrier function. Additionally, sustained
consumption of low-fat yogurt will reduce chronic inflammation in obese women and will
further attenuate the postprandial inflammatory response. These modulations will also be
observed to a lesser degree in lean women. Reductions in intestinal barrier dysfunction and
systemic inflammation will be evident by suppression of fasting levels of and postprandial
increases in lipopolysaccharide (LPS), LPS-binding protein (LBP), and soluble CD14 (sCD14),
as well as the expression of certain pro-inflammatory cytokines.
The secondary hypothesis for this study is that co-consumption of low-fat yogurt with a highcalorie, high-fat meal will reduce postprandial oxidative stress in obese women. In addition,
sustained intake of low-fat yogurt will reduce fasting levels of oxidative stress and will further
attenuate the postprandial oxidative response in obese women. This will be evident by reductions
in MDA and AGEs and increases in plasma SH. Lastly, intake of dairy products, calcium, and
vitamin D will be significantly increased by daily yogurt consumption. However, because this
intervention aims to maintain an isocaloric diet, changes in calorie, carbohydrate, fat, and protein
intake are expected to be negligible.

5

References
[1] Stancliffe, R. A., Thorpe, T., Zemel, M. B., Dairy attentuates oxidative and inflammatory
stress in metabolic syndrome. Am J Clin Nutr 2011, 94, 422-430.
[2] Zemel, M. B., Sun, X., Sobhani, T., Wilson, B., Effects of dairy compared with soy on
oxidative and inflammatory stress in overweight and obese subjects. Am J Clin Nutr 2009, 91,
16-22.
[3] Panagiotakos, D. B., Pitsavos, C. H., Zampelas, A. D., Chrysohoou, C. A., Stefanadis, C. I.,
Dairy products consumption is associated with decreased levels of inflammatory markers related
to cardiovascular disease in apparently healthy adults: the ATTICA study. J Am Coll Nutr 2010,
29, 357-364.
[4] Calder, P. C., Ahluwalia, N., Albers, R., Bosco, N., et al., A consideration of biomarkers to
be used for evaluation of inflammation in human nutritional studies. Br J Nutr 2013, 109 Suppl
1, S1-34.
[5] Zemel, M. B., Sun, X., Dietary calcium and dairy products modulate oxidative and
inflammatory stress in mice and humans. J Nutr 2008, 138, 1047-1052.
[6] Droge, W., Free radicals in the physiological control of cell function. Physiol Rev 2002, 82,
47-95.
[7] Miglio, C., Peluso, I., Raguzzini, A., Villano, D. V., et al., Antioxidant and inflammatory
response following high-fat meal consumption in overweight subjects. Eur J Nutr 2013, 52,
1107-1114.
[8] O'Keefe, J. H., Gheewala, N. M., O'Keefe, J. O., Dietary strategies for improving postprandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 2008, 51,
249-255.
[9] Sanders, T. A., Dietary fat and postprandial lipids. Curr Atheroscler Rep 2003, 5, 445-451.
[10] Bowen, P. E., Borthakur, G., Postprandial lipid oxidation and cardiovascular disease risk.
Curr Atheroscler Rep 2004, 6, 477-484.
[11] Ashfaq, S., Abramson, J. L., Jones, D. P., Rhodes, S. D., et al., The relationship between
plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am
Coll Cardiol 2006, 47, 1005-1011.
[12] Draper, H. H., Hadley, M., Malondialdehyde determination as index of lipid peroxidation.
Methods Enzymol 1990, 186, 421-431.
[13] Lykkesfeldt, J., Determination of malondialdehyde as dithiobarbituric acid adduct in
biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible
spectrophotometry. Clin Chem 2001, 47, 1725-1727.

6

[14] Muttigi, M. S., Kedage, V., Suvarna, R., Rao, S. S., et al., Serum GST Activity and Total
thiols Status in Patients with Liver Disease Secondary to Various Disorders. The Open
Hepatology Journal 2009, 1, 5-8.
[15] Hu, M. L., Measurement of protein thiol groups and glutathione in plasma. Methods
Enzymol 1994, 233, 380-385.
[16] Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., et al., Advanced
glycation endproducts in food and their effects on health. Food Chem Toxicol 2013, 60, 10-37.
[17] Sies, H., Stahl, W., Sevanian, A., Nutritional, dietary and postprandial oxidative stress. J
Nutr 2005, 135, 969-972.
[18] Ghanim, H., Sia, C. L., Upadhyay, M., Korzeniewski, K., et al., Orange juice neutralizes the
proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase
and Toll-like receptor expression. Am J Clin Nutr 2010, 91, 940-949.
[19] van Meijl, L. E., Mensink, R. P., Effects of milk and milk constituents on postprandial lipid
and glucose metabolism in overweight and obese men. Br J Nutr 2013, 110, 413-419.
[20] Ballard, K. D., Mah, E., Guo, Y., Pei, R., et al., Low-fat milk ingestion prevents
postprandial hyperglycemia-mediated impairments in vascular endothelial function in obese
individuals with metabolic syndrome. J Nutr 2013, 143, 1602-1610.
[21] Ross, A. C., The 2011 report on dietary reference intakes for calcium and vitamin D. Public
Health Nutr 2011, 14, 938-939.

7

Chapter 1:
Literature Review
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1.1 Background
Cardiovascular disease (CVD) is the leading cause of death in the United States, responsible for
an estimated 1 in 3 fatalities [1]. Overweight and obesity are associated with marked increases in
the prevalence of CVD and its associated complications [1]. The current obesity rate among
adults in the United States is close to 35%, with the combined rate of overweight and obesity
nearing 70% [1]. Obesity is also closely associated with a myriad of metabolic disruptions,
including insulin resistance and/or diabetes, hyperglycemia, hyperlipidemia,
hypercholesterolemia, and hypertension [1-3]. Together, elevated fasting triglycerides, fasting
glucose, blood pressure, waist circumference, and low HDL cholesterol form the criteria for
metabolic syndrome, a chronic state characterized by the presence of any 3 of these 5 conditions
[2]. Most often, obesity is the main factor in the development of metabolic syndrome [4].
Though there are many drugs and medical interventions designed to modulate these conditions,
treatments are not without side effects and often present serious complications [5]. Therefore,
dietary means of reducing the negative health outcomes associated with obesity are of utmost
importance. One approach is weight loss; however, this is often an unsuccessful endeavor. A
complementary approach is to examine the ability of certain foods to reduce the occurrence of
the metabolic changes associated with obesity and the development of atherosclerosis, thus
reducing future CVD risk.
The hypothesis that the development of atherosclerosis is a postprandial phenomenon has gained
greater acceptance in recent years [6]. The postprandial period is the period following nutrient
intake during which changes occur in the body that enable it to metabolize, transport, and store
these nutrients. The postprandial period may last up to 8 h following consumption of a meal and
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encompasses changes such as increases in metabolic processes, blood glucose and triglycerides,
and oxidative and inflammatory stress [7]. Postprandial dysmetabolism is characterized by
above-normal increments of these changes and is an independent risk factor for future
cardiovascular events [8]. Postprandial dysmetabolism is often seen in obese individuals;
however, it can be induced, even in healthy individuals, by consumption of a high calorie and/or
high-fat meal [6, 9]. This is crucial because postprandial glucose and triglyceride concentrations
are more closely associated with risk of CVD and coronary events than are fasting values [6, 10].
Also of concern for individuals who consume a Western diet is the fact that the majority of the
day is spent in the postprandial state [11]. In many cases, the effects of the previous meal have
not subsided by the time the next is consumed, resulting in a sustained postprandial period. For
individuals with postprandial dysmetabolism, this translates to extended periods of time in which
the body is exposed to these unfavorable metabolic changes. Therefore, strategies to attenuate
postprandial dysmetabolism are potentially beneficial for reduction of CVD risk.

1.2 Inflammation
Acute inflammation is a component of the body’s natural response to injury, pathogens, or other
undue stress [12]. Initiation of inflammation involves the activation of toll-like receptor (TLR)
signaling, activation of the pro-inflammatory gene transcription factor nuclear factor B
(NF-κB), and endoplasmic reticulum stress. The result is an increase in the synthesis and release
of pro-inflammatory cytokines, including tumor necrosis factor α (TNFα), interleukin 6 (IL-6),
interleukin 1β (IL-1β), the chemokine monocyte chemoattractant protein-1 (MCP-1), and Creactive protein (CRP), an acute-phase reactant synthesized by the liver in response to increased
10

IL-6 production [12]. Once the injury is healed or the pathogen eliminated, the pro-inflammatory
pathways are inhibited and the inflammation is reduced. This is known as acute inflammation.
Chronic inflammation is defined as sustained, low-level inflammation and is now known to be a
component of many metabolic diseases [12, 13]. Certain autoimmune diseases, as well as
conditions involving sustained tissue injury, are contributing factors. In addition, chronic
inflammation is associated with obesity, as adipocytes are main contributors to cytokine
production [13]. Indeed, macrophage infiltration into adipose leads to release of proinflammatory cytokines, which contribute not only to inflammation but also to obesity-associated
insulin resistance via modification of the insulin receptor signaling pathway [12]. While some
cytokines act locally to recruit leukocytes and other inflammatory mediators to the site of the
injury or to the adipose, others may enter into systemic circulation, causing inflammatory
changes elsewhere in the body [12].
Inflammation can also be induced in the postprandial period as a result of energy intake [8, 14].
Excess macronutrient intake leads to an increase in free-radical generation; these species are
natural byproducts of carbohydrate and lipid metabolism which, in high amounts, can damage
cells and tissues, eliciting an immune response to repair the damage [15]. This postprandial
inflammation may contribute to chronic inflammation [12]. In addition, high-calorie, high-fat
meals challenge the intestine and may compromise intestinal barrier function [16]. Studies
support an association between intestinal barrier dysfunction and inflammation; therefore, highcalorie, high-fat meals may induce intestinal barrier-mediated inflammation [16].
Obesity is also associated with reduced integrity of the intestinal barrier, though the mechanisms
involved remain unclear. Perhaps obesity-associated intestinal barrier dysfunction occurs due to
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the constant stress of consuming excess calories and/or fat. Alternatively, obesity is known to be
associated with an altered intestinal bacterial profile [17]. As these microbes contribute to the
intestinal immune response, obesity-associated changes in the microbiota may lead to reductions
in these normal protective mechanisms [18]. It is also possible that alterations in intestinal
microbiota are a causal factor in the development of obesity [19]. Clearly much remains
unknown in this area of research.
Regardless of the cause, disruptions in intestinal barrier function lead to increased translocation
of lipopolysaccharide (LPS) into the bloodstream. LPS is a component of the membranes of
Gram-negative bacteria and elicits a strong immune response [18, 20]. It is always present in the
gut microbiota but is not typically absorbed into the bloodstream [21]. However, in cases of
compromised intestinal barrier function, the integrity of tight junctions may be compromised,
allowing LPS to be absorbed paracellularly [20, 21]. LPS is also incorporated into chylomicrons;
thus, a meal high in fat may facilitate LPS uptake [20, 21]. In addition, a chronic high-fat diet has
been shown to alter the intestinal microbiota, in particular by reducing the presence of
Bifidobacterium spp [21]. Bifidobacteria may act to improve intestinal barrier function and are
inversely associated with plasma LPS in mice [16]. Therefore, a chronic high-fat diet may
increase intestinal permeability by both acute and chronic mechanisms [16, 21].
Once in the bloodstream, LPS elicits a strong immune response. This begins with the association
of LPS with LPS-binding protein (LBP), which transports LPS to the CD14/MD-2/TLR4
receptor complex on the surface of macrophages and myeloid cells [18, 22]. LPS binding triggers
a pro-inflammatory cascade that ultimately results in increased NF-κB expression, promoting
inflammation [20].
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Reductions of postprandial and chronic intestinal barrier dysfunction can be assessed by
measuring expression of LPS, LBP, NF-κB, and certain pro-inflammatory cytokines, including
IL-6 and TNFα. In addition, CD14 expression may be indicative of changes in intestinal barrier
function. CD14 is a membrane-bound protein; however, it also exists in a soluble form (sCD14),
which is expressed in many cells, including hepatocytes and adipocytes [18, 22]. sCD14 is
present in plasma due to secretion from cells or by cleavage of membrane-bound CD14 derived
from macrophages [18]. sCD14 is thought to be a protective mechanism, competing with CD14
for LPS binding and acting to prevent LPS-CD14 triggered inflammation [22]. Therefore,
increased sCD14 expression is indicative of increased LPS exposure.

1.3 Oxidative stress
Oxidative stress is defined as an imbalance between the generation and neutralization of
oxidative species in the body [7]. Oxidative species are natural byproducts of human
metabolism. Due to their high reactivity and potential to damage cells and tissues, the body has
endogenous antioxidant defense systems designed to neutralize these species. When oxidant
production exceeds the capacity of these systems, the excess oxidants cannot be neutralized and
are free to interact with cells and tissues, resulting in oxidative damage. Oxidative stress is linked
to the pathogenesis of atherosclerosis as well as chronic inflammation [15, 23].
However, some changes in the oxidative balance of the body are normal and, in fact, integral to
proper control of many enzymes, cytokines, and body systems [24-26]. For example,
transcription of NF-κB can be activated by reactive oxygen species (ROS) [27, 28]. Many other
signaling pathways, under the control of protein kinases and/or phosphatases, are also regulated
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by the redox state of plasma [24, 26, 28]. These pathways are involved in normal physiological
processes, such as cellular signaling, repair, or apoptosis [26]. Recent studies also show that
transient increases in ROS in adipocytes may actually perpetuate insulin signaling while
decreasing further lipid accumulation [4, 29]. Therefore, such regulated short-term alterations in
oxidant concentration are a normal and necessary aspect of proper physiological function.
However, a prolonged state of imbalance does not translate to sustention of these effects [4].
The consequences of dysregulated oxidative stress are widespread and numerous. ROS and
reactive nitrogen species (RNS) can interact with and oxidize LDL, nitric oxide (NO), proteins,
lipids, and nucleic acids, causing irreversible damage [30]. ROS and RNS may also regulate the
activities of certain transcription factors, expression of pro-inflammatory genes, and subsequent
synthesis of pro-inflammatory cytokines [15, 31].
Oxidative stress is induced through nutrient intake, which leads to an increase in metabolic
processes such as glycolysis and fatty acid oxidation [8]. Under normal circumstances, the
oxidative species generated through these processes are neutralized by the body. However, when
excessive nutrient intake occurs, it overwhelms the capacity of these metabolic systems and,
subsequently, mitochondrial oxidative phosphorylation, leading to an increase in free radical
generation [8]. These excess free radicals cannot be neutralized properly. This is known as
postprandial oxidative stress.
A consequence of postprandial oxidative stress is endothelial dysfunction – an impairment in
endothelium-dependent vasodilation and vascular integrity [11]. This is also an early indicator of
CVD. Vasodilation is controlled by numerous endothelial-derived factors, including NO. NO is
also responsible for inhibiting platelet aggregation and monocyte adhesion to the vascular walls,
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as well as decreasing capillary permeability, all of which are critical to the maintenance of
vascular integrity [11]. NO is particularly sensitive to the presence of ROS and can be easily
oxidized, reducing its bioavailability and leading to loss of proper endothelial function [15, 23].
Endothelial dysfunction is apparent even in healthy individuals in as little as a few hours
following fat consumption [32]. Because of the frequency of meal intake, the effects of the
previous meal will not have subsided by the time the next is consumed, leading to a prolongation
of the postprandial state. This in turn translates to extended periods of endothelial dysfunction.
A second byproduct of postprandial oxidative stress is lipid peroxidation. Oxidative modification
of LDL particles is an early step in the formation of atherosclerosis [7]. In addition,
malondialdehyde (MDA) – a product of polyunsaturated fatty acid oxidation – can react with the
amino groups of lipoproteins, forming MDA-adducted LDL particles [7]. Oxidized
phospholipids can also accumulate in LDL particles [7]. Increases in free and protein-bound
MDA are measurable in plasma during the postprandial period [27, 33].
Excess nutrient intake may also lead to oxidative damage via the formation of advancedglycation endproduct(s) (AGE(s)), non-enzymatic modifications of proteins, lipids, and nucleic
acids by aldehydes [30]. Endogenously, glucose is the most common aldehyde involved in AGE
formation. Nutrient-induced ROS production also leads to oxidation of plasma thiols, including
glutathione (GSH), methionine (Met), and cysteine (Cys). When ROS react with thiols, oxidized
glutathione (GSSG), homocysteine (Hcy), and cystine (CysS), are generated [34]. These
oxidized species often dimerize, forming disulfide bridges. To counteract this, additional thiols
may be released into the bloodstream to restore the plasma antioxidant capacity [6, 25]. This is
measurable in the postprandial period.
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Due to the nature of these reactions, chronic elevations in glucose or triglycerides in the plasma
may lead to elevated levels of MDA, AGEs, and/or oxidized thiols. This is indicative of elevated
levels of oxidative stress and thus, increased risk of oxidative damage. Therefore, dietary
interventions aimed at reducing baseline plasma glucose and lipids may reduce oxidative stress.
Likewise, strategies to blunt the postprandial increases in plasma glucose and triglycerides
triggered by excess nutrient intake may reduce postprandial oxidative changes that are associated
with atherosclerotic changes in the body.

1.4 Connections between inflammation and oxidative stress
That co-consumption of antioxidants (such as fruit juice) can attenuate postprandial
inflammation induced by a high-fat meal supports a connection between oxidative state and
inflammation [35]. There are multiple methods by which this modulation may occur.
Inflammation is the body’s natural response to injury; therefore, damage caused by oxidative
species activates the immune response [24]. This includes the release of pro-inflammatory
cytokines and macrophage recruitment to the affected area [24]. Reduction of oxidative species
will reduce these damages, thus attenuating the inflammatory response.
A second pathway connecting inflammation and oxidative stress is via lipid peroxidation, which
occurs naturally in the body in apoptotic cells as part of the programmed cell death process [36].
Lipid peroxidation elevates the immune response to properly carry out the apoptotic process.
However, lipid peroxidation in non-apoptotic cells can also occur in cases of elevated oxidative
stress, such as that associated with obesity. Indeed, lipid peroxidation is positively correlated
with BMI and waist circumference [4]. Though transient lipid peroxidation is necessary in cases
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of apoptosis, excessive or sustained exposure to lipid peroxides upregulates the immune response
[37, 38]. As such, long-term pro-oxidative conditions may lead to a steady state of chronic, lowlevel inflammation [14]. This type of inflammation is associated with the development and
progression of many chronic diseases, including atherosclerosis, vascular diseases, and metabolic
syndrome [39, 40]. It is also associated with obesity [13].
ROS and RNS also modulate cytokine release. In the postprandial state, NO reacts with the
superoxide radical to generate peroxynitrite, a highly reactive species that oxidizes proteins and
lipids [7]. Peroxynitrite, along with oxidative byproducts of meal intake (oxidized glucose and
fatty acids), stimulates the release of inflammatory cytokines as well as cell adhesion molecules
(CAMs), which promote monocyte adhesion to the endothelium [7, 26]. These oxidative species
may also interact with and damage the endothelium, similarly triggering an immune response.
Adherent monocytes then migrate into the subendothelial space, where they differentiate into
macrophages and begin to take up circulating lipids [41]. In particular, uptake of oxidized LDL
is an unregulated process; excess uptake leads to foam cell formation. Concurrently, recruitment
of more macrophages, as well as proliferation of smooth muscle cells, are promoted by
macrophage proinflammatory cytokine release, which further damages the endothelium [42].
Thus begins the cyclical process of lesion and, ultimately, plaque formation [41, 42]. In this way,
oxidative stress is directly related to inflammation.
Additionally, in adipose tissue, ROS production leads to a dysregulation in adipokine production
triggered by macrophage infiltration [4, 43]. In adipocytes ROS increase NADPH oxidase 4
activity, which leads to continued ROS production, perpetuating this cycle [4]. ROS damageinduced macrophage infiltration into adipocytes also contributes to increased proinflammatory
cytokine production, including induction of IL-6 and MCP-1 synthesis. Moreover, adipose tissue
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seems to be the main mediator of circulating inflammatory cytokine concentration; increasing
adiposity is associated with increased plasma proinflammatory cytokines [4, 6]. Adipose may
also be the main contributor to circulating oxidative species and byproducts, including lipid
peroxides [4]. The result of these processes is a state of chronically-elevated oxidative stress and
inflammation in overweight and obese individuals.
Because oxidative stress and inflammation are so closely connected, attenuation of one may
subsequently reduce the other. Decreases in chronic oxidative stress may reduce cellular injury,
thereby reducing activation of the inflammatory response. Likewise, reductions in oxidative
stress, particularly in adipose, may attenuate ROS-induced dysregulation of cytokine production.
In the postprandial period, reduction of nutrient-induced ROS generation will limit oxidative
damage and, subsequently, inflammation. Therefore, dietary interventions aimed at reducing
both baseline and postprandial oxidative stress and inflammation, particularly among obese
individuals, are of great interest.

1.5 Induction of postprandial oxidative stress and inflammation
It has long been established that certain dietary alterations can reduce plasma glucose, lipids,
and/or cholesterol, as well as blood pressure, over the long term. However, due to the emerging
understanding of the connection between postprandial dysmetabolism and atherosclerosis,
research is shifting to focus on the extent to which dietary interventions can attenuate these
changes. It is well documented that just one instance of excess nutrient intake can trigger
postprandial changes in the body [9, 24]. This includes meals containing high amounts of
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carbohydrates, fat, and/or calories. High-carbohydrate meals lead to postprandial hyperglycemia.
High-fat meals lead to postprandial hypertriglyceridemia and may increase the absorption of
LPS, which was discussed previously [20].
To further examine these postprandial phenomena, Miglio, et al. designed an intervention to
examine the 8 h postprandial response to a high-fat meal among overweight and obese
individuals [6]. The meal was comprised of fried eggs, fried potatoes, cheese, a roll, and a highsugar beverage, totaling approximately 1400 calories, including 82 g of fat, 123 g of
carbohydrates, and 51 g of protein. Following the meal, they observed increases in plasma
glucose, triglycerides, total cholesterol, TNFα, and IL-6. Glucose levels peaked within the first
hour and returned to their baseline values rather rapidly. However, triglyceride, cholesterol,
TNFα, and IL-6 concentrations remained elevated throughout the entire study period, indicating
that postprandial changes associated with a high-fat meal can last most of the day [6]. In a review
by Sanders, the author suggests that as little as 40-50 g of fat in a single meal is sufficient to
induce these changes. Subsequent meals may further prolong these postprandial alterations [9]. A
pair of studies suggests that an increase in plasma triglycerides of as little as 20-50 mg/dL may
be sufficient to reduce endothelial function and increase expression of CAMs in healthy
individuals. Ceriello, et al. report that a high-fat meal or a high glucose load each increase CAM
levels postprandially and that, when combined, this effect is additive and may endure for greater
than 4 h [44].
Additionally, dietary interventions have been designed to examine the impact of long-term
dietary patterns on the postprandial response. A study by Sanders, et al. revealed that high oleic
acid and high trans-fat diets, consumed for two weeks, increased postprandial lipemia to a
greater extent than a high carbohydrate diet [45]. Therefore, long-term dietary habits may alter
19

the postprandial response. One food group that has generated much interest for its potential
health effects is dairy. In recent years, dairy consumption has been examined in relation to
overall health status, weight, body composition, and inflammation. More recently, dairy has been
examined for its potential impacts on metabolism, particularly during the postprandial state.

1.6 Positive health outcomes associated with chronic dairy consumption
Epidemiological and intervention studies show strong inverse associations between low-fat dairy
consumption and weight, body composition, blood pressure, and inflammatory biomarkers, as
well as incidence of inflammatory diseases and all-cause mortality [46-48]. Analysis of data
from NHANES III found that the odds of being in the highest quartile for body fat were reduced
to 0.75, 0.40, and 0.16, respectively, in the three highest quartiles of calcium intake (p < 0.0009)
[49]. An epidemiological study conducted in Iran divided individuals into quartiles by dairy
consumption and found that individuals in the upper quartile had a significantly lower risk for
overweight or obesity and those in the third quartile had a lower risk for being obese [50]. The
top two quartiles contained proportionally fewer individuals with BMI > 30 kg/m2 versus
individuals in the normal (< 25) range. Likewise, individuals with a BMI < 25 consumed
significantly more dairy products and calcium than their overweight or obese counterparts [50].
A later study by the same group divided Iranian women into quintiles based on low-fat dairy
consumption and found that those in the highest quintile had a lower BMI and waist
circumference as well as circulating concentrations of IL-6 and soluble vascular cell adhesion
molecule (VCAM). [51]. However, in this study, there were no associations with total dairy
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consumption, suggesting that perhaps low-fat dairy products confer beneficial effects not
demonstrated by their full fat counterparts.
An observational study involving individuals with metabolic syndrome found that consumption
of dairy products (excluding cheese), cheese, and an increased calcium density of the diet
(defined as amount of calcium per 1000 calories) were all associated with lower diastolic blood
pressure at the 9-year follow-up period [52]. Dairy consumption and calcium density were also
inversely associated with the incidence of type-2 diabetes at follow-up. Tavani, et al. examined
the relationship between dairy intake and risk of acute myocardial infarction among Italian adults
[53]. Weekly consumption of ≥ 7 cups of milk, ≥ 7 cups of yogurt, ≥ 350 g of cheese, and daily
consumption of ≥ 1000 mg calcium were each associated with reduced odds of acute myocardial
infarction when compared with individuals consuming < 1 cup of milk per week or < 800 mg
calcium per day [53].
A cross-sectional study of Greek adults found a relationship between moderate (11-14 servings
per week) and high (>14 servings per week) dairy consumption and lower total cholesterol and
triglycerides versus individuals with low (< 8 servings per week) dairy consumption [40].
Greater dairy consumption was also inversely correlated to concentrations of certain
inflammatory markers; CRP and Hcy were correlated with low-fat milk, TNFα and IL-6 with
low-fat and full-fat milk, and TNFα with low-fat yogurt. CRP, IL-6, and TNFα were also
inversely associated with general dairy consumption; individuals with moderate dairy
consumption had 16%, 5%, and 12% lower levels of these biomarkers, respectively, compared
with individuals in the low dairy group, and those with high dairy consumption had 29%, 9%,
and 20% lower concentrations, respectively, versus low dairy consumers [40]. Because this was
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observational data, other lifestyle factors may also contribute to these observations. For example,
the CARDIA study, a cohort study of American adults, found dairy consumption to be positively
associated with consumption of fruits, vegetables, and whole grains, and inversely associated
with intake of soft drinks, all of which are considered to be healthier dietary habits [54]. The
CARDIA study also found dairy consumption to be associated with a > 67% reduction in
incidence of metabolic syndrome at 10-year follow-up among overweight individuals consuming
> 5 servings of dairy per day versus those consuming < 1.5 servings per day [54]. The odds of
having elevated triglycerides, blood pressure, BMI, and abnormal glucose metabolism were also
reduced among individuals with greater daily dairy consumption [54]. As this study was also
observational, dairy consumption alone cannot be attributed as the sole effector of these
outcomes. Nevertheless, consuming greater amounts of dairy appears to be associated with
positive health outcomes.
As a result of these observations, numerous intervention studies have been conducted on the
health benefits of dairy consumption. Indeed, dairy consumption is associated with beneficial
changes in biomarkers linked to many diseases in animal and human studies [6, 55-57]. These
changes include reductions in fat absorption and deposition, increases in fatty acid β-oxidation,
increases in fat excretion, reductions in blood pressure, reductions in plasma glucose, and
reduced CRP [55-57].
Reductions in fat absorption and deposition and increases in fat oxidation and fecal fat excretion
in both animals and humans have been attributed to the calcium content of dairy products [3, 55].
Calcium may interfere with fat absorption, disrupting micelle formation in the small intestine by
reducing bile acid solubility [58]. Dietary calcium also moderates circulating levels of 1,25dihydroxyvitamin D (calcitriol), the hormone responsible for controlling intracellular calcium
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concentration [3, 49]. When calcitriol levels are high, it stimulates cellular uptake of calcium.
Increased intracellular calcium in adipocytes increases fatty acid synthase and decreases
lipolysis, thereby favoring storage of lipids in adipose tissue. Increased dietary calcium intake
reduces circulating calcitriol, reducing calcium uptake by adipocytes and reversing the inhibition
of lipolysis. Intracellular calcium also increases expression of uncoupling protein [3]. Together,
these modulations lead to increased lipolysis and fatty acid β-oxidation and reduced adipocyte
lipid accumulation [3, 49].
Reductions in blood pressure associated with dairy consumption are attributed to the presence of
bioactive angiotensin-converting enzyme (ACE)-inhibitory peptides found in milk, particularly
in the casein fraction, which comprises approximately 80% of milk protein [59]. These peptides
are known as casokinins [60]. Individual casokinins, and the evidence supporting their
bioactivity, are reviewed elsewhere [59]. Nevertheless, most ACE-inhibitory peptides exert their
activity in a similar manner – by binding one of the two active sites of ACE. ACE catalyzes the
conversion of angiotensin I to angiotensin II, leading to vasoconstriction and triggering the
release of aldosterone, which acts to increase sodium (and therefore water) retention by the
kidneys [59]. This leads to an increase in blood pressure. Inhibition of this hormone arrests this
process; therefore, consumption of dairy peptides may have a hypotensive effect.
It is noteworthy that intake of supplemental calcium does not confer similar benefits to those
associated with dairy consumption [61]. This may account for the seemingly conflicting results
of numerous intervention trials examining the influence of calcium on postprandial metabolic
parameters. Perhaps other components of dairy interact favorably with calcium to increase its
absorption or bioactivity, thus requiring calcium to be fully intact to achieve maximum effect. In
addition to calcium, dairy contains many bioactive components, including whey and casein,
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short-chain fatty acids, vitamins and minerals, and, in fermented products, probiotics [40, 43, 56,
57]. An intervention study examined the interplay between calcium and protein [62]. Overweight
participants consumed a low-calcium normal-protein (LC/NP), high-calcium normal-protein
(HC/NP), or high-calcium high-protein (HC/HP) diet for one week each, with low-fat dairy
products as the main source of each nutrient. The HC/NP diet led to a significant increase in
fecal fat and energy excretion. This translated to an increase of 5.4 g of fat excretion per 1000
mg of calcium [62]. Both systolic and diastolic blood pressure also decreased on both HC diets,
though the reductions did not reach significance. Triglycerides, fatty acids, cholesterol, and
insulin were unchanged; this may be attributed to the short duration of each dietary period. The
authors attributed the lack of increased fat excretion on the HC/HP diet to the potential for
calcium to bind casein, thereby inhibiting its ability to modulate fat absorption in the intestines
[62]. However, formation of these casein phosphopeptide-calcium complexes may act to increase
calcium absorption [60].
A dietary intervention conducted by Zemel, et al. compared the impact of dairy versus soy on
oxidative stress and chronic inflammation in overweight and obese individuals [43]. Twenty
healthy, overweight or obese men and women participated in the study. Subjects were placed on
a dairy-free (soy protein isolate) or adequate dairy (nonfat dry milk powder) diet for 28 days,
separated by an approximately 28-day washout period. Soy or dairy products consisted of
smoothies that were consumed 3 times daily. Aside from the smoothies, diets were designed to
be similar in macronutrient and caloric content. The adequate dairy diet led to significant
reductions in plasma MDA and urinary 8-isoprostanes, markers of oxidative stress. Changes
were measurable within the first week of the intervention. No changes in either biomarker were
observed during the soy diet. The adequate dairy diet also lead to reductions in inflammation, as
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indicated by reduced expression of TNFα and IL-6, while the soy diet led to increases in these
biomarkers. MCP-1 and CRP were significantly decreased (-20% and -57%, respectively) upon
consuming the adequate dairy diet. LDL cholesterol was also significantly decreased by the
adequate dairy diet [43]. Due to the nature of the intervention, it is not possible to determine
what components of dairy are responsible for these changes [43].
Stancliffe, et al. examined the influence of adequate dairy consumption on oxidative stress in
overweight and obese individuals with metabolic syndrome [63]. Individuals were placed on a
low dairy (< 0.5 servings per day) or adequate dairy (> 3.5 servings per day) diet for 12 weeks.
Two of the daily servings on the adequate dairy diet were milk or yogurt. Plasma samples were
collected following weeks 1, 4, and 12. Systolic blood pressure was significantly lowered
following just 1 week on the adequate dairy diet, with further reductions seen after 12 weeks.
Diastolic blood pressure was also significantly reduced by 12 weeks. Plasma MDA and oxidized
LDL were also decreased following week 1, and continued to decrease throughout the
intervention. By week 12, individuals in the adequate dairy diet exhibited a 35% reduction in
MDA and a 25% reduction in oxidized LDL. The adequate dairy diet also led to reductions in
inflammatory biomarkers as early as week 1, with additional reductions by the end of the
intervention. This was indicated by reductions in TNFα, IL-6, CRP, and MCP-1 [63].
However, Wennersberg, et al. did not observe any differences in inflammatory markers, plasma
glucose, or insulin following 6 months of 3 to 5 servings of dairy per day versus habitual lower
intake (≤ 2 servings per day) [64]. Possible explanations for the lack of reduction in
inflammatory biomarkers include the high baseline dairy intake among individuals in the
intervention group (about half already consumed > 700 mg calcium per day) and the fact that
individuals in the control group continued their normal dairy intake patterns (< 2 servings per
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day) [64]. However, the authors did observe an increase in serum cholesterol in the dairy group,
an outcome not reported in other studies. This warrants further investigation.
The above data support a long-term association between dairy intake and positive health
outcomes, including changes in body composition, body weight, and reductions in baseline
levels of inflammation and oxidative stress. However, it is important to note that these positive
health outcomes associated with increased dairy and/or calcium consumption are often most
beneficial for individuals with suboptimal calcium intake. This ‘suboptimal’ threshold of calcium
consumption has been set at 700-800 mg per day, an intake level that a large portion of the
population fails to meet [55, 64]. Therefore, a dietary intervention that incorporates dairy
products would be a means of increasing daily calcium intake, particularly in individuals who
fall below the 700-800 mg daily threshold. Indeed, studies have shown that increasing calcium
consumption to optimal levels can lead to increases in weight and fat loss during energy
restriction and may also reduce blood pressure in hypertensive individuals [55, 64].
Increased dairy intake has also been associated with increased intakes of protein, fat, saturated
fat, and cholesterol [64]. It is important to take into consideration that the saturated fats present
in dairy products are primarily stearic acid and short- and medium-chain fatty acids, which are
not associated with increases in plasma cholesterol [65]. Vitamin D is also an important
component of dairy products. Due to its fat solubility, vitamin D can be sequestered in adipose
tissue [66]. Therefore, its bioavailability may be reduced in obese individuals, necessitating
increased dietary intake. Regular dairy consumption would be a means of reaching this goal.
Though numerous studies support the benefits of dairy on body composition, body weight, and
oxidative and inflammatory parameters, which components of dairy products are responsible for
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these changes and by what mechanisms these effects are conferred remains unknown.
Additionally, data is lacking on the postprandial impacts of dairy consumption on intestinal
barrier function and biomarkers of inflammation and oxidative stress. Furthermore, the antiinflammatory and antioxidative effects of individual dairy products, including low-fat yogurt,
have not been well characterized.

1.7 Attenuation of postprandial oxidative stress and inflammation by dietary intervention
Many foods have been examined for their ability to modulate postprandial metabolism, including
orange juice, protein, individual components of dairy, and a variety of dairy products [23, 48, 6769]. A 2010 study found orange juice to have a favorable effect on postprandial inflammation
and oxidative stress among healthy, normal weight (BMI 20-25) individuals [23]. In this
intervention, a high-carbohydrate, high-fat meal was consumed along with either a glucose drink,
orange juice, or water [23]. The meal consisted of egg-muffin and sausage-muffin sandwiches
and two hash brown patties, totaling 900 calories, 81 g carbohydrates, 51 g fat, and 32 g protein.
A statistically significant postprandial rise in blood glucose was observed following the meals
consumed with water or glucose but not following those consumed with orange juice. Orange
juice also blunted postprandial increases in ROS generation, TLR4 and p38 MAP kinase
expression, and circulating LPS [23]. While the nutrient profile of orange juice is markedly
different from that of low-fat dairy products, the results of this intervention are indicative of the
ways in which certain foods can positively influence the postprandial response.
Whey protein comprises approximately 20% of the protein content of milk and milk products
[67]. Bioactive peptides in whey include lactalbumin, β−lactoglobulin, immunoglobulin,
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lactoperoxidase, and a large proportion of branched chain amino acids [68]. An intervention trial
on healthy individuals found that consumption of whey protein or whey protein isolate prior to a
meal led to a reduction in postprandial glucose and insulin [67]. The first intervention consisted
of men consuming 0, 10, 20, 30, or 40 g of whey protein (WP) concentrate 30 minutes prior to
consumption of pizza. Pizza was consumed until subjects were full but within a 20-minute time
limit. The second portion of the trial consisted of men and women consuming 0, 5, 10, 20, or 40
g of WP concentrate or 10 g whey protein hydrolysate (WPH) followed 30 minutes later by 12
kcal/kg body weight of pizza, to be consumed in 20 minutes. In trial 1, ingestion of 20, 30, and
40 g doses of WP significantly reduced postprandial plasma glucose concentrations versus the
control at 30 minutes, and all doses led to significantly lower plasma glucose at 50 and 65
minutes postprandially versus the control. Glucose AUC was significantly reduced in all WP
supplemented groups as well [67]. In trial 2, post-meal and cumulative postprandial plasma
glucose was significantly reduced by all WP doses when compared to the control. WP also
decreased total food intake in trial 1, which would similarly serve to reduce postprandial glucose.
Cumulative glucose AUC was not reduced by WPH consumption [67]. This suggests that the
protein needs to be fully intact for these postprandial effects to be observed.
Ingestion of 54 g of supplemental whey, casein, or a glucose control (two 27 g capsules
dissolved in water, one prior to breakfast and one prior to dinner) daily for 12 weeks was linked
to a significant decrease in both systolic and diastolic blood pressure in overweight and obese
individuals [68]. However, inflammatory parameters – as indicated by IL-6, CRP, and TNFα –
were unchanged [68]. It is unknown what components of whey and casein mediate these
hypotensive actions, but this study does suggest that the proteins need not necessarily be
consumed as complete dairy products to exert a beneficial effect on blood pressure. Following
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these outcomes, the authors designed a second study to examine whether whey and casein would
exert similar effects on an acute basis [48]. Overweight and obese women consumed a high-fat
meal containing approximately 600 calories, with 45 g of either whey protein isolate, sodium
caseinate, or glucose (control) dissolved in water. However, no changes in inflammatory
biomarkers were observed over the 6-h postprandial period in either treatment group when
compared with the control [48].
Another dietary intervention tested the intake of casein, a commercial mixture of mono- and
oligosaccharides, or both, in concert with a high-fat meal [69]. The study was a crossover design
involving healthy males and females. Both interventions delayed the peak and lowered total
triglyceride concentration in the bloodstream. Though the oligosaccharides exhibited a much
stronger effect than the casein, when combined the effect was even greater [69]. Casein and
casein + oligosaccharides also lowered plasma free fatty acid concentration following the highfat meal. As yogurt contains both casein and oligosaccharides, it may possess the ability to
attenuate the postprandial lipemic response.
An intervention study comparing the influence of dairy and supplemental calcium on
postprandial metabolism found that only dairy calcium successfully attenuated the postprandial
lipid response [61]. In the trial, healthy men consumed a low dairy calcium (LC), medium dairy
calcium (MC), high dairy calcium (HC), or calcium carbonate (CC) supplemented meal, and the
postprandial response was monitored for 7 h. Chylomicron triglyceride AUC was lower
following the MC and HC meals than the CC meal, suggesting a reduction in fat absorption in
these meals [61]. This is in agreement with previous research establishing the impact of calcium
on fat absorption and fecal fat excretion. These results also support the notion that dairy calcium
is more efficacious than supplemental calcium in modulating the postprandial response.
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To examine the benefits of intact dairy products, Ballard, et al. designed an intervention to test
the impact of low-fat dairy milk versus rice milk on the postprandial endothelial response in
individuals with metabolic syndrome [27]. Low-fat milk has a low glycemic index that would
limit postprandial hyperglycemia and any associated increases in oxidative stress. Indeed,
glucose increased to a lesser extent and returned to baseline more rapidly following dairy milk
than rice milk consumption [27]. Examination of oxidative biomarkers revealed that low-fat milk
decreased oxidative stress and preserved NO bioavailability, thereby helping to maintain normal
vascular function. MDA increased postprandially during the rice milk trial but not the dairy milk
trial, suggesting that low-fat milk may also mitigate postprandial lipid peroxidation [27].
van Meijl, et al. examined the impact of milk on postprandial lipemia and glycemia in
overweight and obese men in response to a high-fat meal [56]. The ingredients of interest were
calcium and protein. The intervention consisted of 4 meals consumed on 4 days, each separated
by at least 3 days. The meal consisted of a butter cake and a 500 mL beverage: either skim milk,
water with lactose, water with lactose and calcium, and water with lactose, calcium, and milk
protein. Fat content was 44 g, carbohydrate was 109 g, and calorie content was between 870 and
950 in each meal. Calcium and protein content varied by design between each intervention meal.
Plasma glucose and triglycerides were measured for 6 h postprandially. The calcium meal
decreased the triglyceride AUC by 48% versus the milk meal. The protein meal reduced
maximal plasma glucose concentration versus the control meal, and the milk meal also reduced
peak plasma glucose, though the reduction did not reach significance [56]. This suggests that
calcium and protein need not be fully intact in milk in order to lower postprandial triglycerides or
glucose; in fact, reductions did not reach significance when the calcium and protein were
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consumed as milk. Therefore, it is possible that the health benefits attributed to dairy products
are due to components other than calcium or protein.
Clearly, the ability of dairy products to attenuate the postprandial response requires further
examination. In addition, the connections between postprandial reductions in glucose and
triglycerides and corresponding changes in oxidative stress have not been well characterized.

1.8 Potential health benefits of yogurt consumption
In addition to whey, casein, proteins, and other bioactive components found in dairy products,
yogurt also contains probiotics – live microorganisms that, when consumed in sufficient
quantities, confer a benefit to the host. Probiotic consumption has been linked to improved
intestinal health, alterations in the indigenous intestinal microflora and changes in the metabolic
profile of the host [70, 71]. More recently, animal studies have shown connections between
probiotic consumption, the intestinal microflora profile of the host, and neurological changes.
This is reviewed in detail elsewhere [72, 73] Alterations in microbiota composition are also
associated with obesity and other metabolic disorders; this was reviewed by Chen, et al. [74] and
Walsh, et al. [75].
Probiotics themselves possess the ability to act as indirect antioxidants both by trapping ROS in
the intestine and by stimulating the synthesis of cellular antioxidants, including glutathione
peroxidase (GPx) and superoxide dismutase (SOD) [57]. Indeed, a dietary intervention study
examined the 3-week intake of a low-fat dairy diet, a non-fermented dairy diet, and a fermented
dairy diet on various cardiovascular outcomes [46]. TNFα, MCP-1, IL-1β, and VCAM were all
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non-significantly decreased following the fermented dairy versus low-fat dairy diet. However,
both the low-fat and fermented dairy diets resulted in a significant reduction in IL-6
concentrations. Sphingomyelin, a biomarker indicative of early atherosclerosis, was also
decreased by the low-fat dairy diet, though not by the fermented dairy diet [46].

1.9 Examination of postprandial and chronic biomarkers of oxidative stress
Malondialdehyde:
MDA is a product of polyunsaturated fatty acid oxidation and an established biomarker for the
measurement of lipid peroxidation [76]. The structure of MDA is shown in Figure 1.1. MDA
increases during the postprandial period [27, 33, 77]. MDA can react with amino groups of
lipoproteins, generating MDA-adducted LDL particles [7]. These adducts often exhibit epitopic
similarities to antigens; they are recognized as such by the immune system and are, therefore,
pro-inflammatory [37]. Thus, dietary means of reducing MDA formation may reduce
inflammation.
Long-term calcium supplementation and/or dairy intake has been shown to decrease MDA in
both mice and humans [13]. Interestingly, supplemental calcium reduced MDA to a greater
extent than dietary calcium in obese mice. The high-calcium diet also reduced NADPH oxidase
and ROS production [13]. Since MDA is a product of lipid oxidation, decreases in ROS
generation should reduce its concentration. A second study by Zemel, et al. found that 28-day
consumption of a dairy-rich diet by overweight and obese individuals led to a reduction in
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oxidative stress, as indicated by a 22% reduction in plasma MDA [43]. This reduction was seen
after just 1 week on the high-dairy diet.
An intervention by Ballard, et al. comparing the influence of low-fat milk versus rice milk on the
postprandial response found that 435 mL of rice milk was associated with a 17-33% increase in
MDA from 30-120 minutes while MDA concentration following intake of 475 mL of low-fat
milk did not change [27]. Low-fat milk also resulted in a smaller MDA AUC in the 3 h
postprandial period compared with rice milk (p < 0.01). Finally, MDA AUC was correlated with
glucose AUC (p < 0.01; r = 0.75), suggesting that postprandial hyperglycemia is associated with
MDA formation [27]. As excess plasma glucose is associated with increased ROS generation,
this would seem a logical correlation. Therefore, consumption of low-fat yogurt may reduce
postprandial plasma glucose, thereby attenuating formation of MDA.
Advanced glycation endproducts:
AGEs are natural byproducts of human metabolism, formed by the non-enzymatic reaction of
aldehydes with exposed amino groups of lipids, proteins, and nucleic acids, to form covalentlymodified proteins [30, 78, 79]. Such proteins include collagen and plasma lipoproteins, of which
lysine and arginine side chains are the most reactive for this process [30, 80]. There is a wellestablished correlation between diabetes and/or renal dysfunction and elevated plasma AGEs.
Increased production of AGEs has also been observed in cases of hypertriglyceridemia and
hyperglycemia; as such, high plasma AGEs are associated with obesity [81]. As obesity is often
comorbid with some or all of the above conditions, the reduction of plasma AGEs in obese
individuals may have simultaneous beneficial impacts on insulin sensitivity, renal function, and
hypertriglyceridemia. Increased plasma AGEs is also observed in concert with higher levels of
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oxidative stress and inflammation [30, 81]. Indeed, oxidative stress exacerbates the formation of
AGEs and vice versa [82]. Thus, any potential means of reducing postprandial oxidative stress
would tend to decrease formation of postprandial AGEs.
Elevated levels of AGEs also lead to activation of RAGE, a pattern recognition receptor that
recognizes AGE-adducted proteins [83]. Activated receptors trigger a variety of pro-oxidative
and pro-inflammatory pathways, including the synthesis of CAMs and activation of NF-κB [81,
83, 84]. However, it is important to note that most studies of RAGE activation have been
conducted in animals and much remains unknown with regard to its mechanisms of activation
and action [85].
AGEs are always present in some quantities the body but in addition, about 10% of those
ingested are absorbed in the intestine [83]. AGEs are present in higher amounts in animal-based
foods (meat, eggs) than in fruits and vegetables. Dairy products may have AGEs as well, though
the water content of the products tends to impede their formation [79]. The preparation methods
of foods can also greatly increase the exogenous supply of AGEs. In particular, hot, dry cooking
methods such as frying, grilling, and broiling increase formation of AGEs more so than wet
cooking methods such as boiling and steaming [79].
Once absorbed, exogenous AGEs enter the bloodstream, where they form crosslinks to proteins,
lipids, and nucleic acids [30]. Crosslinks formed between AGEs and endogenous proteins are
irreversible and damaging, with greater amounts of damage accumulating on proteins that have a
lower turnover rate [30]. Examples include collagen and LDL, leading to an increase in arterial
stiffness, decreased LDL uptake, and an overall increase in endothelial dysfunction. It is
necessary to note that the eventual degradation of these bound AGEs leads to formation of other

34

highly reactive intermediates, which, upon entering circulation, are once again available to
crosslink with plasma proteins [80]. Two commonly measured AGEs in plasma are Ncarboxymethyllysine (CML) and N-carboxyethyllysine (CEL) [30]. They can be measured
individually or in combination with each other and the numerous other AGE species present in
plasma to give a more thorough indication of plasma AGE status. The structures of CML and
CEL are shown in Figure 1.2.
Postprandial effects of AGE consumption include increased endothelial dysfunction and
decreased adipokine secretion [30]. A study examining the impacts of a high-AGE meal in both
diabetic and non-diabetic patients found significant increases in plasma AGE concentrations
beginning 1 to 2 h postprandially and peaking 4 to 6 h after meal consumption [80]. Elevated
levels in healthy subjects were observed as much as 18 h following consumption of the highAGE meal; AGE levels in diabetic subjects remained elevated for much longer.
Long-term impacts of high-AGE diets are still somewhat unknown. However, existing studies
show that extended consumption of a high-AGE diet leads to elevated plasma AGE levels [83].
In a study reviewed by Sebekova and Somoza, 21 healthy volunteers consumed either a high- or
low-AGE diet for 1 week each; the only difference in the diets was the content of AGEs [86].
After one week, fasting serum concentration of CML was elevated in those individuals on the
high-AGE diet.
Due to reduced clearance of glucose, AGE production is higher in individuals with diabetes;
methods to decrease AGE absorption and formation may thus be particularly beneficial to these
individuals [30, 79]. While the exact quantitative definition of a low-AGE diet has not been
established, dietary reduction of AGE intake has been shown to positively impact levels of
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oxidative stress and insulin resistance [85]. In a study in which obese participants were placed on
either a high-AGE (14,090 kU/day) or low-AGE (3,302 kU/day) diet, consumption of the lowAGE diet led to improvements in renal function and the inflammatory profile after a 2-week
intervention [87].
Endogenously, glucose is the most available and commonly-used sugar in AGE formation [30,
81]. By this logic, it stands to reason that a reduction in fasting blood glucose and/or postprandial
glycemia may reduce formation of AGEs. Previous studies show a reduction in postprandial
hyperglycemia following a meal supplemented with dairy products [10, 27]. A randomized,
double-blind study comparing the postprandial effects of consumption of rice milk versus a lowfat dairy milk revealed a blunted postprandial increase in plasma glucose and glucose AUC, with
values returning to baseline much more rapidly following dairy milk than rice milk [27]. An
intervention study by van Meijl, et al. found that the addition of milk or milk protein to a high-fat
meal attenuated the postprandial rise in plasma glucose levels [10]. Finally, a third study showed
that consumption of whey protein prior to a high-carbohydrate meal led to a dose-dependent
reduction in postprandial blood glucose levels [67].
A study examining long-term calcium and vitamin D supplementation found a significant
decrease in fasting plasma glucose levels in non-diabetic adults [88]. Although these results
cannot be attributed to dairy consumption, calcium and vitamin D are present in dairy products
and the effects of calcium are also known to be much more profound when the mineral is from
dairy versus a supplemental form [61]. Because dairy consumption can reduce postprandial
glycemia, it may also possess the ability to limit postprandial formation of AGEs.
Total thiols:
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Protein thiols are indicators of oxidative and nitrosative stress, as well as plasma antioxidant
status [89, 90]. They are preferentially oxidized in cases of increased oxidative stress; a higher
concentration of oxidized thiols is often interpreted as an increase in oxidative damage [90, 91].
This occurs via the oxidation of sulfhydryl groups on cysteine, methionine, and glutathione
residues, forming disulfide bridges [90]. Plasma thiols include GSH, glutathione disulfide
(oxidized glutathione - GSSG), Cys and cystine (oxidized cysteine - CysS), Met and its oxidized
form, Hcy [27]. Structures of these molecules are depicted in Figure 1.3. GSH is synthesized
from other sulfur-containing amino acids, of which Cys concentration is the rate-limiting factor
[34]. GSSG and CysS are formed by the reaction of hydrogen peroxide or peroxynitrite with
GSH and Cys, respectively. It has been shown that CysS concentrations exhibit no variations in
association with meal consumption [25]. However, Cys and GSH do vary in relation to meal
consumption and meal composition, as well as endogenous oxidative conditions [34, 92].
It is noteworthy that thiol concentration and oxidation status is known to vary throughout the
day, as well as in response to meals [25]. For example, plasma Cys concentration varies between
its minimum in the early morning and its maximum in the evening. This cycle is in addition to
peaks occurring 2 to 3 h following each meal [25]. CysS concentration also shows diurnal
fluctuations; this was seemingly not in correlation to meal consumption but rather on a 12 h
cycle with maximum levels at midday and minimum levels in the middle of the night [25].
Plasma GSH also increased following meal consumption, though this occurred much later than
with Cys [25]. Lowest GSH oxidation levels were present in the early morning and evening.
It is possible to measure total thiols (SH), which includes GSH, Cys, Met, and protein and nonprotein thiols [6]. Protein and non-protein thiols often dimerize in the presence of increased
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oxidative stress as a protective mechanism. These disulfides are indicative of an elevated
oxidative burden, a state which is also measurable by a decrease in the ratio of SH:disulfides [6].
There are many biological pathways whose regulation relies on redox status, including thiol
redox state [26]. Postprandial increases in ROS trigger increased generation of CysS; the
oxidation status of Cys/CysS is known to modulate adhesion of monocytes to endothelial cells
via activation of CAMs [25, 26]. Thiol oxidation is also involved in the modulation of NO
activity. Increased oxidative stress leads to the oxidation of thiols by ROS and RNS, triggering
subsequent NO dysregulation [89, 93]. As such, preservation of normal levels is necessary for
maintenance of the endogenous antioxidant defense system and proper endothelial function.
It is well established that consumption of a high-fat meal decreases endogenous antioxidant
status in healthy individuals, leading to an increase in ROS [94]. As these ROS promote thiol
oxidation, it is reasonable to expect that meal consumption may trigger this phenomenon. Indeed,
Miglio, et al. found that consumption of a high-fat meal significantly increased plasma total
thiols, with a peak 2 to 4 h post-ingestion [6]. The caloric content of the high-fat meal used in
this intervention is slightly greater than that used in the present study, but the macronutrient
compositions are similar [6]. As this is the case, we can expect to see an increase in total thiols 24 h postprandially. However, as observed by Miglio et al., SH levels remained elevated for 8 h
postprandially [6].
It is important not to discount the potential impact of protein intake on thiol concentration. There
is evidence that ingestion of proteins rich in sulfur-containing residues can raise plasma thiol
levels [25]. It is also important to note that Cys groups are prone to oxidation and are
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preferentially oxidized, altering the plasma thiol redox status [6]. To counteract this, GSH from
the tissues is released into the plasma; this may result in an increase in plasma thiols.
Finally, postprandial hyperglycemia increases ROS generation and, hence, thiol oxidation [90].
One clinical study found an inverse relationship between postprandial glucose levels and reduced
protein thiols [90]. Therefore, reductions in postprandial plasma glucose levels may also lead to a
reduction in oxidative damage to proteins, resulting in a restoration of normal protein thiol
levels. As this is known to be a potential impact of dairy consumption, low-fat yogurt may blunt
the postprandial increase in thiol oxidation following consumption of a high-fat meal.

1.10 Conclusions
Atherosclerosis is primarily a postprandial phenomenon, the development of which is associated
with postprandial dysmetabolism as a result of excess nutrient intake. Among these changes are
increases in oxidative stress and inflammation, conditions that are closely linked. Excess nutrient
intake may also compromise intestinal barrier function, leading to increased LPS entry into the
bloodstream, which elicits a strong inflammatory response.
Among the suspected causes of postprandial oxidative stress are increases in plasma glucose and
triglycerides, as well as excess ROS generated by nutrient metabolism. These oxidative species
can damage cells and tissues; this injury leads to activation of the inflammatory response. ROS
also promote CAM synthesis and subsequent promotion of monocyte adhesion to the vascular
walls, an early step in the pathogenesis of atherosclerosis. Both circulating glucose and ROS can
also interact with nucleic acids, proteins and lipids; resultant byproducts include AGEs, MDA,
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and oxidized thiols. However, it is important to note that these three biomarkers do not provide a
full picture of postprandial oxidative changes in the body. The body’s endogenous antioxidant
enzymes – including GPx and SOD – are also key regulators of oxidative stress that may be
altered by intake of a high-fat meal [94]. In addition, urinary isoprostanes and 8deoxyguanosine, a marker of DNA oxidation, are well-established markers of oxidative stress.
Uric acid has also recently been shown to decrease in healthy subjects following a high-fat meal,
and may also be indicative of oxidation status [94]. Finally, conflicting research on postprandial
plasma thiols suggests that regulation of oxidant status is far more complicated, as dietary thiols
may contribute to plasma thiols [6]. Furthermore, additional thiols may be released from cells in
response to oxidation of existing plasma thiols to maintain redox balance [6]. Therefore,
numerous factors may need to be examined to elucidate the full impact of low-fat yogurt
consumption on oxidative stress.
Nevertheless, as evidence of the consequences of postprandial stress become more apparent,
dietary strategies to reduce these changes are of necessity. Past studies link chronic dairy
consumption to many beneficial health outcomes, including decreased odds of obesity,
reductions in blood pressure, postprandial glucose, and triglycerides, and reductions in
inflammation. Postprandially, dairy and its individual components have been shown to reduce
plasma glucose and triglycerides, as well as certain inflammatory biomarkers. However, the
impacts of individual dairy products remain largely unexplored.
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Figure 1.1. Structure of malondialdehyde (MDA).

Figure 1.2. Structure of two common plasma advanced glycation endproducts (AGEs): (a) Ncarboxymethyllysine, and (b) N-carboxyethyllysine.
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Figure 1.3. Structure of four common plasma thiols: (a) glutathione, (b) glutathione disulfide, (c)
cysteine, and (d) cystine.

42

1.11 References
[1] Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., et al., Heart Disease and Stroke
Statistics--2014 Update: A Report From the American Heart Association. Circulation 2013, 129,
e28-e292.
[2] Grundy, S. M., Definition of Metabolic Syndrome: Report of the National Heart, Lung, and
Blood Institute/American Heart Association Conference on Scientific Issues Related to
Definition. Circulation 2004, 109, 433-438.
[3] Shi, H., Dirienzo, D., Zemel, M. B., Effects of dietary calcium on adipocyte lipid metabolism
and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J 2001, 15,
291-293.
[4] Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., et al., Increased oxidative stress in
obesity and its impact on metabolic syndrome. Journal of Clinical Investigation 2004, 114,
1752-1761.
[5] Altmaier, E., Fobo, G., Heier, M., Thorand, B., et al., Metabolomics approach reveals effects
of antihypertensives and lipid-lowering drugs on the human metabolism. Eur J Epidemiol 2014.
[6] Miglio, C., Peluso, I., Raguzzini, A., Villaño, D. V., et al., Antioxidant and inflammatory
response following high-fat meal consumption in overweight subjects. European Journal of
Nutrition 2012, 52, 1107-1114.
[7] Bowen, P. E., Borthakur, G., Postprandial lipid oxidation and cardiovascular disease risk.
Curr Atheroscler Rep 2004, 6, 477-484.
[8] O’Keefe, J. H., Gheewala, N. M., O’Keefe, J. O., Dietary Strategies for Improving PostPrandial Glucose, Lipids, Inflammation, and Cardiovascular Health. Journal of the American
College of Cardiology 2008, 51, 249-255.
[9] Sanders, T. A. B., Dietary fat and postprandial lipids. Current atherosclerosis reports 2003,
5, 445-451.
[10] van Meijl, L. E., Mensink, R. P., Effects of low-fat dairy consumption on markers of lowgrade systemic inflammation and endothelial function in overweight and obese subjects: an
intervention study. Br J Nutr 2010, 104, 1523-1527.
[11] de Koning, E. J., Rabelink, T. J., Endothelial function in the post-prandial state. Atheroscler
Suppl 2002, 3, 11-16.
[12] Calder, P. C., Ahluwalia, N., Albers, R., Bosco, N., et al., A consideration of biomarkers to
be used for evaluation of inflammation in human nutritional studies. Br J Nutr 2013, 109 Suppl
1, S1-34.
[13] Zemel, M. B., Sun, X., Dietary calcium and dairy products modulate oxidative and
inflammatory stress in mice and humans. J Nutr 2008, 138, 1047-1052.

43

[14] Peairs, A. D., Rankin, J. W., Lee, Y., Effects of acute ingestion of different fats on oxidative
stress and inflammation in overweight and obese adults. Nutrition Journal 2011, 10, 122.
[15] Droge, W., Free radicals in the physiological control of cell function. Physiol Rev 2002, 82,
47-95.
[16] Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., et al., Selective increases of
bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a
mechanism associated with endotoxaemia. Diabetologia 2007, 50, 2374-2383.
[17] Ley, R. E., Turnbaugh, P. J., Klein, S., Gordon, J. I., Microbial ecology: human gut
microbes associated with obesity. Nature 2006, 444, 1022-1023.
[18] Manco, M., Putignani, L., Bottazzo, G. F., Gut microbiota, lipopolysaccharides, and innate
immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev, 31, 817-844.
[19] Maynard, C. L., Elson, C. O., Hatton, R. D., Weaver, C. T., Reciprocal interactions of the
intestinal microbiota and immune system. Nature, 489, 231-241.
[20] Harris, K., Kassis, A., Major, G., Chou, C. J., Is the Gut Microbiota a New Factor
Contributing to Obesity and Its Metabolic Disorders? Journal of Obesity 2012, 2012, 1-14.
[21] Moreira, A. P. B., Texeira, T. F. S., Ferreira, A. B., do Carmo Gouveia Peluzio, M., de
Cássia Gonçalves Alfenas, R., Influence of a high-fat diet on gut microbiota, intestinal
permeability and metabolic endotoxaemia. British Journal of Nutrition 2012, 108, 801-809.
[22] Fernandez-Real, J. M., Perez del Pulgar, S., Luche, E., Moreno-Navarrete, J. M., et al.,
CD14 modulates inflammation-driven insulin resistance. Diabetes, 60, 2179-2186.
[23] Ghanim, H., Sia, C. L., Upadhyay, M., Korzeniewski, K., et al., Orange juice neutralizes the
proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase
and Toll-like receptor expression. American Journal of Clinical Nutrition 2010, 91, 940-949.
[24] Sies, H., Stahl, W., Sevanian, A., Nutritional, dietary and postprandial oxidative stress. J
Nutr 2005, 135, 969-972.
[25] Blanco, R. A., Ziegler, T. R., Carlson, B. A., Cheng, P. Y., et al., Diurnal variation in
glutathione and cysteine redox states in human plasma. Am J Clin Nutr 2007, 86, 1016-1023.
[26] Go, Y. M., Intracellular Proatherogenic Events and Cell Adhesion Modulated by
Extracellular Thiol/Disulfide Redox State. Circulation 2005, 111, 2973-2980.
[27] Ballard, K. D., Mah, E., Guo, Y., Pei, R., et al., Low-Fat Milk Ingestion Prevents
Postprandial Hyperglycemia-Mediated Impairments in Vascular Endothelial Function in Obese
Individuals with Metabolic Syndrome. Journal of Nutrition 2013, 143, 1602-1610.
[28] Sies, H., Strategies of antioxidant defense. Eur J Biochem 1993, 215, 213-219.

44

[29] Krieger-Brauer, H. I., Kather, H., Human fat cells possess a plasma membrane-bound
H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor
kinase. J Clin Invest 1992, 89, 1006-1013.
[30] Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., et al., Advanced
glycation endproducts in food and their effects on health. Food and Chemical Toxicology 2013,
60, 10-37.
[31] Matés, J. M., Segura, J. A., Alonso, F. J., Márquez, J., Intracellular redox status and
oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Archives of
Toxicology 2008, 82, 273-299.
[32] Vogel, R. A., Corretti, M. C., Plotnick, G. D., Effect of a single high-fat meal on endothelial
function in healthy subjects. Am J Cardiol 1997, 79, 350-354.
[33] Hudthagosol, C., Haddad, E. H., McCarthy, K., Wang, P., et al., Pecans Acutely Increase
Plasma Postprandial Antioxidant Capacity and Catechins and Decrease LDL Oxidation in
Humans. Journal of Nutrition 2010, 141, 56-62.
[34] Ashfaq, S., Abramson, J. L., Jones, D. P., Rhodes, S. D., et al., The Relationship Between
Plasma Levels of Oxidized and Reduced Thiols and Early Atherosclerosis in Healthy Adults.
Journal of the American College of Cardiology 2006, 47, 1005-1011.
[35] Peluso, I., Raguzzini, A., Villano, D. V., Cesqui, E., et al., High fat meal increase of IL-17
is prevented by ingestion of fruit juice drink in healthy overweight subjects. Curr Pharm Des
2012, 18, 85-90.
[36] Weismann, D., Binder, C. J., The innate immune response to products of phospholipid
peroxidation. Biochim Biophys Acta 2012, 1818, 2465-2475.
[37] Bertoia, M. L., Pai, J. K., Lee, J.-H., Taleb, A., et al., Oxidation-Specific Biomarkers and
Risk of Peripheral Artery Disease. Journal of the American College of Cardiology 2013, 61,
2169-2179.
[38] Weismann, D., Binder, C. J., The innate immune response to products of phospholipid
peroxidation. Biochimica et Biophysica Acta (BBA) - Biomembranes 2012, 1818, 2465-2475.
[39] Labonte, M. E., Couture, P., Richard, C., Desroches, S., Lamarche, B., Impact of dairy
products on biomarkers of inflammation: a systematic review of randomized controlled
nutritional intervention studies in overweight and obese adults. American Journal of Clinical
Nutrition 2013, 97, 706-717.
[40] Panagiotakos, D. B., Pitsavos, C. H., Zampelas, A. D., Chrysohoou, C. A., Stefanadis, C. I.,
Dairy Products Consumption Is Associated with Decreased Levels of Inflammatory Markers
Related to Cardiovascular Disease in Apparently Healthy Adults: The ATTICA Study. Journal
of the American College of Nutrition 2010, 29, 357-364.

45

[41] Ross, R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993,
362, 801-809.
[42] Jagla, A., Schrezenmeir, J., Postprandial triglycerides and endothelial function. Exp Clin
Endocrinol Diabetes 2001, 109, S533-547.
[43] Zemel, M. B., Sun, X., Sobhani, T., Wilson, B., Effects of dairy compared with soy on
oxidative and inflammatory stress in overweight and obese subjects. The American journal of
clinical nutrition 2010, 91, 16-22.
[44] Ceriello, A., Quagliaro, L., Piconi, L., Assaloni, R., et al., Effect of postprandial
hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress
generation and the possible role of simvastatin treatment. Diabetes 2004, 53, 701-710.
[45] Sanders, T. A., Oakley, F. R., Crook, D., Cooper, J. A., Miller, G. J., High intakes of trans
monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic
risk markers for CHD in young healthy men. Br J Nutr 2003, 89, 767-776.
[46] Nestel, P. J., Mellett, N., Pally, S., Wong, G., et al., Effects of low-fat or full-fat fermented
and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults.
British Journal of Nutrition 2013, 110, 2242-2249.
[47] Lamarche, B. t., Review of the Effect of Dairy Products on Non-Lipid Risk Factors for
Cardiovascular Disease. Journal of the American College of Nutrition 2008, 27, 741S-746S.
[48] Pal, S., Ellis, V., Acute effects of whey protein isolate on blood pressure, vascular function
and inflammatory markers in overweight postmenopausal women. British Journal of Nutrition
2011, 105, 1512-1519.
[49] Zemel, M. B., Shi, H., Greer, B., Dirienzo, D., Zemel, P. C., Regulation of adiposity by
dietary calcium. FASEB J 2000, 14, 1132-1138.
[50] Mirmiran, P., Esmaillzadeh, A., Azizi, F., Dairy consumption and body mass index: an
inverse relationship. International Journal of Obesity 2004, 29, 115-121.
[51] Esmaillzadeh, A., Azadbakht, L., Dairy consumption and circulating levels of inflammatory
markers among Iranian women. Public Health Nutrition 2009, 13, 1395-1402.
[52] Fumeron, F., Lamri, A., Abi Khalil, C., Jaziri, R., et al., Dairy consumption and the
incidence of hyperglycemia and the metabolic syndrome: results from a french prospective
study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
Diabetes Care 2011, 34, 813-817.
[53] Tavani, A., Gallus, S., Negri, E., La Vecchia, C., Milk, dairy products, and coronary heart
disease. J Epidemiol Community Health 2002, 56, 471-472.

46

[54] Pereira, M. A., Jacobs, D. R., Jr., Van Horn, L., Slattery, M. L., et al., Dairy consumption,
obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 2002,
287, 2081-2089.
[55] Zemel, M. B., Donnelly, J. E., Smith, B. K., Sullivan, D. K., et al., Effects of dairy intake on
weight maintenance. Nutrition & Metabolism 2008, 5, 28.
[56] van Meijl, L. E. C., Mensink, R. P., Effects of milk and milk constituents on postprandial
lipid and glucose metabolism in overweight and obese men. British Journal of Nutrition 2013,
110, 413-419.
[57] Ebringer, L., Ferencik, M., Krajcovic, J., Beneficial health effects of milk and fermented
dairy products--review. Folia Microbiol (Praha) 2008, 53, 378-394.
[58] Govers, M. J., Van der Meet, R., Effects of dietary calcium and phosphate on the intestinal
interactions between calcium, phosphate, fatty acids, and bile acids. Gut 1993, 34, 365-370.
[59] Silva, S. V., Malcata, F. X., Caseins as source of bioactive peptides. International Dairy
Journal 2005, 15, 1-15.
[60] Meisel, H., Overview on milk protein-derived peptides. International Dairy Journal 1998,
8, 363-373.
[61] Lorenzen, J. K., Nielsen, S., Holst, J. J., Tetens, I., et al., Effect of dairy calcium or
supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy
intake. Am J Clin Nutr 2007, 85, 678-687.
[62] Jacobsen, R., Lorenzen, J. K., Toubro, S., Krog-Mikkelsen, I., Astrup, A., Effect of shortterm high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat
excretion. International Journal of Obesity 2005, 29, 292-301.
[63] Stancliffe, R. A., Thorpe, T., Zemel, M. B., Dairy attentuates oxidative and inflammatory
stress in metabolic syndrome. American Journal of Clinical Nutrition 2011, 94, 422-430.
[64] Wennersberg, M. H., Smedman, A., Turpeinen, A. M., Retterstol, K., et al., Dairy products
and metabolic effects in overweight men and women: results from a 6-mo intervention study.
American Journal of Clinical Nutrition 2009, 90, 960-968.
[65] Grundy, S. M., Denke, M. A., Dietary influences on serum lipids and lipoproteins. J Lipid
Res 1990, 31, 1149-1172.
[66] Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z., Holick, M. F., Decreased bioavailability
of vitamin D in obesity. The American journal of clinical nutrition 2000, 72, 690-693.
[67] Akhavan, T., Luhovyy, B. L., Brown, P. H., Cho, C. E., Anderson, G. H., Effect of premeal
consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and
insulin responses in young adults. American Journal of Clinical Nutrition 2010, 91, 966-975.

47

[68] Pal, S., Ellis, V., The Chronic Effects of Whey Proteins on Blood Pressure, Vascular
Function, and Inflammatory Markers in Overweight Individuals. Obesity 2009, 18, 1354-1359.
[69] Westphal, S., Kastner, S., Taneva, E., Leodolter, A., et al., Postprandial lipid and
carbohydrate responses after the ingestion of a casein-enriched mixed meal. The American
journal of clinical nutrition 2004, 80, 284-290.
[70] Tuohy, K. M., Probert, H. M., Smejkal, C. W., Gibson, G. R., Using probiotics and
prebiotics to improve gut health. Drug Discovery Today 2003, 8, 692-700.
[71] Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., et al., Gut microbiota from twins
discordant for obesity modulate metabolism in mice. Science 2013, 341, 1241214.
[72] Collins, S. M., Bercik, P., The relationship between intestinal microbiota and the central
nervous system in normal gastrointestinal function and disease. Gastroenterology 2009, 136,
2003-2014.
[73] Dinan, T. G., Cryan, J. F., Melancholic microbes: a link between gut microbiota and
depression? Neurogastroenterol Motil 2013, 25, 713-719.
[74] Chen, J., He, X., Huang, J., Diet Effects in Gut Microbiome and Obesity. Journal of Food
Science 2014, 79, R442-R451.
[75] Walsh, C. J., Guinane, C. M., O'Toole, P. W., Cotter, P. D., Beneficial modulation of the gut
microbiota. FEBS Lett 2014.
[76] Nielsen, F., Mikkelsen, B. B., Nielsen, J. B., Andersen, H. R., Grandjean, P., Plasma
malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style
factors. Clin Chem 1997, 43, 1209-1214.
[77] Haddad, E. H., Gaban-Chong, N., Oda, K., Sabaté, J., Effect of a walnut meal on
postprandial oxidative stress and antioxidants in healthy individuals. Nutrition Journal 2014, 13,
4.
[78] Vistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., et al., Advanced glycoxidation and
lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.
Free Radical Research 2013, 47, 3-27.
[79] Uribarri, J., Woodruff, S., Goodman, S., Cai, W., et al., Advanced Glycation End Products
in Foods and a Practical Guide to Their Reduction in the Diet. Journal of the American Dietetic
Association 2010, 110, 911-916.e912.
[80] Koschinsky, T., He, C. J., Mitsuhashi, T., Bucala, R., et al., Orally absorbed reactive
glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl
Acad Sci U S A 1997, 94, 6474-6479.

48

[81] Gaens, K. H. J., Stehouwer, C. D. A., Schalkwijk, C. G., Advanced glycation endproducts
and its receptor for advanced glycation endproducts in obesity. Current Opinion in Lipidology
2013, 24, 4-11.
[82] Stirban, A., Negrean, M., Götting, C., Uribarri, J., et al., Dietary Advanced Glycation
Endproducts and Oxidative Stress. Annals of the New York Academy of Sciences 2008, 1126,
276-279.
[83] Aldini, G., Vistoli, G., Stefek, M., Chondrogianni, N., et al., Molecular strategies to prevent,
inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free
Radical Research 2013, 47, 93-137.
[84] Wautier, J. L., Boulanger, E., Wautier, M. P., Postprandial hyperglycemia alters
inflammatory and hemostatic parameters. Diabetes & Metabolism 2006, 32, 2S34-32S36.
[85] Jara, N., Leal, M. J., Bunout, D., Hirsch, S., et al., Dietary intake increases serum levels of
carboxymethil-lysine (CML) in diabetic patients. Nutr Hosp 2012, 27, 1272-1278.
[86] Sebekova, K., Somoza, V., Dietary advanced glycation endproducts (AGEs) and their health
effects--PRO. Mol Nutr Food Res 2007, 51, 1079-1084.
[87] Harcourt, B. E., Sourris, K. C., Coughlan, M. T., Walker, K. Z., et al., Targeted reduction of
advanced glycation improves renal function in obesity. Kidney Int 2011, 80, 190-198.
[88] Pittas, A. G., Harris, S. S., Stark, P. C., Dawson-Hughes, B., The effects of calcium and
vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.
Diabetes Care 2007, 30, 980-986.
[89] Di Simplicio, P., Franconi, F., Frosal , S., Di Giuseppe, D., Thiolation and nitrosation of
cysteines in biological fluids and cells. Amino Acids 2003, 25, 323-339.
[90] Jenkins, D. J., Kendall, C. W., Josse, A. R., Salvatore, S., et al., Almonds decrease
postprandial glycemia, insulinemia, and oxidative damage in healthy individuals. J Nutr 2006,
136, 2987-2992.
[91] Frei, B., Stocker, R., Ames, B. N., Antioxidant defenses and lipid peroxidation in human
blood plasma. Proc Natl Acad Sci U S A 1988, 85, 9748-9752.
[92] Park, Y., Ziegler, T. R., Gletsu-Miller, N., Liang, Y., et al., Postprandial cysteine/cystine
redox potential in human plasma varies with meal content of sulfur amino acids. J Nutr 2010,
140, 760-765.
[93] Masha, A., Brocato, L., Dinatale, S., Mascia, C., et al., N-acetylcysteine is able to reduce
the oxidation status and the endothelial activation after a high-glucose content meal in patients
with Type 2 diabetes mellitus. J Endocrinol Invest 2009, 32, 352-356.
[94] Cardona, F., Tunez, I., Tasset, I., Garrido-Sanchez, L., et al., Circulating antioxidant
defences are decreased in healthy people after a high-fat meal. Br J Nutr 2008, 100, 312-316.

49

Chapter 2:
Experimental Design
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2.1 Introduction
The overall goal of this intervention study is to determine the impact of yogurt consumption on
intestinal barrier function in obese individuals. Obesity is associated with compromised intestinal
barrier function; animal and human studies support this connection [1, 2]. A compromised
intestinal barrier may promote chronic, low-level systemic inflammation. Obesity is also
associated with a chronically elevated inflammatory status, which is a contributing factor in the
development and pathogenesis of many diseases [2, 3]. In addition, postprandial inflammation
contributes to chronic inflammation [2]. Indeed, human trials show that ingestion of a highcalorie and/or high-fat meal acutely compromises intestinal barrier function and increases
translocation of lipopolysaccharide (LPS) from the intestine into the bloodstream [4-6]. Once in
the bloodstream, LPS elicits a strong inflammatory response, triggering the expression of many
pro-inflammatory cytokines [7, 8]. Chronic intake of high-fat foods also contributes to intestinal
barrier dysfunction and chronic inflammation by unfavorably altering the makeup of the
intestinal microbiota [9]. In their unaltered state, these microbes contribute to the normal
protective mechanisms of the intestinal barrier and reduce LPS translocation [9]. Due to the
frequency of meal consumption and the prevalence of high-fat foods in the Western diet, many
individuals spend large portions of the day in a state of elevated intestinal barrier dysfunction
and/or inflammation [10]. Therefore, dietary approaches to reduce postprandial and chronic
inflammation are of importance.
Human trials support the role of low-fat dairy in decreasing chronic inflammation in obese
individuals [13, 14]. In addition, numerous observational and intervention studies suggest the
potential benefits of dairy consumption over both the short and long term in lean, overweight,
and obese individuals [13-17]. However, the impact of low-fat yogurt consumption on intestinal
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barrier function and inflammation in the obese population has not been elucidated. This research
was designed to examine these associations. Secondary outcomes of this study were to examine
the impact of low-fat yogurt consumption on oxidative stress in obese women and to characterize
changes in dietary intake associated with this intervention.

2.2 Materials and Methods
2.2.1 Subject recruitment and screening
This study was approved by the Institutional Review Board at the University of Connecticut,
approval number H12-168. The study was registered at www.clinicaltrails.gov, identifier number
NCT01686204. Recruitment began in September 2012; as of August 2014, the study was still in
progress. A complete timeline of the study is depicted in Figure 2.1.
Healthy, lean (BMI 18.5-27 kg/m2; n = 66) and obese (BMI 30-40 kg/m2; n = 66),
premenopausal women between the ages of 21 and 55 were targeted for recruitment from the
University of Connecticut in Storrs, CT and surrounding areas. Only women were selected for
the study in order to reduce the potential for confounding variables. For example, it has been
shown that men and women have different metabolic responses to a high-fat meal [19-22].
Addition of carbohydrates to a high-fat meal reduced postprandial plasma triglycerides in women
but not men [22]. Plasma triglyceride responses following meals high in unsaturated and
saturated fats also differed between genders, and the plasma triglyceride AUC was significantly
higher in men versus women [20]. Finally, plasma interleukin 6 (IL-6) and tumor necrosis factor
alpha (TNFα) increased to a greater degree in women than men following intake of a high-
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calorie, high-fat meal [21]. Hormonal changes associated with menopause may increase
oxidative stress and facilitate the establishment of a pro-atherogenic lipid and cholesterol profile
[23]. Therefore, only premenopausal women were recruited for participation in this study. In
addition, only healthy women were recruited; this was to eliminate the potential for confounding
inflammatory status, as many diseases have some component of inflammation. Also, antihypertensives and other medications may interfere with or obscure the mechanisms by which
yogurt modulates postprandial changes.
Recruitment methods included posting flyers in academic buildings, dining halls, and residence
halls, submitting written ads to university email groups, and placing ads on TV monitors around
campus. Additional methods included advertising in local and regional publications, public
buses, attending various health fairs and promotional events, and posting flyers in area
businesses and other public locations.
Following initial contact with potential participants, a phone screening interview was arranged
for interested individuals. The phone screening consisted of a 15 to 20 minute call, during which
potential participants received a detailed explanation of our study aim and the procedures.
Participants were also asked a series of health questions to ensure eligibility. Eligibility criteria
included a self-reported lack of cancer, diabetes, high blood pressure (≥ 140/90 mm Hg), high
cholesterol (≥ 240 mg/dL), cardiovascular disease, arthritis, anemia, gastric conditions,
vegetarianism, allergies to dairy, soy, or egg products, and participation in a weight-loss
regimen. The use of medications for high blood pressure, blood sugar, gastric conditions,
estrogen replacement therapy, and regular use of anti-inflammatory drugs were also causes for
disqualification. Medications for cholesterol, hypothyroidism, mental health conditions, and the
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use of contraceptives were allowed. Individuals who met all inclusion criteria and remained
interested in participating were scheduled for a screening visit (Visit 1).
At Visit 1, written informed consent was obtained from all participants, following which a health
questionnaire was completed to ensure that the individual met the inclusion criteria for our study.
Then, anthropometric measurements were taken. Measurements included height, weight, waist
circumference, and blood pressure. Height and weight were measured to the nearest half
centimeter and tenth of a kilogram, respectively, with a Detecto 758C scale, from which BMI
was calculated. Waist circumference was measured by hand with a measuring tape, and blood
pressure was measured using an Omron HEM-780 monitor for lean individuals and an Omron
BP710 monitor for obese individuals. Two measurements were taken; the first after 5 minutes of
sitting upright in a phlebotomy chair, and the second at least 3 minutes following the first.
All individuals who attended Visit 1 cleared and were enrolled in the study. Following
anthropometric measurements, subjects were provided with a binder of information, including
reminder lists for each visit, a guide to dairy serving sizes, and instructions and supplemental
materials for completing dietary records. Subjects were also trained in completing dietary
records. Following Visit 1, subjects were randomized to either the yogurt or soy pudding
(control) group.
Two weeks prior to the second study visit, all participants were asked to begin the washout
period, during which no foods containing probiotics could be consumed. Participants were
provided with an extensive list of probiotic-inclusive foods. This restriction endured for the
entire length of the study. Participants were also asked to limit their dairy consumption to ≤ 4
servings per day for the duration of the study. Finally, participants were asked to complete 3 days
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of dietary records. This was to ensure compliance to the dietary restrictions as well as to provide
a broad overview of the individual’s typical dietary patterns. Diets were recorded during the
washout period, on nonconsecutive days, and included 1 weekend day. All food and beverages
(including water) consumed during a 24 h period were recorded. Participants were instructed to
provide as much information as possible about each food item and to save the packaging of any
items about which they were unsure. If individuals consumed food from a dining hall or
restaurant, they were asked to make their best estimation of serving size. Home-prepared recipes
were to be broken down into each individual component to increase the accuracy of the record.
Individuals were provided with serving sizes and typical amounts of common foods to assist with
their estimations. Finally, participants were asked to refrain from taking any dietary supplements
during their enrollment in the study.
2.2.2 Dietary intervention and sample collection
Visit 2 took place after a 2-week washout period. This visit constituted the initial acute portion of
the dietary intervention. Participants were instructed to avoid caffeine consumption and vigorous
exercise for 24 h prior to Visit 2, to fast for 12 h, and to consume sufficient amounts of water to
avoid light-headedness during the blood draw.
Visit 2 was conducted in the morning, typically beginning between 7:00 a.m. and 9:30 a.m., and
lasted approximately 5 h per person. Upon arrival at the study center, subjects gave verbal
confirmation that they had met the pre-visit requirements, and that they were well hydrated.
Dietary records were collected, and anthropometric measurements were taken and recorded.
Protocol for anthropometrics was identical to that described for Visit 1. Next, 50 mL of venous
blood (30 mL in sodium heparin vacuum tubes and 20 mL in EDTA vacuum tubes) was
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collected from the antecubital vein either through a catheter or via a single-stick insertion. After
blood collection, tubes were gently inverted 8-10 times; 2 heparin tubes were placed at room
temperature for white blood cell separation while the other 3 tubes were placed on ice.
Processing occurred within 30 min of obtaining the samples. Briefly, samples were centrifuged
at 1500 x g for 15 min at 4°C. Plasma was aliquotted into labeled 2 mL cryogenic vials and
flash-frozen in liquid nitrogen. All samples were stored at -80°C until further analysis.
Following the fasting blood draw, participants were informed of their randomization to either the
low-fat yogurt the soy pudding group, and were asked to consume 8 oz. of the snack. The yogurt
was Yoplait Original, offered in strawberry, strawberry banana, raspberry, and peach flavors.
This particular type of yogurt was chosen because it is widely available and representative of
most commercial low-fat yogurts. The soy pudding was Zensoy Organic, offered in chocolate,
vanilla, and chocolate/vanilla swirl flavors. This pudding was selected as a control because it is
dairy-free, isocaloric, contains no probiotics, and is similar in nutrient content to the yogurt. In
addition, previous studies have found soy to have no impact on modulating chronic oxidative
stress and inflammation or postprandial metabolism in obese individuals [14, 24]. The soy
pudding was also selected because it is similar in texture to the yogurt and both products are
packaged in the same size of container and can be consumed in a similar manner. This is
important because these qualities may influence how and when participants consume the snacks
[25]. Texture is also associated with feelings of satiety [25]. The nutrient content of both snacks
is listed in Table 2.1.
After 10 min and ingestion of 8 oz. of yogurt or pudding, participants were given a high-calorie,
high-fat meal. The meal consisted of 2 Jimmy Dean sausage egg muffin sandwiches and 2 hash
brown patties (Stop & Shop brand). Ketchup was also provided; approximately 20% of subjects
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opted to add it to the breakfast in moderate quantities. The breakfast (excluding yogurt or
pudding and ketchup) contained approximately 960 calories. With the yogurt or pudding, total
calorie content of the breakfast was 1180 calories. Complete nutrient composition of the
breakfast is listed in Table 2.2. Participants were supervised throughout consumption of the meal
and when they finished, the time was recorded. Subjects were allowed only water during and
after the meal.
Following consumption of the high-fat meal, blood samples were collected 1,2, 3, and 4 h
postprandially. At each time point, 10 mL of heparinized blood and 10 mL of EDTA blood was
collected. As before, tubes were gently inverted 8-10 times and placed on ice for up to 30 min
prior to centrifugation. After collection of the last blood sample, Visit 2 was complete. At this
time, subjects were instructed to resume their normal dietary and exercise habits, but to continue
to avoid probiotic foods, refrain from taking dietary supplements, and limit dairy consumption.
For individuals in the yogurt group, the yogurt constituted 2 servings of dairy; an additional 2
were allowed each day. The pudding was dairy-free; individuals in this group were allowed a full
4 servings of dairy each day. Once Visit 2 was completed, caffeine was allowed at all times
except 24 h prior to each visit. Alcohol was acceptable when consumed in moderation.
Prior to their departure from Visit 2, participants were provided with yogurt or pudding supplies
to last approximately 1 week. Subjects visited the study center every 7 to 10 days for the duration
of the study to restock yogurt or pudding supplies. The intervention period was 9 weeks in
length. This 9-week period constituted the chronic portion of the intervention.
During this period, participants were required to consume 12 oz. of yogurt or soy pudding each
day. Product lids were saved and returned to us weekly to ensure compliance, and it was
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necessary for subjects to maintain at least 80% compliance in order to continue their
participation. Additionally, at each visit to the study center subjects were monitored for illness,
health status, were asked for verbal confirmation of consumption of the products, and were
encouraged to voice any other questions or concerns they might have. It was also noted how and
when subjects preferred to consume their yogurt/pudding each day.
At the end of week 5 and again at the end of week 8, subjects visited the study center in the
morning for anthropometric measurements and to provide a fasting blood sample. For these visits
(Visit 3 and Visit 4), participants arrived fasted and with no caffeine or vigorous exercise within
the previous 24 h. Anthropometric measurements were taken as before, following which 40 mL
(20 mL in heparinized vacuum tubes and 20 mL in EDTA vacuum tubes) of venous blood was
collected via the single stick method. This was the duration of each visit.
Between Visit 4 and Visit 5, subjects were again asked to complete 3 days of dietary records.
Guidelines were identical to those described previously, and completed records were used to
assure compliance to all dietary restrictions as well as adherence to yogurt or pudding
consumption. Visit 5 took place at the end of week 11. This visit comprised the final day of the
intervention and the second acute portion of the trial. The procedure for this visit was identical to
that for Visit 2, as described above.
Following Visit 5, subjects’ participation in the study was complete. All dietary records were
entered into the Nutrition Data Systems for Research (NDSR) dietary analysis software
following Visits 2 and 5. The program analyzes daily dietary intakes and provides output files of
nutrient intake by meal, food, food group, and total daily intake. This data was used to examine
changes in dietary intake associated with chronic yogurt and soy pudding consumption in lean
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and obese individuals. Fasting blood samples from each visit were used to examine the impact of
chronic yogurt consumption on biomarkers of oxidative stress in obese individuals. Visit 2 and 5
fasting and hourly blood samples were used to examine the impacts of co-consumption of yogurt
with the high-calorie, high-fat meal on postprandial oxidative stress in obese individuals.
Individual biomarkers, expected outcomes, and results will be discussed in later chapters.
2.2.3 Statistical Analysis
The study was powered to detect an 8.2% difference in sCD14 (the primary outcome), a 29%
difference in LPS, and a 21% difference in toll-like receptor 4 (TLR4) [4, 31]. For fasting plasma
samples, the study was powered to detect an 11% difference in IL-6 and a 5% difference in
TNFα [14]. Level of significance was set at α = 0.05 with a two-sided 95% confidence interval.
Attrition rate was expected to be 10%.
Analysis of meal consumption time was done by paired and unpaired t-test using GraphPad
Prism 5.0. Level of significance was set at P = 0.05. Statistical analysis of dietary intake and
oxidative stress variables will be discussed in upcoming chapters.
2.3 Results and Discussion
2.3.1 Enrollment
A full chart detailing study enrollment in provided in Figure 2.2. Initial rates of reply to our
emails and/or voicemails were less than 50%, and among those who scheduled a phone screening
interview, around 50% were not available at their specified time and never returned our calls. Of
those who began the phone screening, approximately 15% of lean and 23% of obese individuals
did not clear. The most common reasons for disqualification included being postmenopausal,
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having a hysterectomy, high blood pressure or diabetes, a BMI that fell outside of our range, or
vegetarianism. Of those who cleared the phone screening, 11% failed to attend Visit 1; some
individuals gave health or scheduling-related reasons while others failed to contact us in
advance. When attempts to make contact failed, these individuals were dropped from the study.
As of June 2014, 121 individuals had cleared the phone screening and 106 attended Visit 1. All
individuals who attended Visit 1 cleared the screening process and were enrolled in the study.
Between Visit 1 and Visit 2, 11 lean individuals and 8 obese individuals (15% of enrolled
individuals in each group) withdrew from the study. Reasons for withdrawal included scheduling
conflicts, loss of interest, and changes in health status. Additionally, 2 lean and 2 obese
participants voluntarily withdrew from the study between Visit 2 and Visit 3; of these, 3 were
unable to comply with the yogurt/pudding consumption and the fourth was unable to attend her
scheduled visits. A participant in the obese yogurt group was removed from the study prior to
Visit 4 due to a lack of compliance. As of June 2014, 47 lean individuals (24 assigned to the
yogurt group and 23 to the pudding group) and 35 obese individuals (17 assigned to the yogurt
group and 18 assigned to the pudding group) had completed the study.
2.3.2. Participant characteristics
Both lean and obese participants were primarily Caucasian (77% and 80%, respectively),
unmarried (83% and 54%, respectively), and in college or graduate school (87% and 54%,
respectively). There were no statistically significant differences in height between lean and obese
participants. However, obese participants were significantly older (P < 0.0001), and had a larger
BMI (P < 0.0001) and waist circumference (P < 0.0001) than the lean participants. Additionally,
systolic blood pressure (P = 0.0002) and diastolic blood pressure (P = 0.0025) were significantly
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higher in the obese study population. However, no changes in any anthropometric parameters
changed as a result of the intervention in either lean or obese individuals. Initial participant
characteristics are listed in Table 2.3.
2.3.3 Nutritional changes of study products
In September 2013, Zensoy discontinued the vanilla (and therefore chocolate/vanilla swirl)
formulation of the soy pudding and from then on, only chocolate pudding was available. There
were also slight changes to the product in terms of ingredients and nutrient content. Notably,
calcium decreased (15%-6% DV), saturated fat increased (0-0.5 g), potassium increased (30-150
mg), and vitamin B12 decreased (25%-6% DV) per 4 oz. container. Also, sea salt was replaced
by evaporated salt. Subjects enrolled at the time noted an improvement in taste and texture.
The nutrient profile of the breakfast sandwiches also changed midway through the study.
Initially, nutrient content of each sandwich totaled 330 calories, 20 g fat, 14 g protein, and 800
mg sodium. In October 2013, each sandwich increased by 20 calories and 1 g of fat, while
protein and sodium content decreased by 1 g and 100 mg, respectively. This brought the total for
each sandwich to 350 calories, 21 g fat, 13 g protein, and 700 mg of sodium. Carbohydrate
content did not change. Overall, the high-calorie, high-fat breakfast increased by 40 calories and
2 g fat while protein decreased by 2 g and sodium by 200 mg. In the context of the entire
breakfast, the impact of these changes is expected to be negligible.
2.3.4 Observational outcomes
Initially, many individuals expressed a preference towards being randomized to the yogurt group,
possibly due to their unfamiliarity and/or reluctance towards consuming the soy pudding. Most
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participants did not consume much soy as a part of their normal diet and of those that did, none
mentioned having previously consumed this particular type of pudding. However, reactions to
the pudding were largely favorable, though preference for the vanilla pudding was highly
polarized whereas most participants did not mind the other two flavors. Overall compliance to
yogurt/pudding consumption was nearly 90%, and only 1 person was removed for failure to
comply. Three others voluntarily withdrew due to compliance issues; of these, 2 were due to a
dislike of the pudding, and the third individual could not consume 12 oz. of yogurt per day.
Despite the strong desire to be placed in the yogurt group, individuals in both groups reported
fatigue of consuming each product by about week 6 of the intervention. At this time, dietary
consumption patterns often changed as well. Initially, individuals expressed common tendencies:
(1) eating one 4 oz. container of yogurt or pudding with each meal, (2) eating all 12 oz. of yogurt
at breakfast; or (3) eating all 12 oz. of yogurt or pudding for dessert following dinner. As the
study progressed, more subjects seemed inclined to consume all 12 oz. at the same time and
mixed with other foods to simply “get it over with.” Making the product into smoothies was
common in the yogurt group but much less so in the pudding group. In fact, only 1 subject
reported making smoothies out of the pudding, while many individuals reported consuming the
yogurt in this manner.
Notably, consumption of the high-calorie, high-fat meal was not asked to be completed within a
certain timeframe, and varied from 20 min to nearly 2 h, with an average of 38.2 ±13.74 min at
Visit 2 and 34.44 ± 12.94 min at Visit 5, though this difference was not significant (p = 0.086).
There was also no difference in meal consumption time between lean and obese individuals.
Though these differences are not significant, with such a range of times it would be interesting to
examine the association between the speed of meal consumption and postprandial parameters.
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2.3.5 Strengths and limitations
Strengths of this study include the large sample size and the enrollment of only healthy,
premenopausal women. This eliminated numerous confounding variables associated with gender
differences in postprandial metabolism and fasting levels of oxidative stress and inflammation.
This also eliminated documented differences in oxidative stress and metabolic parameters
between pre- and postmenopausal women, thus reducing individual variation in biomarkers. The
use of healthy women eliminated potential effects of conditions that may have complicated the
blood draw and/or medications that may have blunted or interfered with the effects of the yogurt.
All participants were healthy, without signs of cardiovascular disease, diabetes, or any other
metabolic conditions. Studies show that 10-25% of obese individuals are classified as
metabolically healthy obese (MHO) [34]. These individuals are obese in terms of their BMI but
do not experience the metabolic abnormalities that are typically associated with obesity, though
the causal factors behind this phenomenon are not well understood [34]. This subpopulation was
the one from which our study participants were recruited. Due to this difference, and the
inclusion of only MHO individuals in our study, outcomes may not be readily extrapolated to
non-MHO individuals, who constitute the majority of the obese population. In addition, these
MHO individuals may not exhibit the same degree of postprandial dysmetabolism as non-MHO
individuals. Therefore, the impact of yogurt consumption on postprandial metabolism in nonMHO individuals remains to be seen.
The use of Yoplait Original yogurt is a strength of this study, as this brand is formulated
similarly to most commercial low-fat yogurts. Therefore, any beneficial health outcomes
associated with this study could be feasibly translated into the average person’s diet. However,
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the use of Yoplait Original is a limiting factor in that it contains more added sugars and less
protein and probiotics than other commercial regular or Greek-style yogurts. For individuals with
impaired glucose tolerance, the increased sugar intake associated with incorporation of low-fat
yogurt into the diet may be detrimental. In addition, any benefits of probiotic consumption may
be somewhat limited due to the presence of fewer numbers and strains of the bacteria than in
yogurts formulated with probiotics.
Perhaps the greatest limitation of this study is that it is not a crossover design. This is due to the
lack of evidence in regards to washing out the intervention effects. Even with this data available,
the length of the study would limit feasibility. Due to the nature of the intervention, the study is
also not blinded. Additionally, it remains to be seen whether the soy pudding was an adequate
control snack. Because the pudding was only offered in the chocolate flavor for the majority of
the intervention, it is possible that individuals were not consuming the 2 snacks in a similar
manner. For instance, many participants seemed to prefer to consume the yogurt with breakfast
while pudding consumption, likely attributable to its chocolate flavor, seemed to take place
primarily later in the day and often as a snack or dessert rather than as part (or all) of a meal.
A final limitation is that where the women were in their menstrual cycle was not taken into
consideration. Previous studies show differences in certain metabolic parameters in association
with phases of the cycle [35, 36]. For example, insulin sensitivity exhibits variation throughout
the cycle. Insulin sensitivity was reduced following an oral glucose tolerance test in women in
the luteal phase of their cycle [36]. Oxidative stress levels also vary, with highest levels
occurring in the luteal phase [35]. This can be attributed to the antioxidant capacity of estrogen
and the natural fluctuations of the hormone throughout the cycle. Indeed, one study found both
urinary hydrogen peroxide and thiobarbituric acid-reactive substances to be increased during the
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luteal phase of the cycle [35]. Because of this, previous studies examining inflammation and
oxidative stress required the women to begin participation in the intervention during the
follicular phase of the cycle to eliminate this potential source of variation in oxidative stress
biomarkers [22, 29, 37]. As this is not something we controlled for in this study, it may confound
observed changes in biomarkers of oxidative stress, particularly in fasting plasma samples.
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Table 2.1. Nutritional profile of the low-fat yogurt and soy pudding snacks.

Serving size

Low-fat
yogurt
4 oz

Soy pudding
(initial)
4 oz

Soy pudding
(final)
4 oz

Calories

110

110

110

Calories from fat

10

10

10

Fat (g)

1

1

1

Saturated fat (g)

0.5

0

0.5

Cholesterol (mg)

5

0

0

Carbohydrates (g)

22

22

22

Sugars (g)

17

18

18

Protein (g)

3

3

3

Potassium (mg)

0

30

150

Calcium (mg)

150

150

60

Vitamin D (mcg)

2.25

2.25

2.25

Vitamin B12 (mcg)

-

0.6

0.14
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Table 2.2. Nutritional profile of the high-calorie, high-fat meal.
Sandwich

Hash brown
patty

Serving size

1 sandwich

1 patty

Calories

330-350

130

2 sandwiches + 2
hash brown patties
920-960

Calories from fat

180-190

60

480-500

Fat (g)

20-21

7

54-56

Saturated fat (g)

8

1

18

Cholesterol (mg)

125

0

250

Carbohydrates (g)

26

15

82

Fiber (g)

1

2

6

Protein (g)

13-14

1

28-30

Sodium (mg)

700-800

300

2000-2200

Potassium (mg)

290

170

920
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Meal total

Table 2.3. Initial anthropometric characteristics of lean and obese study participants.

Age (y)

LY
(n = 24)
24.8 ± 5.0

LS
(n = 23)
23.9 ± 3.7

OY
(n = 17)
33.6 ± 11.8 **

OS
(n = 18)
31.3 ± 8.5 ‡

Weight (kg)

63.2 ± 8.5

60.1 ± 7.7

92.8 ± 9.7 **

92.5 ± 12.3 ‡

BMI (kg/m2)

23.0 ± 2.5

22.0 ± 2.0

33.9 ± 3.2 **

34.1 ± 2.8 ‡

Waist
94.7 ± 7.2 ‡
73.3 ± 7.7
69.8 ± 6.8
93.5 ± 8.1 **
circumference (cm)
Systolic blood
117 ± 12 †
103 ± 11
107 ± 12
113 ± 9 *
pressure (mm Hg)
Diastolic blood
71 ± 8
75 ± 10
78 ± 7 *
79 ± 6 †
pressure (mm Hg)
LY = lean yogurt, LS = lean soy, OY = obese yogurt, OS = obese soy. Between-group analysis
by unpaired t-test. * P < 0.05 from LY, ** P < 0.0001 from LY, † P < 0.05 from LS, ‡ P <
0.0001 from LS.
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Figure 2.1. Study design.
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Phone prescreening
(n = 159)

Passed phone
prescreening
(n = 121)

Dropped prior to randomization
(n = 3, all lean)
Scheduling conflict (1)
Other (2)

Attended visit 1
(n = 106)

Obese enrolled
(n = 46)

Assigned
Obese/Yogurt
(n = 24)

Assigned
Lean/Pudding
(n = 26)

Withdrew (n = 5)
Excluded (n = 0)

Withdrew (n = 6)
Excluded (n = 0)

Withdrew (n = 3)
Excluded (n = 0)
Visit 2

Withdrew (n = 0)
Excluded (n = 0)

Lean/Yogurt
Completed All Visits
(n = 26)

Did not clear (n = 38)
Wrong BMI (9)
Smoking (5)
Not Interested (4)
Vegetarian (5)
Hysterectomy (4)
Postmenopausal (3)
High blood pressure (2)
Anemia (1)
Met other exclusion
criteria (5)

Visit 1

Lean enrolled
(n = 57)

Assigned
Lean/Yogurt
(n = 31)

•
•
•
•
•
•
•
•
•

Assigned
Obese/Pudding
(n = 22)

Withdrew (n = 2)
Excluded (n = 0)

Visit 2

Withdrew (n = 1)
Excluded (n = 1)

Withdrew (n = 2)
Excluded (n = 0)

Obese/Yogurt
Completed All Visits
(n = 16)

Lean/Pudding
Completed All Visits
(n = 21)

Lean completed
all visits
(n = 47)

Withdrew (n = 1)
Excluded (n = 0)

Obese/Pudding
Completed All Visits
(n = 19)

Obese completed
all visits
(n = 35)

Figure 2.2. Diagram of study progress, including recruitment, enrollment, and completion of
participants as of August 2014.
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Chapter 3:
Changes in Nutrient Intake Associated with Daily
Consumption of Low-Fat Yogurt
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3.1 Introduction
The main goal of this intervention is to determine the impact of low-fat yogurt consumption on
intestinal barrier function in obese women. However, when conducting a dietary intervention, it
is necessary to record any alterations from normal dietary habits that may arise as a result of the
intervention. Therefore, a secondary aim of this study is to examine the impact of daily
consumption of low-fat yogurt and soy pudding on dietary intake patterns in both lean and obese
women. This chapter will focus on self-reported changes in intake of calories, macronutrients,
and micronutrients relevant to dairy products that may change as a result of the intervention.
Epidemiological studies support an inverse association between calcium intake and body fat, and
between low-fat dairy consumption and BMI, blood pressure, and all-cause mortality [1-4]. In
the postprandial period, co-consumption of dairy products is associated with reductions in fat
absorption and deposition, increases in fatty acid β-oxidation, and greater fecal fat excretion [6,
7]. While many of these modulations cannot be directly associated with individual components
of dairy products, calcium is known to interfere with fat absorption and increase fecal fat
excretion by disrupting micelle formation [8]. Therefore, co-consumption of calcium-containing
foods with a high-fat meal may limit fat absorption, thereby modulating the postprandial effects
of the meal. Chronically, increased calcium consumption may also foster favorable changes in
body composition due to promotion of fatty acid β-oxidation.
It is important to note that 700-800 mg/day of non-supplemental calcium sources are needed to
achieve its benefits [7, 9]. For individuals who regularly consume < 700 mg/day, increasing
calcium intake to > 700 mg/day is associated with reductions in blood pressure and increases in
weight and fat loss when combined with an energy-restricted diet [7, 9]. Individuals that
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consume > 700 mg/day may not receive the same benefits from increased calcium intake as those
who consume less. However, the recommended dietary allowance (RDA) for adult women is
1000 mg/day of calcium and many women, particularly those over the age of 50, do not reach
this amount [10]. Therefore, incorporation of low-fat yogurt into the diet may be a means to
reach this goal, as adequate calcium intake is necessary for maintenance of many facets of
physiological function [10].
Studies suggest that absorption of calcium is vitamin D dependent [12, 13]. Indeed, the
biosynthesis of intestinal calbindin, a protein required for active calcium uptake, is modulated by
vitamin D [14]. Though calcium is also absorbed by passive diffusion, this occurs only when
intake is high. Therefore, under circumstances of normal calcium intake, adequate vitamin D is
critical to maintain calcium absorption [10]. Low serum 25-hydroxyvitamin D and calcium
intake are associated with an increased risk for developing type-2 diabetes [15]. Though vitamin
D is also synthesized by the body in response to ultraviolet light, latitude and season play large
roles in daily sun exposure [10]. Particularly during winter months or in climates that lack
exposure to intense sunlight, vitamin D synthesis by the body is likely to be low. Therefore,
dietary intake will need to increase to supplement this deficit. The low-fat yogurt and soy
pudding used in the present study are fortified with vitamin D; incorporation into the diet would
contribute to adequate vitamin D intake.
In addition to calcium and vitamin D, dairy products contain many bioactive components that
may contribute to the observed health benefits, including casein, whey, vitamins, minerals, shortchain fatty acids, probiotics (in fermented products), and certain bioactive peptides [5, 16-18].
Despite the established health benefits of dairy consumption and the identification of these
bioactive components, much remains unknown. For example, the impact of consumption of
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individual dairy products on various health outcomes has not been established. No studies
specifically examine the impacts of low-fat yogurt consumption on postprandial and chronic
inflammatory parameters in obese women. This study aims to examine these associations. In
establishing these outcomes, it is also necessary to monitor changes in dietary intake associated
with the intervention, as dietary changes may be important contributors to the observed results.

3.2 Materials and methods
3.2.1 Dietary restrictions
Two weeks prior to commencement of the dietary intervention, participants began a washout
period. During this period, participants were asked to stop taking any dietary supplements, limit
their dairy intake to no more than 4 servings per day, and refrain from consuming any foods
containing probiotics. This included yogurt and any yogurt-based product, coleslaw, sauerkraut,
miso, tempeh, kimchi, probiotic milk products, and other specialty items fortified with probiotic
bacteria, including teas and chocolates. At their initial screening visit, participants were provided
a list of items, as well as instructions to examine food labels for indications of probiotic cultures.
Adherence was ensured by verbal affirmation and completion of dietary records. The protocol
for recording dietary intake will be discussed in more detail below.
3.2.2 Dietary intervention
A complete explanation of this intervention is provided in Chapter 2. Briefly, the intervention
period began at week 2, following the 2-week washout. During the intervention, participants
were asked to maintain the same restrictions as during the washout period while continuing with
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their normal dietary and exercise patterns. The intervention was 9 weeks in length, during which
participants were asked to consume either 12 oz. of low-fat yogurt (Yoplait Original in
strawberry, strawberry-banana, raspberry, or peach flavors) or dairy-free soy pudding (Zensoy
Organic in chocolate, vanilla, or chocolate-vanilla swirl flavors) each day. Participants were
required to maintain 80% compliance as assessed by product lids returned on a weekly basis.
Compliance to dietary restrictions was assessed by verbal affirmation and analysis of a second
set of dietary records, completed prior to the final study visit (week 11).
In September 2013, Zensoy reformulated the soy pudding and eliminated the vanilla and
chocolate-vanilla swirl flavors, leaving only chocolate pudding. The ingredient profile was also
slightly modified, thereby altering the nutrient profile. Saturated fat content increased (0-0.5 g),
potassium increased (30-150 mg), calcium decreased (15%-6% DV), and vitamin B12 decreased
(25%-6% DV) per 4 oz. container. Of greatest importance is the change in calcium content. Prior
to the reformulation, both the yogurt and soy snacks contained the same amount of calcium (45%
DV per 12 oz.), such that all subjects received the same amount of calcium as a result of the
intervention. Following the reformulation, participants in the soy group received only 18% DV
calcium per 12 oz. of pudding. However, this reformulation occurred early in study. Therefore,
the majority of participants consumed the reformulated, lower calcium version of the pudding.
3.2.3 Dietary records
As discussed in Chapter 2, materials to record dietary records were provided to subjects during
their screening visit, along with instructions and a detailed example chronicling how to complete
the dietary records. The records included time of intake, food item, and amount. Supplemental
materials were provided, listing common serving amounts and examples of 0.5 cup and 1 cup of
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food to assist with estimation of intake. The instructions highlighted the importance of specificity
when recording the diet, i.e. reporting brand names and qualifiers listed on the labels, cooking
methods, and any additives, particularly fats and salt used in cooking and additions to coffee.
Recipes needed to be broken down into individual ingredients while components of purchased
meals needed to be estimated to the best of the subject’s ability. Participants were also instructed
to save the packaging of any products that might cause confusion; these were handed in along
with the completed records.
Dietary records were collected from each subject at weeks 2 and 11. Each set consisted of 3 days
of records, 2 during the week and 1 on a weekend, from non-consecutive days, so as to receive a
broad overview of the subject’s typical diet. Records turned in at week 2 took place during the
washout period and should have included no probiotic-containing products and ≤ 4 daily
servings of dairy. Those from week 11 were from the final 3 weeks of the intervention period,
and should have included the yogurt or pudding products but no other probiotic foods and ≤ 4
daily servings of dairy. All dietary information was self-reported. On site, records were checked
to ensure comprehensibility and specificity; where this was lacking, subjects were asked to
provide necessary details to the best of their ability.
3.2.4 Entry of dietary records
Dietary intake data was recorded using Nutrition Data System for Research (NDSR) software
versions 2011, 2012, and 2013, developed by the Nutrition Coordinating Center (NCC),
University of Minnesota, Minneapolis, MN. Final calculations were completed using NDSR
version 2013. The NDSR time-related database updates analytic data while maintaining nutrient
profiles true to the version used for data collection. Subjects’ name, identification number,
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gender, and age range were recorded, along with the date of each record. NDSR allows for the
selection of meal time and meal type (breakfast, lunch, dinner, snack, beverage only). All records
were assumed to be accurate and representative of the participant’s normal diet.
Entering the records was more challenging than anticipated. While fruits, vegetables, and other
common items were fairly simple to locate and record, packaged foods, restaurant or commercial
meals, and university meals proved much more complicated. Because many of our participants
were university students, meals purchased from dining halls, campus markets, and local
restaurants were common. However, nutritional information for these meals was often difficult to
locate. Additionally, new, local, and uncommon products were often not listed in the database.
Frequently, upon entering individual records into the database, it became evident that the
provided data were not in agreement with the level of specificity required by NDSR. When
possible, subjects were contacted and asked to clarify the composition of foods. If the subject
was unable to be reached or was unable to provide more specific information, alternate steps
were taken. Where possible, the ingredient and/or nutrition fact labels of these foods were
searched online. A picture of the ingredient labels could sometimes be located on the product
website, and restaurants often provide basic nutrition facts for their menu items. When this
information was accessible, it was compared to that of the products listed in NDSR, and the most
similar alternative was selected. For restaurant menu items, the ingredients, measurements, and
preparation methods were established as accurately as possible via the information provided.
When dietary information could not be located, a visual comparison of foods was performed,
whereby the recorded food and the options in the database were searched online, and the most
similar alternative was selected based on pictures of the food itself, the packaging, any labels or
claims, and any other available information. In these cases, the original food and the database
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substitute were recorded. For cases in which preparation methods or the list of ingredients were
not detailed enough to allow for accurate estimation, the ‘unknown’ option was selected in
NDSR.
To ensure consistency, a standardized list was created for common items. These were items that
were assumed by most subjects to be of a normal size. Items included many fruits and
vegetables, slices of pizza, eggs, and bread slices. All items were assumed to be of medium size,
unless expressly specified by the participant. Items such as butter and peanut butter, which are
most commonly salted, were assumed to be so unless otherwise specified. Food preparation
methods were also standardized.
3.2.5 Analysis of dietary records
Analysis of dietary intake was also conducted using the NDSR software. The database provided
a comprehensive list of daily nutrient intake that included calories, all macro- and
micronutrients, as well as individual amino acids, fatty acids, and artificial sweeteners. For our
analysis, we elected to focus on caloric intake, macronutrients, and a select few micronutrients
that were likely to be impacted by yogurt consumption. These nutrients included fat, saturated
fat, carbohydrates, protein, cholesterol, calcium, vitamin D, and vitamin C. NDSR also provided
output reports of dietary intake by food group. NDSR defined a serving of dairy as 8 fl. oz. of
milk, 1 cup of yogurt, 1.5 oz. of cheese, 2 oz. of cream cheese, and 0.5 cups of ice cream. A
serving of fruit was defined as 1 medium piece, or approximately 0.26 cups dried fruit.
Vegetable servings was highly varied; 0.39 cups carrots, 0.5 cups broccoli, 1 cup lettuce or corn,
and 1 medium potato were each equivalent to a serving of vegetables. These reports were
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examined for associations between changes in macro- and micronutrient intake and changes in
consumption of foods from certain food groups.
3.2.6 Statistical analysis
A participant in the lean soy group was excluded from the analysis due to missing records. Final
sample size was n = 24 in the lean yogurt (LY) group, n = 22 in the lean soy (LS) group, n = 17
in the obese yogurt (OY) group, and n = 18 in the obese soy (OS) group.
All statistical analysis was conducted using GraphPad Prism 5.0 software. This included analysis
of macro- and micronutrient intake and intake by food group. Between-group analysis was
conducted by repeated-measures two-way ANOVA, using time and treatment as factors;
Bonferroni post-tests were carried out where appropriate. Within-group analysis was conducted
by paired t-test as indicated in tables and figures. Significance level for all statistical tests was set
at P < 0.05.

3.3 Results
3.3.1 Changes in macronutrient intake
For this analysis, calorie, carbohydrate, fat, saturated fat, cholesterol, and protein intake were of
interest. Among lean individuals, there were no significant changes in calorie, fat, saturated fat,
protein, or cholesterol intake following consumption of the yogurt or soy pudding (Table 3.1).
However, there was a significant time effect for carbohydrate intake in the lean group (P =
0.0009) (Figure 3.1 (a)). Carbohydrate intake increased in the LY group, from 197 ± 39 g/day
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(mean ± SD) at week 2 to 224 ± 54 g/day at week 11 (P = 0.0260), and in the LS group, from
201 ± 54 g/day at week 2 to 232 ± 46 g/day at week 11 (P = 0.0146).
Among obese individuals, there were no differences in calorie, fat, or saturated fat intake (Table
3.2). As with lean individuals, there was a significant time effect for carbohydrate intake in obese
individuals from the intervention (P = 0.0089) (Figure 3.2 (a)). Carbohydrate intake increased in
the OY group (210 ± 72 g/day at week 2 to 246 ± 54 g/day at week 11; P = 0.0162). However,
this increase was not observed among the OS group. There was a weak trend towards a
significant time effect for protein intake among obese individuals (P = 0.0824) (Figure 3.2 (b)).
In fact, despite the protein content of the yogurt (9 g per 12 oz.), protein intake decreased
significantly in the OY group, from 81 ± 17 g/day at week 2 to 72 ± 13 g/day at week 11 (P =
0.0349). However, this change was not observed in the OS group. Interestingly, there was also a
significant time effect observed for cholesterol intake (P = 0.0106) (Figure 3.2 (c)); intake
decreased significantly in the OY group, from 337 ± 159 mg/day at week 2 to 216 ± 87 mg/day
at week 11 (P = 0.0066). The decrease in cholesterol intake in the OS group did not reach
significance.
3.3.2 Changes in micronutrient intake
For micronutrient analysis, calcium, vitamin D, and vitamin C were nutrients of interest. Though
vitamin C is not found in either snack in significant quantities, it may favorably impact calcium
absorption and therefore is of interest [19]. Changes in intake of all 3 nutrients were observed as
a result of the intervention (Table 3.3 and Table 3.4).
There was a significant time effect (P < 0.0001) and a treatment-time interaction (P = 0.0147)
for calcium intake among lean individuals (Figure 3.3 (a)). Calcium intake increased
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significantly in the LY group, from 696 ± 214 mg/day at week 2 to 1026 ± 230 mg/day at week
11 (P < 0.0001). Though calcium intake increased modestly in the LS group during the
intervention period, it did not reach statistical significance (P > 0.05). This was expected, as the
yogurt contained more calcium than the soy pudding (45% DV versus 18% DV per 12 oz.)
following the reformulation of the pudding. Because this change was made early in the study,
more participants consumed the reformulated version than the initial version. Therefore, this
supports our hypothesis that calcium intake would increase to a larger degree in the LY group
than in the LS group.
Among lean individuals, there was a significant time effect for vitamin D intake (P < 0.0001)
(Figure 3.3 (b)). Vitamin D intake significantly increased in both the LY and LS groups. This
was expected, as both the yogurt and soy pudding were fortified with vitamin D (45% DV per 12
oz.). In the LY group, intake of vitamin D increased from 4.07 ± 3.13 mcg/day at week 2 to 9.91
± 2.40 mcg/day at week 11 (P < 0.0001). In the LS group, vitamin D intake increased from 5.71
± 3.72 mcg/day at week 2 to 11.18 ± 3.31 mcg/day at week 11 (P < 0.0001). Interestingly,
individuals in the LY group showed a decrease in vitamin C intake from week 2 to week 11 (102
± 46 mg/day to 70 ± 49 mg/day; P = 0.0056) (Figure 3.3 (c)). There was also a weak trend
towards decreasing vitamin C intake in the LS group (P = 0.0756).
As with lean individuals, there was a significant time effect for calcium intake among obese
individuals (P = 0.0002), though there was no significant treatment effect (Figure 3.4 (a)).
Calcium intake increased from 860 ± 462 mg/day at week 2 to 1178 ± 253 mg/day at week 11 (P
= 0.0089) in the OY group and from 801 ± 225 mg/day at week 2 to 1013 ± 369 mg/day at week
11 (P = 0.0102) in the OS group. There was also a significant time effect for vitamin D intake
among obese individuals (P < 0.0001) (Figure 3.4 (b)). In the OY group, vitamin D intake
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increased from 4.43 ± 3.97 mcg/day at week 2 to 10.22 ± 1.94 mcg/day at week 11 (P < 0.0001)
and in the OS group from 5.01 ± 4.27 mcg/day at week 2 to 9.79 ± 2.06 mcg/day at week 11 (P =
0.0011). Unlike that observed in lean individuals, there was no change in vitamin C intake in
either the OY or OS groups (Figure 3.4. (c)). Individuals in all groups were exceeding the RDA
for vitamin C intake prior to the intervention, and there was no difference in initial vitamin C
intake between lean and obese individuals that may account for these differences. This will be
discussed in more detail below.
3.3.3 Changes in intake by food group
To better describe the basis for observed changes in macro- and micronutrient intake, dietary
intake by food group was examined, using the Food Group Totals output reports in NDSR.
Though participants were asked to limit their dairy intake to ≤ 4 servings per day throughout the
washout and intervention periods, dairy intake in lean individuals increased over time (P =
0.0055), as shown in Table 3.5. There was also a significant treatment effect among both lean (P
= 0.0038) and obese (P = 0.0226) individuals and a significant time-treatment interaction for
dairy intake among lean (P < 0.0001) and obese (P = 0.0023) individuals (Figure 3.5).
Dairy intake (including the daily yogurt consumption) increased among individuals in the LY
group, from 1.13 ± 0.66 servings/day at week 2 to 2.15 ± 0.54 servings/day at week 11 (P <
0.0001) (Figure 3.5 (a)). This change was also observed among obese individuals; intake in the
OY group increased from 1.67 ± 1.40 servings/day at week 2 to 2.57 ± 0.90 servings/day at week
11 (P = 0.0130) (Figure 3.5 (b)). The soy pudding was dairy-free; no increases in dairy
consumption were observed in either the LS or OS groups. Interestingly, despite the 4 daily
servings of dairy limit imposed upon both groups, there was a slight but insignificant decrease in
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dairy consumption in both the LS and OS groups. Thus, participants were found to adhere to the
requirement to consume ≤ 4 dairy servings/day.
To examine the unexpected decreases in vitamin C intake, fruit and vegetable intake was
assessed (Table 3.6 and Table 3.7). Interestingly, there was a significant time effect for both
fruit (P = 0.0217) and vegetable (P = 0.0001) intake among lean individuals (Figure 3.6). Fruit
intake in the LY group decreased from 1.96 ± 1.20 servings/day at week 2 to 1.19 ± 1.11
servings/day at week 11 (P = 0.0031) (Figure 3.6 (a)) and there was a weak trend towards
decreased vegetable intake (P = 0.0909) in this group (Figure 3.6 (b)). There were no changes in
fruit intake in the LS group. However, vegetable intake in the LS group decreased significantly,
from 3.94 ± 1.64 servings/day at week 2 to 2.59 ± 1.27 servings/day at week 11 (P = 0.0001).
Among obese individuals, there was a significant time effect only for fruit consumption (P =
0.0067) (Figure 3.7 (a)). Intake in the OY group decreased from 1.81 ± 1.56 servings/day at
week 2 to 1.00 ± 0.95 servings/day at week 11 (P = 0.0318). No change was observed in the OS
group. Likewise, no significant changes in vegetable intake were observed in either group
(Figure 3.7 (b)).

3.4 Discussion
3.4.1 Macronutrient intake
Because the intervention was designed to be isocaloric, the participants were encouraged to
substitute the intervention snacks into the diet rather than adding them onto normal intake was
stressed. Therefore, it was anticipated that calorie and macronutrient intake would not change as
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a result of the intervention. Indeed, intake of calories, fat, and saturated fat did not change
significantly in any group. Though calorie intake increased by 60-130 calories per day in all
groups, this did not reach significance. Moreover, the intervention snacks contributed 330
calories per day. Therefore, it appears that most participants were fairly successful in substituting
the snacks into their diets. In addition, as discussed in Chapter 2, no significant changes in
weight or BMI were recorded.
However, carbohydrate intake increased significantly in 3 of the 4 intervention groups (LY, LS,
OY) and protein and cholesterol intakes decreased in the OY group. A likely explanation for the
increase in carbohydrate intake is the carbohydrate content of the intervention snacks.
Consumption of 12 oz. of yogurt or soy pudding per day resulted in the addition of 66 g of
carbohydrates to the diet. Although the RDA for carbohydrate intake for women is 130 g/day,
average intake is 180-230 g/day. This intake, though in excess of the RDA, is necessary in order
to meet caloric needs while consuming appropriate proportions of each macronutrient [20]. 66 g
is a substantial portion of this amount; therefore it is likely that the foods for which the yogurt or
pudding was substituted did not contribute an equivalent amount of carbohydrates to the diet,
leading to the observed increase. In addition, because fat and protein intake remained largely
unchanged, the minor increases in calorie intake were probably a result of this increased
carbohydrate intake.
Though protein intake remained fairly stable in 3 of the groups, intake decreased significantly in
the OY group. This was unexpected, as the yogurt contributed 9 g protein per 12 oz. In addition,
the fact that this occurred only in 1 group is noteworthy, as both the yogurt and pudding
contained the same amount of protein. There was also a significant decrease in cholesterol intake
in the OY group only. As the yogurt and pudding contained negligible amounts of cholesterol,
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this decrease was not directly related to the intervention snacks. However, many individuals
reported consuming the yogurt as breakfast, often in tandem with granola or as a smoothie, while
the pudding was not commonly consumed in this manner. Therefore, it is possible that
consumption of other protein and/or cholesterol-containing breakfast foods, such as eggs,
decreased in the OY group. However, this change was not seen in the LY group. Clearly there
were differences in dietary substitution patterns between lean and obese individuals; this is
something that should be examined more closely at a later date.
3.4.2 Micronutrient intake
As expected, changes in micronutrient intake were observed in all intervention groups. Calcium
intake increased significantly in 3 of the 4 intervention groups (LY, OY, OS) and vitamin D
intake increased significantly in all groups.
During the washout period, women in all 4 study groups consumed approximately 700-800
mg/day of calcium. The yogurt provided 45% DV (450 mg) calcium per day. Inclusion of 12 oz.
of yogurt into the diet helped individuals in the LY and OY groups to increase their daily
calcium intake by > 300 mg/day. Interestingly, this is less than the amount provided by the
yogurt, suggesting that daily consumption of 12 oz. of yogurt resulted in a reduction in
consumption of other calcium sources. Indeed, dairy intake increased by approximately 1
serving/day in each group; 12 oz. of yogurt is approximately 1.5 servings of dairy. Therefore,
consumption of non-yogurt dairy products decreased by approximately 0.5 servings/day during
the intervention in both the LY and OY groups.
Though the soy pudding contained much less calcium than the yogurt, incorporation of the
pudding into the diet helped individuals in the OS group to significantly increase their intake.
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The soy pudding was fortified with calcium (18% DV per 12 oz.), which added 180 mg/day from
the intervention. The mean increase in calcium intake in the OS group was 213 ± 311 mg/day.
This also suggests that the decrease in non-intervention-snack dairy intake observed in the LY
and OY groups did not take place in the OS group. Indeed, the OS group reported only a small
reduction in dairy intake; though it did not reach significance, intake decreased by 0.37 ± 0.94
servings per day. Therefore, incorporation of 12 oz. of soy pudding into the diet helped obese
women increase calcium intake.
Interestingly, the increase in calcium intake in the LY group fell short of significance. Despite
the 180 mg calcium contributed by the soy pudding, intake increased by just under 100 mg/day
in this group, suggesting that calcium from other sources decreased during the intervention.
However, dairy intake decreased insignificantly, by a mere 0.26 ± 0.87 servings/day. This
reduction is less than that observed in the OS group and yet the increase in calcium intake in the
OS group did reach significance. Therefore, the types of dairy products being eliminated in each
group may have been different. It is also possible that the yogurt or pudding were consumed in
place of non-dairy sources of calcium, such as vegetables, fortified juices, or fortified non-dairy
milks. This will be discussed in more detail below.
Regardless, incorporation of low-fat yogurt into the diet significantly increased dairy and
calcium intake in lean and obese women. This is important, because consumption of dairy
products is associated with numerous positive health outcomes [1, 2, 4, 5, 11, 17, 21]. In
addition, increasing calcium consumption from suboptimal (< 700 mg/day) to optimal (> 700
mg/day) leads to beneficial changes in body mass, composition, and various health outcomes [7,
22]. Though individuals in this study were already reaching this threshold without addition of the
yogurt or pudding, low-fat yogurt may be a means of increasing calcium intake among
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individuals who regularly consume suboptimal amounts of calcium. In addition, though the
optimal amount of calcium in terms of various body composition and inflammatory outcomes is
700 mg/day, the RDA for women age 19-50 y is 1000 mg/day [10]. This is because calcium is
also necessary for bone health and other physiological functions [10]. Prior to the intervention,
average calcium intake in all groups was below the RDA. Addition of low-fat yogurt to the diet
helped lean and obese women meet the RDA for calcium intake.
Among obese women, the soy pudding was also successful in raising calcium intake to reach the
RDA. However, some studies support the benefit of dairy calcium over other forms of calcium in
various health outcomes [23]. Though the reasons for this are not known, it has been
hypothesized that the other bioactive components of dairy may work in tandem to carry out the
health benefits associated with calcium [24, 25]. For example, casein and calcium can interact,
forming a casein-phosphopeptide-calcium complex that may increase calcium absorption [25]. In
addition, a study by Zemel, et al. compared the impact of dairy versus soy on biomarkers of
chronic oxidative stress and inflammation in overweight and obese individuals and found no
significant changes in the soy intervention [18]. However, the dairy-consuming group had
reductions in biomarkers of oxidative stress and inflammation [18]. Finally, many Americans do
not consume the suggested 3 servings of dairy per day [26]. This suggests that yogurt, but not the
soy pudding, would be a more effective method of increasing calcium intake as it may also help
individuals reach current recommendations for dairy intake.
The low-fat yogurt and soy pudding were both fortified with vitamin D (45% DV per 12 oz.);
intake increased in all intervention groups. The 45% DV is equivalent to 6.75 mcg vitamin D
provided by the intervention snacks. The RDA for vitamin D for women age 19-50 y is 15
mcg/day [10]. Initial intake in each group averaged 4-6 mcg/day, while final intake averaged 9.889

11.2 mcg/day, an average increase of approximately 5.5 mcg/day. This is slightly less than the
6.75 mcg/day provided by the yogurt and pudding. Because fortified dairy products are common
sources of vitamin D, the aforementioned reduction in intake of non-yogurt dairy products may
explain this discrepancy among the LY and OY groups. However, as with calcium intake,
individuals in the LS and OS groups reported only minor decreases in dairy intake. Therefore, as
before, non-dairy sources of vitamin D (including fish, and fortified juices, cereals, and nondairy milk) must have contributed to intake prior to the intervention but were substituted out of
the diet during the intervention period.
While daily yogurt and soy pudding consumption significantly increased vitamin D intake,
intake still did not reach the RDA; therefore, other dietary strategies are needed to assure
adequate vitamin D intake in both lean and obese women. Adequate vitamin D is necessary for
modulation of calcium uptake and intracellular calcium concentration (which regulates the
balance of fatty acid storage and breakdown). This is especially important among obese
individuals. Vitamin D is a fat-soluble vitamin and is sequestered by adipose tissue, reducing its
bioavailability [27]. Therefore, obese individuals may need to consume more vitamin D than
lean individuals. Though data from randomized controlled trials is scarce and results are mixed,
some studies suggest an inverse relationship between serum 1,25-dihydroxyvitamin D
concentrations and risk of cardiovascular-related deaths in older individuals [28]. Clearly
adequate vitamin D intake is important; however, among women in the present study intake was
lacking. Incorporation of low-fat yogurt or fortified soy pudding into the diet successfully
increased vitamin D intake in lean and obese women. Nevertheless, intake of these products
needs to be combined with other vitamin D-rich foods, such as fish, fortified cereals or juices, or
other dairy products, to reach the RDA.
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Though many studies support the health benefits of overall dairy consumption, low-fat dairy
products in particular are associated with lower BMI and waist circumference, as well as lower
concentrations of certain inflammatory biomarkers in epidemiological studies [4, 21]. A Greek
study found inverse associations between low-fat milk and C-reactive protein (CRP), low-fat
milk and homocysteine, and low-fat yogurt and TNFα [5]. A fourth study reported increased
reductions in inflammatory biomarkers in individuals on a diet containing fermented dairy
products compared with those on a low-fat dairy diet [1]. Therefore, because it is low-fat and
contains calcium, vitamin D, and probiotics, low-fat yogurt may be of particular benefit.
The low-fat yogurt and soy pudding used in the present study were not sources of vitamin C.
However, vitamin C may facilitate calcium absorption [19]. Therefore, intake was examined
closely. Interestingly, addition of yogurt or soy pudding to the diet decreased vitamin C intake in
both the LY and LS groups. The decrease observed in the LY group was unexpected, as many
individuals reported consuming the yogurt as smoothies, and fruit is a typical component of
smoothies, as well as a main contributor to vitamin C intake. However, some individuals added
milk and/or protein powder to their smoothies instead. It is possible that the addition of yogurt
and pudding to the diet resulted in elimination of other foods. Fruit juice and vegetables also
contain vitamin C; if yogurt and pudding consumption replaced such foods, vitamin C intake
would then decrease. This will be further discussed below.
3.4.3 Intake by food group
During the washout and intervention periods, dairy consumption was limited to ≤ 4 servings per
day in both the yogurt and soy groups. Initial intake in all groups was low – between 1.1-1.7
servings/day. Interestingly, initial intake in the obese groups was higher than in the lean groups.
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Though these differences did not reach significance, it is worth noting that epidemiological
studies report lower dairy intake among obese individuals compared to lean individuals [11, 29].
However, this was not the case for individuals enrolled in the present study.
As a result of the intervention, dairy intake increased in the yogurt groups by approximately 1
serving/day in both the LY and OY groups, to 2.15 ± 0.54 and 2.57 ± 0.90 servings/day,
respectively. This suggests that, rather than replacing consumption of other dairy products with
the yogurt, individuals tended to consume the yogurt in addition to their normal dairy intake.
However, because calorie intake did not significantly decrease, the 330 calories contributed by
the yogurt and soy pudding must have been removed from the diet by way of eliminating foods
from other food groups.
Indeed, fruit intake decreased in all groups, though only the decreases in the LY and OY groups
reached significance. Vegetable intake also significantly decreased in the LS group and there was
a trend towards decreased intake in the LY group. This may be explained by variability in
consumption of the intervention snacks. Yogurt, due to its fruit flavor, tended to be consumed
early in the day, often as breakfast. If the yogurt was being consumed as a meal replacement, it
may have led to a reduction in consumption of other breakfast foods, of which fruit is often a
component. On the other hand, consumption of the soy pudding, likely due to its chocolate
flavor, most often took place later in the day. Many participants reported consumption of the
pudding as a snack, or as dessert after lunch or dinner. Vegetables are a common snack or
component of lunch and dinner; perhaps the pudding was consumed in their place. On the other
hand, these changes in vegetable intake were only observed among lean individuals.
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Therefore, as discussed briefly above, there were significant differences in the ways in which
individuals chose to substitute the yogurt and pudding into their diets. Though no changes in
calorie consumption reached the level of significance, there were slight increases in all groups.
Moreover, these increases were larger among lean individuals. It is possible that the obese
women were more concerned about gaining weight as a result of the intervention and were
therefore more careful to maintain their normal fruit and vegetable intake while reducing
consumption of other foods. In addition, the nutritional counseling provided to participants
during the intervention was minimal. Perhaps a more intense counseling session would have lead
to less divergence in the ways in which the intervention snacks were substituted into the diet.
Regardless, these outcomes support the notion that it is necessary to monitor dietary changes
associated with any dietary intervention. Though there are many positive health outcomes
associated with consuming adequate dairy, vitamin D, and calcium, there is also ample evidence
supporting the importance of adequate fruit and vegetable intake [30-32]. Therefore,
incorporation of low-fat yogurt or soy pudding into the diet should be done in tandem with the
maintenance of adequate fruit and vegetable intake.
3.4.4 Strengths and limitations
The main strength of this intervention is that the low-fat yogurt provided is representative of
most commercial yogurts. It is widely available and more affordable than Greek-style or other
specialty yogurts. Therefore, increasing calcium, vitamin D, and dairy intake by addition of lowfat yogurt to the diet is a strategy that would be easily translatable to the general population. A
second strength is the use of a comprehensive, in-depth dietary assessment program. NDSR is a
widely-used and well-established diet analysis program [33]. It has numerous options, including
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foods from many specific restaurants and brands. It also requires a high degree of specificity for
each food item entered, thereby increasing the accuracy of the nutritional analysis. However, a
downside to this high specificity is that many individuals are not able to sufficiently report these
parameters; therefore, the “unknown” option was selected when entering some items, reducing
accuracy of the analysis.
The well-documented National Health and Nutrition Examination Survey (NHANES) is a
nationwide, multi-year study that examines, among other parameters, health status and dietary
intake in the United States. As of 2013, data was available for nine NHANES study periods [34].
To gather information on nutrient intake data, researchers primarily utilized the 24 h dietary
recall interview method [34]. However, a recent review examining the accuracy of such
reporting methods found that, particularly among women, misreporting of intake was highly
prevalent. This misreporting was found in three forms; underreporting intake, over-reporting
intake, and underreporting intake as a result of simultaneously increased calorie intake and
physical activity levels. Of these, underreporting was the most prevalent, while over-reporting
was the least common [34]. Degree of underreporting also tended to be directly associated with
body weight [35]. In addition, underreporting was more highly associated with nutrients deemed
“unhealthy,” i.e. fat and sugar, while over-reporting was associated with “healthy” nutrients,
such as protein [34, 36]. Focus groups discussing the recording of dietary intake and found that
many overweight and obese women were embarrassed of their diets and therefore consciously
ate less on days during which they recorded intake [37]. This would also tend to bias the
reliability of dietary records.
Archer, et al. defined underreporting as the ratio between reported energy intake (rEI) and basal
metabolic rate (BMR); a value < 1.35 was indicative of an rEI not physiologically compatible
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with survival [34]. This value is based on previous assessments examining the reporting of
energy intake compared with BMR, energy expenditure, body weight, and other parameters [38].
An examination of all NHANES dietary intake data revealed that the average rEI:BMR ratio was
1.19, supporting the notion that underreporting is widespread [34]. Furthermore, underreporting
tended to increase with BMI. Over the course of all NHANES surveys, no more than 43% of
overweight and obese women reported intake values that fell within the plausible range. When
this category was modified to include only obese women, this number declined to just 31%.
Even among normal weight women, rEI:BMR scores often fell below 1.35, with just 48 to 65%
of women reporting intakes compatible with physiological survival [34].
It is important to note that determination of BMR is not an exact science, and individual
variation is common due to a variety of factors. Nevertheless, it is important to examine dietary
intake data for plausibility. Indeed, many of the problems faced by NHANES researchers are
apparent in our research. Many daily intakes totaled less than 1500 calories, while the
recommended for healthy females age 20-50 y ranges from 1800-2400 calories/day, depending
on age and physical activity level [39]. Anything less than this would be expected to lead to
weight loss, which was not observed among any of the intervention groups in the present study.
Average calorie intake among lean participants ranged from approximately 1000 to 2400
(average 1598 ± 353) calories per day while among obese participants, intake ranged from
approximately 800 to 2600 (average 1865 ± 442) calories per day. While we did not determine
BMR or individual energy expenditures, it is clear based on normal caloric recommendations and
weight status that many individuals underreported their intake.
Possible reasons for this inconsistency include improper estimations, measuring, or reporting,
discrepancy between consumed foods and those available in the database, and the potential
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impact of recording ones diet on daily food intake. As discussed above, fear of being judged may
lead individuals to underestimate foods widely considered to be unhealthy, or to simply avoid
recording their diet on days in which such foods were consumed. Due to the tedious nature of
recording dietary intake, individuals may also be inclined to selectively report days in which
their food choices are less complex and/or easier to properly measure or estimate. All of these
factors may contribute to inaccuracies and may also reduce the representativeness of the records.
Training in proper estimation, measuring, and reporting methods has been shown to decrease
underreporting. Therefore, a short course in dietary intake reporting could be incorporated to
future studies to reduce the prevalence of underreporting.
Another limitation we faced was with NDSR. As with any diet analysis software, it is not
possible to include all existing food items. Sometimes the actual food consumed could not be
found, thereby reducing the accuracy of the analysis. Additionally, a large portion of our study
population consisted of university students, faculty, and staff, many of whom frequently dined on
campus. While the university is fairly comprehensive in its listing of nutritional information for
food items purchased at markets, food consumed in the dining halls is much more difficult to
analyze. These items are not often served in measured quantities, dish size varies, and there can
be numerous options for additional toppings, garnishes, condiments, etc. Unfortunately, this
greatly complicated estimations of intake. Additionally, previous research shows that reported
nutrient information from restaurants is often highly inaccurate [40]. As most of our participants
consumed at least 1 meal from a restaurant during their 6 days of dietary records, this is a
potential source of inaccuracy. Because many restaurant foods are not listed in NDSR, we were
often required to look up nutrition data on the restaurant’s website and find the closest match in
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NDSR. However, if the data listed on the website was inaccurate, so too was the substituted
food.
To overcome these limitations, a more in-depth dietary record should be developed that includes
more specific questions. There are also programs designed to assist individuals in determining
the most accurate means of recording each food. Ideally, participants would be provided with
adequate training in proper measuring and estimation techniques and would enter their dietary
intake directly into the computer program with the assistance of researchers. This would allow
for participants to become familiar with the qualifiers associated with certain foods (i.e. what
part of the chicken was eaten, how was it prepared, was the amount consumed based on the
before or after cooking amount), thereby increasing their awareness of the specificity necessary
for accurate reporting. Participants could also be provided with a scale or other measuring
implements to assist with their estimations.
Lastly, it remains to be seen whether the soy pudding was an adequate control snack. Benefits of
the pudding are that it was dairy-free, lower in calcium, isocaloric, and similar in texture to the
low-fat yogurt. This is important, as texture is known to impact feelings of satiety [41]. Because
the pudding was dairy-free, dairy consumption in the yogurt group increased significantly, while
dairy consumption in the soy group remained largely unchanged. However, the fortification of
the pudding with vitamin D led to similar increases in intake in both intervention groups;
therefore any oxidative and inflammatory outcomes cannot be linked to the vitamin D content of
the yogurt. In addition, it appears that the yogurt and soy pudding were not consumed in similar
manners, likely due to the more dessert-like flavor of the pudding. Therefore, the patterns by
which each product was substituted into the diet varied. This also led to reductions in fruit and
vegetable intakes in some of the intervention groups, while intake in the others remained stable.
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Perhaps other non-dairy control snacks or alternate flavors of soy pudding should be examined in
an effort to reduce these differences.

Table 3.1. Self-reported changes in macronutrient intake of lean women during a two-week
washout period (initial) during which probiotic-containing foods were eliminated from the diet
and dairy consumption was limited to ≤ 4 servings/day and during a dietary intervention (final)
consisting of daily consumption of 12 oz. low-fat yogurt or soy pudding.
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Nutrient

Group

Initial

Final

Change

LY

1556 ± 352

1692 ± 532

136 ± 442

LS

1644 ± 257

1764 ± 289

120 ± 352

LY

56.4 ± 20.3

56.5 ± 28.5

0.13 ± 24.1

LS

64.0 ± 16.7

59.0 ± 15.7

- 5.0 ± 20.7

LY

18.5 ± 8.6

18.2 ± 9.0

- 0.3 ± 10.2

LS

20.9 ± 7.15

19.2 ± 6.17

- 1.7 ± 7.7

LY

256 ± 116

253 ± 176

- 4 ± 134

LS

254 ± 145

225 ± 162

- 29 ± 126

LY

197 ± 39

224 ± 54*

27 ± 57

LS

201 ± 54

232 ± 46*

30 ± 53

LY

70.8 ± 20.5

71.3 ± 29.5

0.6 ± 25.1

LS

71.9 ± 19.8

73.8 ± 18.9

1.9 ± 18.5

Calories

Fat (g)

Saturated Fat (g)

Cholesterol (mg)

Carbohydrates (g)

Protein (g)

LY = lean yogurt (n = 24); LS = lean soy (n = 22). Data are mean ± SD. Within-group analysis
by paired t-test. * P < 0.05 from Visit 2.

Table 3.2. Self-reported changes in macronutrient intake of obese women during a two-week
washout period (initial) during which probiotic-containing foods were eliminated from the diet
and dairy consumption was limited to ≤ 4 servings/day and during a dietary intervention (final)
consisting of daily consumption of 12 oz. low-fat yogurt or soy pudding.
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Nutrient

Group

Initial

Final

Change

OY

1802 ± 499

1895 ± 386

92.9 ± 380

OS

1924 ± 385

1987 ± 524

63.4 ± 571

OY

72.5 ± 26.3

74.1 ± 38.1

1.5 ± 41.7

OS

76.8 ± 19.0

68.8 ± 25.7

- 8.0 ± 26.9

OY

25.6 ± 9.3

23.0 ± 10.5

- 2.6 ± 10.7

OS

25.9 ± 8.3

23.7 ± 12.7

- 2.2 ± 8.3

OY

337 ± 159

216 ± 87*

- 130 ± 171

OS

273 ± 119

244 ± 148

- 29 ± 166§

OY

210 ± 72

246 ± 54*

36 ± 56

OS

235 ± 58

264 ± 76

29 ± 82

OY

81.0 ± 16.7

71.9 ± 13.4*

- 9.1 ± 16.3

OS

81.9 ± 26.9

75.2 ± 21.0

- 6.7 ± 32.6

Calories

Fat (g)

Saturated Fat (g)

Cholesterol (mg)

Carbohydrates (g)

Protein (g)

OY = obese yogurt (n = 17); OS = obese soy (n = 18). Data are mean ± SD. Within-group
analysis by paired t-test. * P < 0.05 from Visit 2, § P < 0.05 from OY.

Table 3.3. Self-reported micronutrient intake of lean women before and during a 9-week dietary
intervention providing 12 oz. of low-fat yogurt or soy pudding daily.
Nutrient

Group

Initial

Final

Change

Calcium (mg)

LY

696 ± 214

1030 ± 230**

330 ± 341

100

LS

838 ± 265

930 ± 207

92 ± 288§

LY

4.07 ± 3.13

9.91 ± 2.40**

5.85 ± 2.72

LS

5.71 ± 3.72

11.2 ± 3.31**

5.47 ± 3.35

LY

102 ± 46

69.8 ± 48.6*

- 32.0 ± 51.3

LS

102 ± 57

75.0 ± 38.9†

- 27.3 ± 68.5

Vitamin D (mcg)

Vitamin C (mg)

LY = lean yogurt; LS = lean soy. Data are mean ± SD. Within group analysis by paired t-test. *
P < 0.05 from initial, ** P < 0.001 from initial, § P < 0.05 from LY, † P < 0.10 from initial.

Table 3.4. Self-reported micronutrient intake of obese women before and during a 9-week
dietary intervention providing 12 oz. of low-fat yogurt or soy pudding daily.
Nutrient

Group

Initial

Final

Change

OY

860 ± 462

1180 ± 253*

318 ± 440

OS

801 ± 225

1010 ± 369*

213 ± 311

Calcium (mg)

101

OY

4.43 ± 3.97

10.2 ± 1.94**

5.80 ± 3.66

OS

5.01 ± 4.27

9.79 ± 2.06*

4.78 ± 5.15

OY

85.1 ± 46.5

72.95 ± 36.5

- 12.2 ± 53.4

OS

93.3 ± 53.0

92.4 ± 53.0

- 0.88 ± 60.3

Vitamin D (mcg)

Vitamin C (mg)

OY = obese yogurt; OS = obese soy. Data are mean ± SD. Within group analysis by paired t-test.
* P < 0.05 from initial, ** P < 0.001 from initial.

Table 3.5. Self-reported dairy intake of lean and obese women during a 2-week washout period
(initial) during which probiotic-containing foods were eliminated from the diet and dairy
consumption was limited to ≤ 4 servings/day and during a dietary intervention (final) consisting
of daily consumption of 12 oz. low-fat yogurt or soy pudding.
Group

Initial

Final
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Difference

1.13 ± 0.66
2.15 ± 0.54**
1.03 ± 0.91
Yogurt
(n = 24)
Lean
1.35 ± 0.61
1.09 ± 0.76
- 0.26 ± 0.87§
Soy
(n = 22)
1.67 ± 1.40
2.57 ± 0.90*
0.91 ± 1.33
Yogurt
(n = 17)
Obese
1.60 ± 0.80
1.22 ± 1.01
- 0.37 ± 0.94§
Soy
(n =18)
Data are mean ± SD. Between group analysis by two-way ANOVA; within group analysis by
paired t-test. * P < 0.05 from Visit 2, ** P < 0.0001 from Visit 2, § P < 0.05 from yogurt group.

Table 3.6. Self-reported fruit and vegetable intake of lean women before and during a 9-week
dietary intervention providing 12 oz. of low-fat yogurt or soy pudding daily.
Yogurt
Food Group

Fruit
(servings/day)

Soy

Initial

Final

Initial

Final

1.96 ± 1.20

1.19 ± 1.11*

1.83 ± 1.15

1.65 ± 1.20
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Vegetables
(servings/day)

3.12 ± 1.38

2.47 ± 1.36†

3.94 ± 1.64

2.59 ± 1.27*

Data are mean ± SD. Within group analysis by paired t-test. * P < 0.05 from initial, † P < 0.10
from initial.

Table 3.7. Fruit and vegetable intake of obese women before and during a 9-week dietary
intervention providing 12 oz. of low-fat yogurt or soy pudding daily.
Yogurt

Food Group
Fruit
(servings/day)

Soy

Initial

Final

Initial

Final

1.81 ± 1.56

1.00 ± 0.95*

1.51 ± 0.73

1.09 ± 0.73†
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Vegetables
(servings/day)

3.44 ± 1.76

4.05 ± 1.86

3.99 ± 2.91

3.40 ± 1.77

Data are mean ± SD. Within group analysis by paired t-test. * P < 0.05 from initial, † P < 0.10
from initial.

105

(a)

(c)

Carbohydrate Intake

Cholesterol Intake

300

*

*

Initial
Final

400

Initial
Final

300

mg/day

g/day

200

100

200
100

0
LY

LS

0
LY

LS

(b)

Protein Intake

Figure 3.1. Changes in macronutrient intake of lean women

100

participating in the intervention: (a) carbohydrate intake (b)

Initial
Final

80

protein intake (c) cholesterol intake. Dietary intake data is

g/day

based on 3-day self-reported dietary records. Data are mean ±
60

SEM. LY = lean yogurt, n = 24; LS = lean soy, n = 22.
Between group analysis by two-way ANOVA; P = 0.0009 for

40

time effect for carbohydrate intake. Within-group analysis by

20

paired t-test. * P < 0.05 from Initial.
0
LY

LS

106

(a)

(c)

Carbohydrate Intake
300

Cholesterol Intake
400

Initial
Final

*

Initial
Final

300

g/day

mg/day

200

*
200

100
100

0

0

OY

(b)

OS

OY

Figure 3.2. Changes in macronutrient intake of obese women

Protein Intake

participating in the intervention: (a) carbohydrate intake (b)

100

Initial
Final

*

80

g/day

OS

protein intake (c) cholesterol intake. Dietary intake data is
based on 3-day self-reported dietary records. Data are mean ±
SEM. OY = obese yogurt, n = 17; OS = obese soy, n = 18.

60

Between group analysis by two-way ANOVA; P = 0.0089 for

40

time effect for carbohydrate intake, P = 0.0106 by paired t-test
20

for cholesterol intake. * P < 0.05 from Initial by paired t-test.

0
OY

OS

107

(c)

(a)
Calcium Intake

Vitamin C Intake

1500

150

Initial
Final

**

mg/day

mg/day

1000

500

100

†

*
50

0

0
LY

LS

LY

(b)

LS

Figure 3.3. Changes in micronutrient intake of lean women

Vitamin D Intake

participating in the intervention: (a) calcium intake; (b) vitamin

15

**
**
mcg/day

Initial
Final

Initial
Final

D intake; (c) vitamin C intake. Dietary intake data is based on
3-day self-reported dietary records. Data are mean ± SEM. LY

10

= lean yogurt, n = 24; LS = lean soy, n = 22. Between group
analysis by two-way ANOVA; P < 0.0001 for time effect for

5

calcium intake and vitamin D intake, P = 0.0017 for time effect
for vitamin C intake. Within-group analysis by paired t-test.
* P < 0.05 from Initial, ** P < 0.0001 from Initial, † P < 0.10

0
LY

LS

from Initial.

108

(a)

(c)
Vitamin C Intake

Calcium Intake
150

1500

*
*
mg/day

mg/day

1000

Initial
Final

100

50

500

0

0
OY

OY

OS

(b)

OS

Figure 3.4. Changes in micronutrient intake of obese women

Vitamin D Intake

participating in the intervention: (a) calcium intake; (b) vitamin

15

D intake; (c) vitamin C intake. Dietary intake data is based on

**
mcg/day

Initial
Final

*

10

Initial
Final

3-day self-reported dietary records. Data are mean ± SEM. OY
= obese yogurt, n = 17; OS = obese soy, n = 18. Between group
analysis by two-way ANOVA; P = 0.0002 for time effect for
calcium intake and P < 0.0001 for time effect for vitamin D

5

intake. Within-group analysis by paired t-test; * P < 0.05 from
Initial, ** P < 0.0001 from Initial.

0
OY

OS

109

(a)
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Figure 3.6. Fruit (a) and vegetable (b) intake of lean women
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Figure 3.7. Fruit (a) and vegetable (b) intake of obese women
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Chapter 4:
Modulation of Postprandial and Chronic Oxidative Stress by
Consumption of Low-Fat Yogurt
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4.1 Introduction
Reactive oxygen species (ROS), reactive nitrogen species (RNS), and other oxidants are normal
products of nutrient metabolism [1]. In order to quench these highly reactive oxidative species,
the body has endogenous antioxidant defense systems, including enzymes such as glutathione
peroxidase (GPx), catalase, and superoxide dismutase (SOD) [2, 3]. Under normal physiological
conditions, these systems are sufficient to neutralize metabolic oxidative byproducts and
maintain equilibrium. However in response to nutrient intake, metabolic processes such as
glycolysis, fatty acid oxidation, and the mitochondrial electron transport chain are upregulated; a
byproduct of this increase is an increase in the generation of ROS and RNS. This increase in
oxidants overwhelms the endogenous antioxidant defense systems. When these oxidants are
unable to be neutralized, they are free to interact with glucose, fatty acids, amino acids and
nucleic acids, causing cellular and tissue damage [2, 4]. This imbalance between oxidant
generation and neutralization is known as oxidative stress, and is associated with the
development and progression of many diseases [1].
Oxidative stress can be assessed by many biomarkers, including endogenous antioxidant enzyme
activity, the total antioxidant capacity of plasma, and products of oxidative damage, including
oxidized sugars, lipids, proteins, and nucleic acids [2, 4]. An individual biomarker cannot
provide a complete picture of oxidative stress. Instead, a combination of these markers is more
useful to examine oxidative status. Some researchers consider urinary isoprostanes and 8deoxyguanosine to be the gold standard for measures of oxidative stress due to the high degree of
specificity and reliability associated with their presence [4-6]. However, urinary samples were
not collected in the present study; therefore, plasma biomarkers were used to measure oxidative
stress. These included malondialdehyde (MDA) as a measure of lipid peroxidation, advanced
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glycation endproducts (AGEs) as a measure of formation of aldehyde-protein adducts, and total
thiols (SH) as a measure of oxidative damage to proteins. The structures and significance of
these biomarkers were discussed earlier. Analysis of these biomarkers will provide a partial
picture of postprandial and chronic oxidative stress and the ability of yogurt to modulate these
biomarkers in obese individuals.

4.2 Materials and methods
4.2.1 Sample collection and preparation
The total study population consisted of 132 healthy, premenopausal women, age 21-55 y, half of
who were lean (BMI 18.5-27 kg/m2; n = 66) and half of who were obese (BMI 30-40 kg/m2; n =
66). The women were free of cardiovascular disease, high blood pressure, cancer, diabetes,
digestive disorders, and any other pro-inflammatory conditions. One half of the women in each
group were assigned to low-fat yogurt consumption while the other half consumed a dairy-free,
soy-based pudding as the control snack. A detailed discussion of the study design is presented in
Chapter 2. Briefly, the women reported to the study center in the morning following a 2-week
washout period during which probiotic consumption was avoided and dairy consumption was
limited. They arrived fasted and consumed either the yogurt or soy pudding, followed by a highcalorie, high-fat meal. The nutritional profiles of the yogurt, pudding, and meal are elaborated in
Chapter 2. The women remained in the study center for 4 h following meal consumption for
hourly collection of blood samples. Following this study visit, the women consumed 12 oz. of
yogurt or soy pudding daily for 9 weeks. Fasting blood samples were collected at 3 week
intervals during this period. On the final day of the intervention, participants again arrived at the
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study center in the fasted state, where they once again consumed the yogurt or pudding followed
by the high-calorie, high-fat meal. Following collection of 4 h postprandial blood samples, the
intervention was complete.
For this objective, fasting and postprandial plasma samples from 31 healthy, obese women – 15
from the obese yogurt (OY) group and 16 from the obese soy (OS) group – were used. Fasting
blood samples were collected following completion of the washout period at week 2 (initial), and
again at weeks 5, 8, and 11 (final). Postprandial blood samples, collected 1, 2, 3, and 4 h
following consumption of the high-calorie, high-fat meal, were collected at weeks 2 and 11. All
samples were collected via a catheter or single-stick draw from the antecubital vein. Samples
were collected into vacuum tubes with either sodium heparin or EDTA; tubes were gently
inverted 8-10 times then placed on ice. All samples were centrifuged at 1500 x g for 10 min
within 30 min of collection. Plasma was collected and aliquotted into cryogenic vials, then flashfrozen in liquid nitrogen and stored at -80°C until analysis.
4.2.2 Determination of plasma malondialdehyde
Plasma MDA is known to increase in the postprandial period and is an established biomarker for
lipid peroxidation [12-15].
Briefly, EDTA plasma samples were prepared with 1% butylated hydroxytoluene to prevent
further oxidation and 10 N sodium hydroxide for hydrolysis of bound MDA. Following
incubation at 60°C, hydrolysis was halted by addition of 7.2% trichloroacetic acid. Samples were
placed on ice, then centrifuged (14,000 x g for 10 min) and the supernatant collected.
Thiobarbituric acid (TBA, 0.6%) was added to the supernatant, which reacts with MDA at high

119

temperatures to form a pink-colored adduct. Lastly, MDA-TBA adducts were extracted with
isobutyl alcohol and placed in vials for HPLC analysis.
Analysis was conducted using a Dionex UltiMate 3000 UHPLC and an Acclaim RSLC 2.2 µm,
2.1 x 50 mm column. The autosampler was maintained at 4°C and the column oven at 25°C.
Mobile phases were (A) 25 mM potassium phosphate buffer, pH 6.5, and (B) 100% HPLC-grade
methanol. The flow rate was 0.2 mL/minute and was isocratic, at 30% B. Total run time was 4
min. The MDA-TBA adducts eluted at approximately 1.3 min and were measured by
fluorescence; the excitation and emission wavelengths were 553 nm and 515 nm, respectively.
Standards were generated using 1,1,3,3-tetramethoxypropane (TMP) in sodium acetate buffer
(pH 3.5), ranging from 0.0943 to 6.04 µM. Peak area under the curve (AUC) was calculated for
each standard to generate a standard curve. AUC was also determined for each sample to
calculate plasma MDA concentration. All samples were normalized to a control plasma value
that was run daily. Intra-assay variation was 3.3%.
4.2.3 Determination of plasma total thiols
Plasma SH were used to establish levels of protein oxidation [9, 10]. Species detected by this
assay included glutathione (GSH), oxidized glutathione (GSSG), cysteine (Cys), oxidized
cysteine (cystine – CysS), methionine (Met), and homocysteine (Hcy), among others, though the
primary thiols detected are in the reduced form [10].
Briefly, sodium heparinized plasma samples were diluted with 0.25 M Tris-buffer EDTA (pH
8.2) and baseline absorbance was measured at 412 nm using a Beckman Coulter DU 800
spectrophotometer. 5,5'-Dithiobis-(2-nitrobenzoic acid) (DTNB) was added, which reacts with
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plasma thiols and turns yellow. Samples were incubated for 15 min prior to a second absorbance
reading at 412 nm. The difference between initial and final readings, when multiplied by the
dilution factor and transformed by molar absorptivity, gave the SH concentration. All samples
were normalized to 1 mM glutathione and standardized to a control plasma sample. Intra-assay
variation was 4.1%.
4.2.4 Determination of plasma advanced glycation endproducts
Plasma AGEs were measured to establish the concentration of covalently-modified proteins.
Aldehydes react non-enzymatically with amino acids to generate aldehyde-adducted proteins
[11]. Glucose is the predominate sugar that takes part in these reactions; therefore, AGE
formation increases in the presence of elevated plasma glucose [11].
Briefly, EDTA plasma samples were diluted 100 times with 10mM phosphate buffered-saline
(PBS), pH 7.4. Following centrifugation (10 min at 14,000 x g), the samples were transferred to
a black-walled microplate. Fluorescence was measured using a Molecular Devices SpectraMax
M2 microplate reader. Excitation and emission were 360 nm and 460 nm, respectively.
Fluorescence readings were expressed as arbitrary units (AU). Samples were standardized to a
control plasma, run daily. Intra-assay variation was approximately 4.7%.
4.2.5 Determination of plasma total proteins
Analysis of total proteins was conducted to examine any correlations between postprandial
changes in total thiols and/or AGEs and total protein content of plasma. For this assay, fasting
and postprandial samples from 3 participants at week 2 were used. Briefly, EDTA plasma was
diluted 100-fold with ultrapure water and combined with a working reagent (Thermo Scientific
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Pierce BCA Protein Assay Kit) containing bicinchoninic acid (BCA) and 4% cupric sulfate from.
Samples were incubated, cooled to room temperature, and absorbance was measured at 562 nm
using a Molecular Devices SpectraMax M2 microplate reader. A standard curve was generated
using 25-2000 µg/mL bovine serum albumin. Intra-assay variation was 3.5%.
4.2.6 Statistical analysis
Statistical analysis was conducted using GraphPad Prism 5.01 software. Postprandial and fasting
between-group analysis was conducted by repeated measures two-way ANOVA, with
Bonferonni post-tests conducted where appropriate. Within-group analysis was conducted by
paired t-test.
The Shapiro-Wilks normality test was run on all data, and data was transformed when necessary
to obtain normality. One individual in the obese soy (OS) group was excluded from postprandial
analyses due to a missing plasma sample, and a second individual was excluded from fasting
analyses for the same reason. No data was missing from the obese yogurt (OY) group. Therefore,
total sample size was n = 15 in each group.

4.3 Results
4.3.1 Postprandial plasma malondialdehyde
All data for postprandial and fasting MDA was normally distributed so data transformation was
unnecessary. There was a significant time effect (P = 0.0129) and treatment effect (P = 0.0003)
for postprandial MDA (Figure 4.1 (a)). Additionally, despite randomization and a successful
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matching of subjects (P < 0.0001), initial fasting MDA values were significantly higher in the
OY group compared with the OS group (0.80 ± 0.29 mg/dL versus 1.24 ± 0.27 mg/dL; P =
0.0002) (Figure 4.1 (a)). To account for this initial difference, data was evaluated on the basis of
change from fasting baseline (Figure 4.1 (b)). By two-way ANOVA on change from fasting
data, there was a statistically significant time effect (P = 0.0157) and treatment effect (P =
0.0395) for the postprandial change in MDA. At week 2, there was a significant time effect for
MDA (change from fasting) between the OY and OS groups (P = 0.0186). By unpaired t-test,
there was also a weak trend towards a significant difference in MDA concentration (change from
fasting) between the OY and OS groups postprandially at hour 2 (p = 0.0902 by unpaired t-test)
and a significant difference at hour 3 (P = 0.0352 by unpaired t-test) at week 2 (Figure 4.1 (b)).
Within the OY group, there were no significant differences in postprandial MDA (change from
fasting) at any time point at either week 2 or week 11, and there was also no statistically
significant reduction in postprandial elevations in MDA following 9-week yogurt consumption
(Figure 4.2 (a)). However, and unexpectedly, in the OS group there was a significant time effect
(P = 0.0359) and treatment effect (P = 0.0248) from the initial (week 2) to final (week 11)
postprandial challenges (Figure 4.2 (b)). When compared with values from week 2, chronic
consumption of soy pudding reduced postprandial MDA change from baseline at week 11 at
hour 2 (P = 0.0305), hour 3 (P = 0.0029), and hour 4 (P = 0.0086).
Postprandial MDA AUC was also examined at weeks 2 and 11. Because of the statistically
significant difference in baseline fasting values, AUC was calculated using the change from
fasting MDA values (Figure 4.3). However, there were no significant time or treatment effects.
There were also no significant differences in AUC between week 2 and week 11 or between the
OY and OS groups at either time point by post-hoc analysis.
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Because MDA can form adducts with plasma proteins, total protein content of the plasma was
also measured during the postprandial period. Though differences did not reach significance,
total proteins decreased slightly in the first 3 h postprandially before rising slightly at hour 4
(Figure 4.4). It is possible that the 4 h postprandial period was not sufficient to detect changes in
plasma proteins associated with meal intake. If this were the case, it would also be interesting to
examine the MDA response beyond a 4 h postprandial period.
4.3.2 Fasting plasma malondialdehyde
There was a significant time effect (P = 0.0179), treatment effect (P = 0.0346), and a timetreatment interaction (P = 0.0470) for absolute fasting MDA values (Figure 4.5). Because the
same baseline plasma samples were used for determination of fasting and postprandial MDA,
fasting OY was approximately 56% greater than OS at week 2 (P = 0.0002). OY fasting MDA
was also approximately 33% greater than OS at week 11 (P = 0.0127). In contrast, low-fat yogurt
consumption did not change fasting MDA concentrations. Interestingly, sustained consumption
of soy pudding appeared to raise fasting plasma MDA; MDA concentration increased by 55%
between weeks 2 and 5 (P = 0.0101), 65% between weeks 2 and 8 (P = 0.0072), and 27%
between weeks 2 and 11 (P = 0.0203) in the OS group (Figure 4.5).
Due to the significant differences in week 2 fasting values between the OY and OS groups,
fasting MDA values were analyzed as the change from baseline (week 2) fasting values (Figure
4.6). By two-way ANOVA, there were again significant time (P = 0.0179) and treatment effects
(P = 0.0163), and a significant time-treatment interaction (P = 0.0470) for fasting MDA.
Additionally, fasting MDA concentrations (change from week 2) were significantly lower in the
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OY group versus the OS group at week 5 (P = 0.0252) and week 8 (P = 0.0245). There were no
changes in MDA concentration within the OY group throughout the duration of the intervention.
4.3.3 Postprandial plasma total thiols
The raw data for fasting, postprandial, and AUC SH values were normally distributed, so data
were not transformed prior to statistical analysis. The AUC of change-from-fasting SH values
were not normally distributed, and attempts to normalize the data failed. Therefore, common
statistical approaches may not be appropriate for this data set.
There was a significant time effect for postprandial SH concentration (P = 0.0028) (Figure 4.7).
Within the OY group, there was a trend towards an increase in SH concentration (change from
fasting) between hour 0 and hour 4 at week 11 (P = 0.0682) (data not shown). Within the OS
group at week 2, co-consumption of soy pudding with the high-calorie, high-fat meal led to a
significant decrease in plasma SH between hour 0 and 1 (P = 0.0008) and hour 0 and 2 (P =
0.0120) (Figure 4.8(a)) At week 2, postprandial change-from-fasting plasma SH was
significantly higher in the OY group than the OS group at hour 1 (P = 0.0072) and hour 4 (P =
0.0418) (Figure 4.8(b)). However, no significant differences in hourly plasma SH were observed
at week 11.
There were no differences in postprandial SH AUC within the OY and OS groups or between
each group at weeks 2 and 11 (Figure 4.9). However, there was a trend towards a larger
postprandial AUC in the OY group versus the OS group at week 2 (P = 0.0586 by unpaired ttest). Chronic consumption of low-fat yogurt or soy pudding did not appear to have any
significant impact on the postprandial SH response.
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4.3.4 Fasting plasma total thiols
The data for fasting SH were not normally distributed; the data was transformed by the equation
(y = y3) to obtain normality prior to statistical analysis. Following analysis by two-way ANOVA
on the transformed data, there was a significant time-treatment interaction for fasting SH (P =
0.0167) but there were no significant time or treatment effects (Figure 4.10). There were no
differences in fasting SH within the OY group at any time point. However, there was a trend
towards elevated fasting SH in the OY group at week 5 when compared with the OS group (P =
0.0510). Within the OS group, fasting plasma thiols were significantly reduced between weeks 2
and 5 (P = 0.0012). However, this difference did not persist, and fasting SH increased slightly
(though insignificantly) from week 5 to week 8 and remained fairly stable at week 11. These
latter changes did not reach significance.
4.3.5 Postprandial plasma advanced glycation endproducts
The raw values for postprandial plasma AGEs and postprandial AGEs AUC as measured by
change from fasting were normally distributed. However, unadjusted postprandial AGEs AUC
and plasma fasting AGEs values were not, and attempts to normalize the data failed. Therefore,
common statistical approaches may not be appropriate. Visual inspection of these data did not
lead us to suspect any otherwise significant trends (Figure 4.11). Instead, postprandial analysis
focused on the raw postprandial and change-from-fasting postprandial AUC values.
There were also no statistically significant differences in AGE concentration at any time point
within each group or between the OY and OS groups (Figure 4.11). Postprandial change from
fasting AGEs had a weak trend towards a significant time-treatment interaction (P = 0.0907) and
also towards a significant treatment effect (p = 0.0976) (data not shown). There were no
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statistically significant differences in postprandial AUC (reported as change from fasting)
between weeks 2 and 11 or between the OY and OS groups at each visit (Figure 4.12). Finally,
there were no statistically significant differences in AGE concentration at any time point within
each group or between the OY and OS groups (data not shown).
4.3.6 Fasting plasma advanced glycation endproducts
There were no statistically significant differences in fasting AGEs between groups or within
groups at any time point (Figure 4.13).

4.4 Discussion
4.4.1 Plasma malondialdehyde
Baseline (week 2) fasting MDA concentrations were significantly higher in the OY group than
the OS group, despite successful randomization. We observed large variation in MDA
concentrations, which is supported by the literature; reported fasting MDA values range from < 1
mg/dL to almost 4 mg/dL in individuals with prehypertension [16-18]. Due to this variation, it is
possible that this difference will no longer be statistically significant once final sample size is
obtained. It is also possible that individuals in the OY group do indeed have higher baseline
levels of oxidative stress. This could be due to diet, differences in health status, or perhaps
differences in food intake in the day prior to arrival at the study center. However, as discussed in
Chapter 2, there were no differences in any anthropometric parameters between the OY and OS
groups, including BMI. There were also no statistically significant differences in baseline intake
of any macronutrients, calcium, vitamins C and D, fruits, vegetables, or dairy products. Dietary
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intake is discussed in detail in Chapter 3; however, a much more thorough dietary analysis would
be required in order to draw any associations to oxidative stress.
Many studies on postprandial oxidative stress have been reported; however, most examine only
changes associated with the 4-6 h postprandial period [15, 19, 20] Miglio, et al. conducted a trial
in which 8 h postprandial blood samples were collected [21]. At this time point, certain
parameters were just reaching peak plasma concentrations, including total cholesterol, TNFα,
and IL-6. In addition, plasma triglycerides, and SH and uric acid, two measures of oxidative
stress, remained significantly elevated above baseline [21]. Therefore, it is highly plausible that
the oxidative effects of a high-fat meal may extend beyond 8 h. Participants in the present study
reported to the study center following a 12 h fast. However, aside from limiting dairy intake and
avoiding probiotics, there were no specific directives regarding what to consume in the day prior
to the visit. For most participants, Visit 2 took place on a Saturday morning; as Friday night is
often a night for socializing and other activities, consumption of alcohol or of a high-calorie,
high-fat meal may have occurred within 12-14 h of arrival at the study center. Therefore, the
remaining oxidative impacts of such a meal may have been detected in some of our baseline
blood samples. Clearly more evidence is needed on the duration of postprandial changes in
oxidative stress.
Due to the difference in week 2 fasting MDA, all MDA data were evaluated as change from
baseline. By this analysis, low-fat yogurt consumption appeared to inhibit postprandial increases
in MDA. At week 2 in the OY group, MDA slightly increased beginning 1 h postprandially and
remained elevated above baseline values for 4 h. However, none of these differences were
statistically significant. At week 11, postprandial MDA showed little change over fasting
concentrations and actually decreased to below baseline concentrations at the 4 h time point in
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the OY group. However, this decrease was not significantly different from the fasting values. In
addition, postprandial 4 h MDA AUC did not change from week 2 to week 11 in the OY group.
As mentioned above, fasting MDA was significantly higher in the OY group than the OS group
at week 2. When compared to the OS group, OY fasting MDA concentrations were also higher at
week 11. When fasting MDA values were evaluated as change from baseline, MDA was found
to be significantly higher in the OS group than the OY group at weeks 5 and 8; though MDA was
also higher in the OS group at week 11, this difference did not reach significance. Indeed, this is
reflective of the observed increase in fasting MDA in the OS group, while fasting MDA
remained unchanged in the OY group. Therefore, short-term soy pudding consumption may
increase fasting levels of lipid peroxidation in obese women, though the effect may not be
sustained. This is in agreement with the results of a previous intervention, in which 4-week soy
consumption slightly increased biomarkers of inflammation in overweight or obese subjects [22].
Interestingly, MDA was significantly higher at hours 2, 3, and 4 postprandially in the OS group
at week 2 compared with week 11 despite the fact that fasting MDA at week 11 was significantly
higher than that at week 2. In fact, increases in postprandial MDA at week 11 in the OS group
were negligible. This suggests that sustained intake of soy pudding may reduce the postprandial
MDA response. However, the elevation in fasting MDA observed in the OS group indicates that
overall MDA exposure may actually be increased by daily soy pudding consumption.
Fasting MDA in the OY group did not change from week 2 (initial) to week 11 (final).
Therefore, it appears that while sustained yogurt consumption did not reduce fasting MDA
concentrations in obese women, it also did not increase their exposure to oxidative stress.
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Previous studies show that co-consumption of calcium, milk proteins and/or whole dairy
products with a high-fat meal attenuates the postprandial response [19, 23-25]. In addition,
calcium is known to interfere with fat absorption [26]; a reduction in postprandial fat absorption
would tend to lead to a reduction in postprandial elevations in lipids and, therefore, lipid
peroxidation. Data from the present study supports an acute effect of yogurt in the inhibition of
postprandial MDA.
4.4.2 Plasma total thiols
Low-fat yogurt did not appear to impact postprandial or fasting SH. Interestingly, coconsumption of soy pudding with the high-calorie, high-fat meal depleted SH at 1 and 2 h
postprandially at week 2 and SH was also significantly lower in the OS group at hour 4 as well.
Therefore, soy pudding may have a short-term postprandial impact on plasma SH but this
appears to be temporary.
Interpreting plasma SH concentrations is difficult, as there are numerous variables involved for
which we did not account in the present study. The total thiols assay used for this analysis does
not discriminate between protein and non-protein thiols or between each individual thiol. Miglio,
et al. measured plasma SH following intake of a high-fat meal and found that though peak SH
concentration was reached at 4 h postprandially, concentrations remained elevated above
baseline for the entirety of the 8 h postprandial period [21]. It is possible that co-consumption of
the yogurt or soy pudding in the present study delayed the peak plasma protein and SH
elevations that are expected in response to excess energy intake. It is also possible that both the
yogurt and soy pudding were successful in reducing postprandial elevations in SH. A second
study using a non-dairy, non-soy control would be necessary to examine this hypothesis.
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There are also discrepancies in the literature regarding the meaning of changes in plasma SH.
There are natural cyclic variations in plasma thiols throughout the day, though these cycles are
not uniform for each thiol. Cysteine (Cys) tends to increase throughout the day, with lowest
concentrations typically occurring very early in the morning [27]. Oxidized cysteine (cystine –
CysS) fluctuates on a 12 h cycle rather than a 24 h cycle, with maximal values at approximately
noon and midnight [27]. Glutathione (GSH) is on a cycle similar to Cys but delayed by about 6
h, while oxidized glutathione (GSSG) does not appear to fluctuate in such a fashion [27]. The
highest concentration of GSH is measured just after waking; this may be suggestive of a
restoration of the antioxidant capacity of plasma during the overnight fast. It also indicates that
the oxidative burden inflicted by a high-calorie, high-fat meal may be better handled by the body
when the meal is consumed in the morning. This would be an interesting topic to explore in
future research.
It has also been suggested that, following depletion of plasma SH, more thiols (in particular
GSH) are released into the bloodstream to restore antioxidant balance. In particular, Cys is
preferentially oxidized in the plasma in the postprandial state [21]. This reduction in Cys is
counteracted by an increase in GSH release [21]. In fact, an increase in oxidative stress
upregulates genes associated with GSH synthesis [28]. Therefore, an increase in plasma SH may
represent increased antioxidant capacity of the plasma in response to increased oxidative stress.
Because of the natural daily variation in SH, as well as the ability of the body to maintain tight
control over plasma thiol concentrations, changes in fasting thiols were expected to be minimal.
This was the case, as the only significant difference was a reduction in fasting SH at week 5 in
the OS group. However, this reduction was short-lived. It is possible that daily intake of the soy
pudding increased oxidative stress in this group and that, following more sustained consumption,
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the body adapted by increasing plasma SH. Fasting SH also slightly, but insignificantly,
increased in the OY group. This may be representative of an increased antioxidant capacity as a
result of the yogurt. However, it also may be indicative of the body compensating for yogurtinduced oxidative stress by increasing plasma SH. More research is needed to clarify the
mechanisms behind these changes. It would also be prudent to examine changes in individual
thiol species in relation to yogurt and soy pudding consumption.
4.4.3 Plasma advanced glycation endproducts
AGEs are formed by the non-enzymatic reaction of aldehydes with exposed amino groups on
lipids (including plasma lipoproteins), proteins (such as collagen), and nucleic acids [29-32]. The
result is the formation of covalently-modified adducts. Endogenously, glucose is the most
common aldehyde involved in advanced glycation endproduct (AGE) formation [29]. Therefore,
increased concentrations of AGEs are associated with elevations in plasma glucose in cases of
impaired glucose metabolism or in the postprandial period [11]. AGEs also increase in the
postprandial period in response to AGEs provided by the diet, particularly in foods that are fried,
grilled, or broiled [31]. Therefore, the high-calorie, high-fat meal in the present study was
hypothesized to increase plasma AGEs in the postprandial period.
Interestingly, there were no significant changes in postprandial AGE concentration following coconsumption of either the yogurt or soy pudding with the high-calorie, high-fat meal. There were
also no changes in fasting AGEs as a result of the intervention. It is possible that a 4 h
postprandial examination was not sufficient to detect changes in plasma AGEs. It is also possible
that the components of the meal exerted opposing effects on AGEs. For example, milk
consumption is known to minimize postprandial elevations in glucose, which would tend to
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reduce postprandial AGE formation [15, 19]. However, the meal used in the present study likely
contained a high concentration of AGEs. In addition, the low-fat yogurt and soy pudding
contributed large amounts of carbohydrates, which may have exacerbated the postprandial
glucose response, blunting any benefits of the other components of the yogurt that may have
helped to reduce postprandial hyperglycemia.
Though carbohydrate intake increased in the OY group, as discussed in Chapter 3, there was no
increase in fasting AGE concentration. This suggests that perhaps the daily low-fat yogurt
consumption was able to minimize the increase in AGE formation that would be expected with
increased carbohydrate intake. It would be interesting to examine the long-term effects of
consumption of low-fat yogurt versus a non-dairy high-carbohydrate snack to determine whether
yogurt provides a long-term benefit to plasma AGE concentration. It would also be interesting to
conduct an intervention similar to the present study but using a lower carbohydrate yogurt.
Despite the high sugar content of low-fat yogurt in the present study, consumption did not have
any negative impacts on AGEs or oxidative stress in obese women. This is important, as many
individuals do not consume the requisite amounts of calcium, vitamin D, or dairy products [33,
34]. In particular, there is an association between BMI and dairy intake, such that individuals
with higher BMIs tend to consume less dairy and calcium [35]. However, research supports an
association between dairy intake and numerous beneficial health outcomes, including weight
maintenance, additional weight loss when paired with a calorie-restricted diet, and reduced
incidence of high blood pressure, type-2 diabetes, and other metabolic disturbances [35-40].
Therefore, low-fat yogurt would be a beneficial addition to the diet. Participants in the present
study showed no increases in BMI or waist circumference with daily low-fat yogurt intake. More
importantly, while low-fat yogurt did not lower fasting or postprandial oxidative stress, it also
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did not have a negative impact on these parameters. Therefore, low-fat yogurt could be added to
the diet to increase calcium and dairy intake without negatively impacting BMI or oxidative
stress in obese women.
4.4.4 Strengths and limitations
It is important to note that the examination of oxidative stress conducted in the present study is
not representative of overall oxidative status. There are numerous biomarkers of oxidative stress,
including urinary isoprostanes, 8-deoxyguanosine (a measure of DNA oxidative damage), uric
acid, oxidized LDL, and the endogenous antioxidant enzymes, including catalase, GPx, and SOD
[2, 21, 41, 42]. Taken together, all of these biomarkers would be more representative of overall
oxidative stress than the three examined in the present study. Therefore, though soy pudding
appeared to have moderate beneficial impacts on postprandial lipid peroxidation and low-fat
yogurt neither favorably nor unfavorably altered postprandial and fasting oxidative stress, it is
important to consider that the outcomes of the present study do not provide a comprehensive
picture of oxidative stress. Nevertheless, these outcomes do provide a basis for future study.
A strength of the present study is the use of a commercially-available low-fat yogurt that is
representative of most marketed low-fat yogurts. Because chronic consumption of this low-fat
yogurt did not unfavorably alter oxidative stress levels, it could serve as an addition to the diet in
order to increase calcium, Vitamin D, and dairy intake. However, the high carbohydrate content
of this yogurt may have masked the potential benefits of regular consumption. Previous studies
link dairy intake with many beneficial health outcomes, including reductions in oxidative stress
[43, 44]. This was partly confirmed by the present study, as the intervention appeared to inhibit
fasting and postprandial increases in MDA and AGEs and decreases in SH.
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Probiotics are also known to impact intestinal health, and may have indirect antioxidant activity,
by increasing synthesis of antioxidant enzymes [45-47]. The intestinal microbiota profile may
also be altered in association with obesity and other metabolic disturbances; this is reviewed in
detail elsewhere [48]. Though probiotic intake was not examined in the present study, it seems
plausible that they may affect biomarkers relevant to this study; this should be examined further
in relation to yogurt consumption. However, the yogurt used in the present study was fairly low
in probiotics in comparison to other commercial yogurts. Nestel, et al. found 3-week intake of a
fermented dairy diet to be associated with decreases in certain inflammatory biomarkers [36].
Therefore, consumption of a higher-probiotic yogurt may provide additional health benefits.
A limitation of the present study is that we did not account for where the women were in their
menstrual cycles. Due to the antioxidant capabilities of estrogen, baseline oxidative stress levels
fluctuate throughout the cycle [49]. Indeed, TBA-reactive substances were found to be highest
during the luteal phase of the cycle. Future studies should ensure that women begin and end the
intervention in the same phase of their cycles to eliminate the potential confounding effects of
these natural fluctuations.
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Figure 4.1. Initial postprandial changes in plasma MDA in obese women following coconsumption of low-fat yogurt or soy pudding with a high-calorie, high-fat meal. OY = obese
yogurt (n = 15); OS = obese soy (n = 15). (a) Mean group MDA values in OY and OS groups.
Data are mean ± SEM. Between-group analysis by two-way repeated measures ANOVA; P =
0.0129 for time effect, P = 0.0003 for treatment effect, and P = 0.1331 for time-treatment
interaction. *P < 0.05 from OS by unpaired t-test. (b) Mean individual MDA changes from
fasting values in OY and OS groups. Data are mean ± SEM. Between-group analysis by two-way
repeated measures ANOVA; P = 0.0186 for time effect, P > 0.05 for treatment effect and timetreatment interaction. Within-group analysis by paired t-test; * P = 0.05 from OS, † P < 0.10
from OS by unpaired t-test.
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Figure 4.2. Postprandial changes in plasma MDA in obese women following co-consumption of
yogurt or soy pudding and a high-calorie, high-fat meal prior to (initial) and following (final) 9week daily 12 oz. low-fat yogurt or soy pudding consumption. OY = obese yogurt (n = 15); OS =
obese soy (n = 15). (a) Initial (week 2) and final (week 11) postprandial changes in MDA in the
OY group. Data are mean ± SEM. P > 0.05 by two-way repeated-measures ANOVA. (b) Initial
(week 2) and final (week 11) postprandial changes in MDA in the OS group. Data are mean ±
SEM. Analysis by two-way repeated-measures ANOVA; P = 0.0359 for time effect, P = 0.0248
for treatment effect, and P = 0.0677 for their interaction. Within-group analysis by paired t-test.
* P < 0.05 from fasting.
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Figure 4.3. Postprandial plasma MDA change from fasting area under the curve (AUC) in obese
women following co-consumption of low-fat yogurt or soy pudding and a high-calorie, high-fat
meal prior to (initial) and following (final) 9-week daily intake of 12 oz. of low-fat yogurt or soy
pudding. OY = obese yogurt (n = 15); OS = obese soy (n = 15). Data are mean ± SEM. Betweengroup analysis by two-way repeated measures ANOVA; P > 0.05 for time effect, treatment
effect, and their interaction.
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Figure 4.4. Initial postprandial total plasma proteins in obese women following co-consumption
of low-fat yogurt and a high-calorie, high-fat meal. n = 3. Data are mean ± SEM. By one-way
ANOVA, P > 0.05.

139

Fasting MDA
Concentration (mg/dL)

2.0

§

§

1.5

OY
OS
§

*

1.0

*

0.5
0.0
2

5

8

11

Week

Figure 4.5. Fasting plasma MDA concentrations in obese women prior to (week 2), during
(weeks 5 and 8), and after (week 11) 9-week daily consumption of low-fat yogurt or soy
pudding. OY = obese yogurt (n = 15); OS = obese soy (n = 15). Data are mean ± SEM. By twoway, repeated measures ANOVA, P = 0.0179 for time effect, P = 0.0346 for treatment effect,
and P = 0.0470 for their interaction. * P < 0.05 from OY by unpaired t-test and § P < 0.05 from
baseline by paired t-test.
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Figure 4.6. Change in fasting plasma MDA from week 2 in obese women during (weeks 5 and
8), and after (week 11) 9-week daily consumption of 12 oz. of low-fat yogurt or soy pudding.
OY = obese yogurt (n = 15); OS = obese soy (n = 15). Data are mean ± SEM. Between group
analysis by two-way repeated measures ANOVA; P = 0.0179 for time effect, P = 0.0163 for
treatment effect, and P = 0.0470 for their interaction. * P < 0.05 from OY by paired t-test.

141

Postprandial Total Thiols
Concentration (mM)

0.35

OY Initial
OY Final
OS Initial
OS Final

0.34
0.33
0.32
0.31
0.30
0.29
0.28
0

1

2

3

4

Time (hr)

Figure 4.7. Postprandial SH concentration in obese women following co-consumption of low-fat
yogurt or soy pudding and a high-calorie, high-fat meal prior to (initial) and following (final) 9week daily 12 oz. low-fat yogurt or soy pudding consumption. OY = obese yogurt (n = 15); OS =
obese soy (n = 15). Data are mean ± SEM. Between-group analysis by two-way repeated
measures ANOVA; P = 0.0028 for time effect, P > 0.05 for treatment effect and time-treatment
interaction.
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Figure 4.8. Initial postprandial plasma SH concentrations in obese women. OY = obese yogurt
(n = 15), OS = obese soy (n = 15). (a) Postprandial SH following co-consumption of soy pudding
and a high-calorie, high-fat meal. Data are mean ± SEM. * P < 0.05 from fasting by paired t-test.
(b) Postprandial plasma SH in obese women following co-consumption of low-fat yogurt or soy
pudding and a high-calorie, high-fat meal. Data are mean ± SEM. Between-group analysis by
two-way repeated measures ANOVA; * P < 0.05 from OS by unpaired t-test.
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Figure 4.9. Postprandial SH AUC in obese women following co-consumption of soy pudding
and a high-calorie, high-fat meal following a 2-week washout period in which all probioticcontaining foods were avoided and dairy consumption was limited to < 4 servings/day. OY =
obese yogurt (n = 15); OS = obese soy (n = 15). Data are mean ± SEM. Between-group analysis
by two-way repeated measures ANOVA; P > 0.05 for treatment effect, time effect, and their
interaction. † P < 0.10 from OY Initial by unpaired t-test.
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Figure 4.10. Fasting SH concentration in obese women prior to (week 2), during (weeks 5 and
8), and after (week 11) 9-week daily consumption of low-fat yogurt or soy pudding. OY = obese
yogurt (n = 15); OS = obese soy (n = 15). Data are mean ± SEM. Between-group analysis by
two-way repeated measures ANOVA; P > 0.05 for time effect and treatment effect, P = 0.0167
for time-treatment interaction. * P < 0.05 (OS week 5 from OS week 2) by paired t-test, † P <
0.10 from OS by unpaired t-test.
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Figure 4.11. Postprandial plasma AGEs in obese women following co-consumption of low-fat
yogurt or soy pudding and a high-calorie, high-fat meal prior to (initial) and following (final) 9week daily intake of 12 oz. of low-fat yogurt or soy pudding. OY = obese yogurt (n =15); OS =
obese soy (n = 15). Between-group analysis by two-way repeated measures ANOVA; P > 0.05
for time effect, treatment effect, and their interaction.
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Figure 4.12. Change from fasting area under the curve (AUC) of postprandial plasma AGEs in
obese women following co-consumption of low-fat yogurt or soy pudding and a high-calorie,
high-fat meal prior to (initial) and following (final) 9-week daily intake of 12 oz. of low-fat
yogurt or soy pudding. OY = obese yogurt (n = 15); OS = obese soy (n = 15). Data are mean ±
SEM. Between-group analysis by two-way repeated measures ANOVA; P > 0.05 for time effect,
treatment effect, and their interaction.
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Figure 4.13. Fasting plasma AGEs in obese women prior to (week 2), during (weeks 5 and 8),
and after (week 11) 9-week daily consumption of low-fat yogurt or soy pudding. OY = obese
yogurt (n = 15); OS = obese soy (n = 15). Data are mean ± SEM. Between-group analysis by
two-way repeated measures ANOVA; P > 0.05 for time effect, treatment effect, and their
interaction.

148

4.7 References
[1] Bowen, P. E., Borthakur, G., Postprandial lipid oxidation and cardiovascular disease risk.
Curr Atheroscler Rep 2004, 6, 477-484.
[2] Droge, W., Free radicals in the physiological control of cell function. Physiol Rev 2002, 82,
47-95.
[3] Mates, J. M., Segura, J. A., Alonso, F. J., Marquez, J., Intracellular redox status and oxidative
stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol 2008, 82,
273-299.
[4] Hollman, P. C., Cassidy, A., Comte, B., Heinonen, M., et al., The biological relevance of
direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J
Nutr 2011, 141, 989S-1009S.
[5] Offord, E., van Poppel, G., Tyrrell, R., Markers of oxidative damage and antioxidant
protection: current status and relevance to disease. Free Radic Res 2000, 33 Suppl, S5-19.
[6] Roberts, L. J., Morrow, J. D., Measurement of F(2)-isoprostanes as an index of oxidative
stress in vivo. Free Radic Biol Med 2000, 28, 505-513.
[7] Lykkesfeldt, J., Determination of malondialdehyde as dithiobarbituric acid adduct in
biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible
spectrophotometry. Clin Chem 2001, 47, 1725-1727.
[8] Draper, H. H., Hadley, M., Malondialdehyde determination as index of lipid peroxidation.
Methods Enzymol 1990, 186, 421-431.
[9] Hu, M. L., Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol
1994, 233, 380-385.
[10] Muttigi, M. S., Kedage, V., Suvarna, R., Rao, S. S., et al., Serum. Serum GST Activity and
Total Thiols Status in Patients with Liver Disease Secondary to Various Disorders 2009, 1, 5-8.
[11] Gaens, K. H., Stehouwer, C. D., Schalkwijk, C. G., Advanced glycation endproducts and its
receptor for advanced glycation endproducts in obesity. Curr Opin Lipidol 2013, 24, 4-11.
[12] Nielsen, F., Mikkelsen, B. B., Nielsen, J. B., Andersen, H. R., Grandjean, P., Plasma
malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style
factors. Clin Chem 1997, 43, 1209-1214.
[13] Haddad, E. H., Gaban-Chong, N., Oda, K., Sabate, J., Effect of a walnut meal on
postprandial oxidative stress and antioxidants in healthy individuals. Nutr J 2014, 13, 4.
[14] Hudthagosol, C., Haddad, E. H., McCarthy, K., Wang, P., et al., Pecans acutely increase
plasma postprandial antioxidant capacity and catechins and decrease LDL oxidation in humans. J
Nutr 2011, 141, 56-62.
149

[15] Ballard, K. D., Mah, E., Guo, Y., Pei, R., et al., Low-fat milk ingestion prevents
postprandial hyperglycemia-mediated impairments in vascular endothelial function in obese
individuals with metabolic syndrome. J Nutr 2013, 143, 1602-1610.
[16] Nambiar, S., Viswanathan, S., Zachariah, B., Hanumanthappa, N., et al., Possible
modulation of glycated protein levels in prehypertension by lipid peroxides. Clin Exp Hypertens
2012, 34, 517-522.
[17] Bloomer, R. J., Fisher-Wellman, K. H., Lower postprandial oxidative stress in women
compared with men. Gend Med, 7, 340-349.
[18] Tripathi, P., Pandey, S., L-arginine attenuates oxidative stress condition during
cardiomyopathy. Indian J Biochem Biophys 2013, 50, 99-104.
[19] van Meijl, L. E., Mensink, R. P., Effects of milk and milk constituents on postprandial lipid
and glucose metabolism in overweight and obese men. Br J Nutr 2013, 110, 413-419.
[20] Ceriello, A., Quagliaro, L., Piconi, L., Assaloni, R., et al., Effect of postprandial
hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress
generation and the possible role of simvastatin treatment. Diabetes 2004, 53, 701-710.
[21] Miglio, C., Peluso, I., Raguzzini, A., Villano, D. V., et al., Antioxidant and inflammatory
response following high-fat meal consumption in overweight subjects. Eur J Nutr 2013, 52,
1107-1114.
[22] Zemel, M. B., Sun, X., Sobhani, T., Wilson, B., Effects of dairy compared with soy on
oxidative and inflammatory stress in overweight and obese subjects. Am J Clin Nutr 2009, 91,
16-22.
[23] Lorenzen, J. K., Nielsen, S., Holst, J. J., Tetens, I., et al., Effect of dairy calcium or
supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy
intake. Am J Clin Nutr 2007, 85, 678-687.
[24] Akhavan, T., Luhovyy, B. L., Brown, P. H., Cho, C. E., Anderson, G. H., Effect of premeal
consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and
insulin responses in young adults. Am J Clin Nutr 2010, 91, 966-975.
[25] Westphal, S., Kastner, S., Taneva, E., Leodolter, A., et al., Postprandial lipid and
carbohydrate responses after the ingestion of a casein-enriched mixed meal. Am J Clin Nutr
2004, 80, 284-290.
[26] Govers, M. J., Van der Meet, R., Effects of dietary calcium and phosphate on the intestinal
interactions between calcium, phosphate, fatty acids, and bile acids. Gut 1993, 34, 365-370.
[27] Blanco, R. A., Ziegler, T. R., Carlson, B. A., Cheng, P. Y., et al., Diurnal variation in
glutathione and cysteine redox states in human plasma. Am J Clin Nutr 2007, 86, 1016-1023.
[28] Lu, S. C., Regulation of glutathione synthesis. Mol Aspects Med 2009, 30, 42-59.
150

[29] Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., et al., Advanced
glycation endproducts in food and their effects on health. Food Chem Toxicol 2013, 60, 10-37.
[30] Vistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., et al., Advanced glycoxidation and
lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.
Free Radic Res 2013, 47 Suppl 1, 3-27.
[31] Uribarri, J., Cai, W., Sandu, O., Peppa, M., et al., Diet-derived advanced glycation end
products are major contributors to the body's AGE pool and induce inflammation in healthy
subjects. Ann N Y Acad Sci 2005, 1043, 461-466.
[32] Koschinsky, T., He, C. J., Mitsuhashi, T., Bucala, R., et al., Orally absorbed reactive
glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl
Acad Sci U S A 1997, 94, 6474-6479.
[33] Fulgoni, V. L., 3rd, Keast, D. R., Auestad, N., Quann, E. E., Nutrients from dairy foods are
difficult to replace in diets of Americans: food pattern modeling and an analyses of the National
Health and Nutrition Examination Survey 2003-2006. Nutr Res 2011, 31, 759-765.
[34] Ross, A. C., The 2011 report on dietary reference intakes for calcium and vitamin D. Public
Health Nutr 2011, 14, 938-939.
[35] Mirmiran, P., Esmaillzadeh, A., Azizi, F., Dairy consumption and body mass index: an
inverse relationship. Int J Obes (Lond) 2005, 29, 115-121.
[36] Nestel, P. J., Mellett, N., Pally, S., Wong, G., et al., Effects of low-fat or full-fat fermented
and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults. Br J
Nutr 2013, 110, 2242-2249.
[37] Lamarche, B., Review of the effect of dairy products on non-lipid risk factors for
cardiovascular disease. J Am Coll Nutr 2008, 27, 741S-746S.
[38] Esmaillzadeh, A., Azadbakht, L., Dairy consumption and circulating levels of inflammatory
markers among Iranian women. Public Health Nutr 2009, 13, 1395-1402.
[39] Zemel, M. B., Shi, H., Greer, B., Dirienzo, D., Zemel, P. C., Regulation of adiposity by
dietary calcium. FASEB J 2000, 14, 1132-1138.
[40] Fumeron, F., Lamri, A., Abi Khalil, C., Jaziri, R., et al., Dairy consumption and the
incidence of hyperglycemia and the metabolic syndrome: results from a french prospective
study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
Diabetes Care 2011, 34, 813-817.
[41] Sies, H., Stahl, W., Sevanian, A., Nutritional, dietary and postprandial oxidative stress. J
Nutr 2005, 135, 969-972.

151

[42] Campbell, C. G., Brown, B. D., Dufner, D., Thorland, W. G., Effects of soy or milk protein
during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men.
Lipids 2006, 41, 257-265.
[43] Stancliffe, R. A., Thorpe, T., Zemel, M. B., Dairy attentuates oxidative and inflammatory
stress in metabolic syndrome. Am J Clin Nutr 2011, 94, 422-430.
[44] Panagiotakos, D. B., Pitsavos, C. H., Zampelas, A. D., Chrysohoou, C. A., Stefanadis, C. I.,
Dairy products consumption is associated with decreased levels of inflammatory markers related
to cardiovascular disease in apparently healthy adults: the ATTICA study. J Am Coll Nutr 2010,
29, 357-364.
[45] Ebringer, L., Ferencik, M., Krajcovic, J., Beneficial health effects of milk and fermented
dairy products--review. Folia Microbiol (Praha) 2008, 53, 378-394.
[46] Tuohy, K. M., Probert, H. M., Smejkal, C. W., Gibson, G. R., Using probiotics and
prebiotics to improve gut health. Drug Discov Today 2003, 8, 692-700.
[47] Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., et al., Gut microbiota from twins
discordant for obesity modulate metabolism in mice. Science 2013, 341, 1241214.
[48] Chen, J., He, X., Huang, J., Diet effects in gut microbiome and obesity. J Food Sci 2014, 79,
R442-451.
[49] Karowicz-Bilinska, A., Plodzidym, M., Krol, J., Lewinska, A., Bartosz, G., Changes of
markers of oxidative stress during menstrual cycle. Redox Rep 2008, 13, 237-240.

152

Chapter 5:
Conclusions and Future Directions
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5.1 Summary of Key Findings
•

Daily intake of 12 oz. of low-fat yogurt or soy pudding did not lead to any changes in
weight, BMI, waist circumference, or blood pressure in lean and obese women.

•

Daily consumption of 12 oz. of low-fat yogurt increased carbohydrate intake by ~15% in
lean and obese women. Soy pudding consumption increased carbohydrate intake in lean
women only by ~15%. Low-fat yogurt consumption also significantly decreased protein
and cholesterol intake in obese women.

•

Daily low-fat yogurt consumption increased vitamin D and calcium intake in lean and
obese women. Daily consumption of fortified soy pudding also increased vitamin D
intake in lean and obese women and calcium intake in lean women. However, vitamin D
intake in lean and obese women in both groups still fell well below the RDA.

•

Daily low-fat yogurt consumption increased intake of dairy products by ~1 serving/day in
lean and obese women. However, intake still fell below the recommended 3 servings/day.

•

Daily low-fat yogurt and soy pudding consumption decreased vitamin C intake in lean
women. Fruit intake also decreased in the LY and OY groups. Vegetable intake
decreased in the LY and LS groups.

•

Co-consumption of low-fat yogurt with a high-calorie, high-fat meal resulted in no
significant changes in MDA, SH, or AGEs in the postprandial period, suggesting the lowfat yogurt may attenuate the postprandial response in obese women. However, 9-week
daily consumption of low-fat yogurt did not further attenuate this response. Likewise,
daily yogurt intake did not alter baseline levels of MDA, SH, or AGEs in obese women.

•

Co-consumption of soy pudding with a high-calorie, high-fat meal did not attenuate the
postprandial MDA response at week 2. However, at week 11, postprandial MDA was
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significantly decreased compared to week 2 at 2, 3, and 4 h postprandially. Conversely,
9-week daily intake of soy pudding increased baseline levels of MDA in obese women.
In summary, addition of low-fat yogurt to the diet of lean and obese women increased the intake
of calcium and vitamin D, two nutrients which are not consumed in adequate amounts by many
women [1]. Low-fat yogurt also increased dairy intake by ~1 serving/day in lean and obese
women. Though the recommendations for vitamin D and dairy intake were still not met as a
result of this intervention, low-fat yogurt could be added to the diet in concert with other dairy
products and foods containing vitamin D to help meet recommendations. However, nutritional
counseling should be provided to participants to avoid reductions in fruit and vegetable
consumption as a result of the increased dairy intake.
Furthermore, the addition of low-fat yogurt to the diet did not alter BMI, waist circumference, or
blood pressure, parameters that are of particular importance to obese women. Co-consumption of
low-fat yogurt and a high-calorie, high-fat meal led to suppression of postprandial increases in
MDA and AGEs and depletions in SH in obese women at both the initial and final study visits.
Sustained intake of soy pudding resulted in small reductions in postprandial MDA from week 2
to week 11; however daily soy pudding intake increased baseline MDA, suggesting that total
exposure to MDA was likely unchanged. Conversely, sustained low-fat yogurt consumption
showed no effect on chronic levels of oxidative stress in obese women; fasting MDA, SH, and
AGEs were unaffected by daily intake. Therefore, addition of low-fat yogurt to the diet of obese
women could be employed as a strategy to increase vitamin D, calcium, and dairy intake without
any unfavorable changes in body composition, blood pressure, and postprandial or chronic levels
of oxidative stress.
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5.2 Future Directions
Previous epidemiological and intervention studies support an association between adequate
dairy, calcium, and vitamin D intake and numerous favorable health outcomes. In addition, dairy
intake decreases oxidative stress in overweight and obese individuals [2, 3]. However, much
remains unknown regarding this association. For example, the impact of consumption of
individual dairy products on oxidative stress has not been elucidated. Furthermore, though dairy
products contain calcium, vitamin D, protein, whey, casein, numerous bioactive peptides, and
probiotics, the effects of these components, alone and in tandem, are unknown. Furthermore, the
mechanisms responsible for observed reductions in oxidative stress are not well understood.
Future studies should examine the impact of other types of low-fat yogurt on postprandial and
chronic oxidative stress, particularly those products lower in carbohydrates and higher in
probiotics. In the present study, fruit and vegetable intake decreased in some of the study groups
as a result of the intervention. Moreover, the addition of low-fat yogurt to the diet raised dairy
intake by ~1 serving per day and increased vitamin D intake; however, neither of these increases
were sufficient to reach recommendations. Therefore, intervention studies should also be
conducted to examine the impacts of low-fat yogurt intake as a part of a diet rich in fruits and
vegetables. Studies should also incorporate the consumption of low-fat yogurt with other dairy
products and/or foods rich in vitamin D. Finally, future studies should include more
comprehensive measurements of oxidative stress, including not only the markers used in this
study but also the examination of urinary isoprostanes and 8-deoxyguanosine, as well as
endogenous antioxidant enzyme activity.
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